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ABSTRACT 
ADDRESSING THE ISSUES OF DRUG DELIVERY VIA ADVANCED 
MACROMOLECULAR DESIGN 
by Brooks Allen Abel 
May 2016 
 The work described in this dissertation focuses on the development of synthetic 
approaches toward novel polymer architectures that specifically address the issues of in 
vivo drug delivery. Successful implementation of the synthetic methodologies described 
herein required fundamental investigations into the underlying chemistries in ways that 
now provide greater insights into the nature of the these chemical reactions. 
 In Section I, the synthesis of tunable pH- and CO2-responsive sulfonamide-
containing polymers using reversible addition-fragmentation chain transfer (RAFT) 
polymerization is described. Initially, poor polymerization control of methacryloyl 
sulfonamide (MSA) monomers was observed using traditional RAFT polymerization 
conditions. Ultimately, reducing the polymerization temperature to 30 °C afforded 
polymers of controlled molecular weights and low dispersities. A library of sulfonamide-
containing polymers was subsequently synthesized and their tunable pH-responsive and 
reversible CO2-responsive aqueous solution properties investigated. 
 The work in Section II provides mechanistic understanding of the limited 
molecular weight control observed during the RAFT polymerization of MSAs at 70 °C 
(from Section I). This work demonstrates the unique influence of N-arylmethacrylamide 
substitution on trithiocarbonate chain-end degradation during RAFT polymerization at 
elevated temperatures. Detailed kinetic and structural analysis of RAFT polymer small 
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molecule analogs showed trithiocarbonate chain-end degradation occurs by N-5 
nucleophilic attack on the terminal thiocarbonyl by the ultimate methacrylamide unit. On-
going work regarding the development of a mechanistic and kinetic theory aimed at 
explaining the unique influence of N-arylsubstitution on amide nucleophilicity is further 
discussed in Appendix B. 
 In section III we investigate deleterious side reactions that occur during “one-pot” 
aminolysis/thiol-maleimide end group modification of RAFT polymers. Commonly 
employed thiol-ene Michael catalysts including amines, amidines, and phosphines were 
demonstrated to initiate the anionic polymerization of maleimide in a range of organic 
solvents, resulting in reduced RAFT polymer end group functionalization efficiency. 
Additionally, thiols and thiol-maleimide adducts were shown to initiate maleimide 
polymerization in polar solvents in the presence of triethylamine (TEA). Reaction 
conditions which favor rapid and quantitative end group functionalization of RAFT 
polymers using “one-pot” aminolysis/thiol-maleimide chemistry were ultimately 
identified. 
 Section IV details a new “grafting through” synthetic route towards molecular 
brushes capable of intracellular-induced disassembly. RAFT polymer-derived 
macromonomers were synthesized using “one-pot” aminolysis/thiol reactions with 
maleimide- or methanethiosulfonate-functional oxanorbornenes. Subsequent ring opening 
metathesis polymerization (ROMP) of the resulting macromonomers afforded molecular 
brushes with RAFT polymer side chains attached to a polyoxanorbornene backbone via 
either permanent thioether linkages or reversible disulfide linkages. Molecular brushes 
iv 
 
comprised of disulfide linkages were shown to undergo reduction-induced disassembly 
and show promise as a new class of stimuli-responsive polymer therapeutics.  
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CHAPTER I 
INTRODUCTION 
Pharmacologically Active Polymers 
Barriers to Polymer-Facilitated Drug/Gene Delivery 
 The “depot” model (Figure 1.1), first proposed by Helmut Ringsdorf in 1975, has 
been the basis of design for many polymer therapeutics.1 According to this model, 
Ringsdorf proposed the use of a modifiable polymer scaffold that would incorporate four 
major components including i) a water-soluble and biocompatible polymer backbone, ii) 
targeting moiety/diagnostic agent, iii) therapeutic agent, and iv) a degradable spacer for 
reversible attachment of the therapeutic agent. Various interpretations of this approach to 
polymer-facilitated drug delivery have since yielded many new solutions to addressing 
the issues associated with drug delivery. However, successful implementation of the 
idealized “depot” model has proven difficult, largely due to synthetic challenges and the 
complex nature of in-vivo drug delivery.2 
 
 
Figure 1.1. Ringsdorf “depot” model of idealized polymer-based therapeutic. 

2 
 
 
 There are numerous barriers associated with polymer-facilitated cytosolic delivery 
of chemo- and gene-based therapeutics that must be overcome in order for polymer-based 
therapeutics to be a viable treatment option in-vivo.3–9 These barriers include i) 
therapeutic agent degradation, ii) vascular circulation, iii) cell-specific targeting, iv) 
cellular internalization, v) endosomal escape, vi) controlled release of the therapeutic 
agent in its active form, and vii) polymer clearance/elimination from the body. The drug 
delivery “vehicle” must also be simultaneously biocompatible and non-immunogenic. 
Numerous polymer-based approaches have been developed to specifically address each 
of these issues with regard to drug/gene delivery but with varying degrees of success 
owing to the complex nature of drug delivery. Fully understanding each barrier to drug 
delivery is crucial to designing successful polymer therapeutics. 
Therapeutic Agent Protection and Enhanced Vascular Circulation 
 Small molecule drug use in-vivo is largely inefficient due to rapid renal clearance 
in the kidneys and/or liver.10,11 The reduced circulation half-lives of small molecule drugs 
necessitate high initial dosages and frequent administration which can result in 
unintended drug-induced side effects. In-vivo drug degradation also results in reduced 
therapeutic efficacy and may result in complete inhibition of therapeutic activity. For 
example, the extracellular half-life of unprotected small interfering ribonucleic acid 
(siRNA) is 3-5 minutes, making direct delivery of “naked” siRNA therapeutics 
completely ineffective.12 It is therefore desirable to extend the circulation half-life of 
small molecule and nucleotide-based therapeutics by preventing degradation and 
increasing vascular retention. 
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 Some of the earliest polymeric delivery vehicles encapsulated or sequestered 
therapeutic agents inside liposomes or micellar-like structures which simultaneously 
protected the therapeutic agent from degradation while also increasing circulation time 
before ultimate renal clearance.13–15 However, these approaches did not specifically target 
cells, but rather relied upon non-specific cellular uptake and the enhanced permeation and 
retention (EPR) effect to direct the delivery vehicle to tumoral tissues.16–20 As illustrated 
in Figure 1.2, the EPR effect enhances polymeric drug accumulation in tumoral tissue 
due to the combination of a leaky vascular system and poorly formed lymphatic drainage 
system, which are characteristic of rapidly growing tumors. In contrast, polymer 
therapeutics tend not to accumulate in healthy tissues due to tight endothelial junctions 
and improved lymphatic drainage compared to tumoral tissue. 
 
Figure 1.2. Enhanced permeation and retention (EPR) effect.21 

 Interpolyelectrolyte complex (IPEC) formation is a commonly used strategy to 
electrostatically bind negatively charged oligonucleic acids to cationic polymers, 
effectively shielding the nucleic acid from enzymatic degradation.22–24 Traditionally, an 
excess of cationic charge is used to maintain water solubility of IPECs, but the overall 
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positive charge results in non-specific cellular uptake and high in-vitro and in-vivo 
cytotoxicity.25–27 Recently, overall neutral block ionomer complexes (BICs) comprised of 
neutral-block-cationic copolymers and siRNA have shown adequate protection of siRNA 
while allowing for cell-specific uptake when used with appropriate targeting methods.24,28 
 Other approaches, aimed at improving therapeutic agent circulation time involve 
functionalization of nanoparticles or polymeric scaffolds with biocompatible water-
soluble polymers such as poly(N-(2-hydroxypropyl)methacrylamide) (pHMPMA) or 
poly(ethylene glycol) (PEG).29–32 This effectively shields the drug-containing core of the 
delivery vehicle from eliciting a potential immune response while simultaneously 
protecting the therapeutic agent from degradation. 
 The ultimate goal of limiting therapeutic agent degradation while increasing the 
circulation half-life of the delivery vehicle is to allow for suitable time to reach the site of 
intended therapeutic action. To this end, the EPR effect can be exploited as a passive 
tumor targeting mechanism; however, this approach will not specifically target any cell 
of interest when well-defined tumors are not present and does not facilitate cell-specific 
internalization. Therefore, to improve drug delivery specificity and avoid therapeutic 
accumulation in healthy tissue, a cell-specific and preferably modifiable targeting 
strategy is desired. 
Cell-Specific Targeting 
 Polymeric drug carriers can be modified to contain targeting moieties through end 
group functionalization, incorporation along the polymer backbone, or side chains.33 
Availability of the targeting moiety on the surface of the polymer-drug conjugate is 
necessary to ensure appropriate contact with surface receptors expressed on the exteriors 
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of targeted cells. Common targeting moieties include antibodies and antibody fragments, 
peptides, oligosaccharides, and folate among others.34–41 Antibodies represent a versatile 
targeting agent since it is possible to produce an antibody that can uniquely bind to a 
corresponding antigen expressed on any cell-type. Then, by conjugating the antibody to 
the polymer therapeutic, the delivery vehicle can be specifically targeted to the desired 
cell-type. It is also possible to cleave and isolate the variable regions of the antibody 
known as the fragment antigen binding (Fab) regions, which reduces the entire size of the 
targeting moiety from ~150 kDa per antibody to ~50 kDa per Fab.42,43 Kopecek and 
coworkers have shown that Fab-targeted polymer therapeutics promote a 3-fold reduction 
in tumor size compared to the non-targeted therapeutics that relied exclusively upon the 
EPR effect for passive tumor targeting.44 Despite their specificity, antibodies and Fab 
fragments are often recognized as being foreign biological molecules and can induce an 
immunological response that results in rapid elimination/degradation of the targeting 
moiety and the attached polymer therapeutic.  
 The use of oligosaccharides represents another attractive targeting option since all 
cells express saccharide-binding proteins on their surfaces called lectins.45 Due to the 
large number of unique possible combinations of sugar residues in oligosaccharides, 
specific cellular targeting is possible if a unique lectin-oligosaccharide binding 
interaction is known for a particular cell-type. Although lectins exhibit high specificity of 
recognition, not all lectins induced cellular internalization of bound oligosaccharides such 
that an additional means of cellular internalization would be needed. 
 Folate-targeted polymer therapeutics have been used extensively in-vitro and in-
vivo.22,46,47 Folic acid is an essential vitamin required by cells and several cancer cell-
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types are known to over-express folic acid receptors. Furthermore, folate is readily 
available compared to specifically targeted antibodies and other biomacromolecules 
which are more difficult to prepare and isolate. Despite the targeting method used, the 
polymer therapeutic must also be internalized by the cell. In some instances, the mode of 
targeting can result in cellular internalization, known as “piggy-back endocytosis,” 
whereas other routes require an additional strategy to induce cell entry. 
Cellular Internalization and Endosomal Escape 
 Cellular internalization is most often achieved via endocytosis, the process by 
which a portion of the cell membrane invaginates and separates from the rest of the cell 
membrane, subsequently internalizing extracelluar compounds (Figure 1.3). Endocytosis 
is usually triggered in response to an external stimulus, such as binding of a biomolecule 
to a particular cellular receptor.47,48 This type of cellular entry is known as receptor-
mediated endocytosis and is a readily exploited method to internalize polymer 
therapeutics that target cellular surface receptors. Following endocytosis, the internalized 
polymer therapeutic and extracellular media are isolated in endosomes, accompanied by a 
reduction in pH from physiological (7.4) to early endosomal (pH 6-6.5) to late endosomal 
(pH 5-6).49,50 Within approximately 30 minutes of endocytosis, the endosomes fuse with 
or transform into lysozomes, which contain degradative enzymes that are particularly 
detrimental to most small molecule and nucleic acid-based therapeutics.51 Furthermore, 
endosomes can fuse with the cell membrane via a process known as exocytosis, 
subsequently releasing their contents outside of the cell. For this reason, endosomal 
escape is often cited as the “bottle neck” of intracellular drug delivery thus making 
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escape of polymer-based therapeutics from the endosome prior to lysozomal fusion or 
exocytosis crucial for the successful application of polymer therapeutics. 
 
Figure 1.3. Cellular internalization of polymer therapeutics by endocytosis.1 

 Several methods of endosomal release have been developed that disrupt the 
structural integrity of the endosomal membrane, thus facilitating the release of its 
contents into the cytoplasm. One approach utilizes osmotoic swelling of the endosomal 
vesicle by promoting ion influx into the endosome by a process known as the proton 
sponge effect.52 High buffer capacity polymers such as polyethylene imine (PEI), contain 
a large number of unprotonated amines and can act as “proton sponges” when exposed to 
the acidified environment of the endosome.53 The resulting influx of counterions is 
further accompanied by an influx of water, subsequently swelling the endosome which 
results in either compromised membrane integrity or complete endosomal rupture, 
facilitating release of its contents, polymer therapeutic included. pH-responsive peptides 
and polymers that become hydrophobic at endosomal pH (5.0-6.5) have also been used to 
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destabilize the amphiphilic endosomal membrane facilitating the release of the 
endosomal contents.54–57 Ultimately, the goal of endosomal escape is to release the 
polymer therapeutic into the cytoplasm, where triggered release of the therapeutic agent 
can elicit the desired pharmacological response. 
Therapeutic Release and Ultimate Polymer Fate 
 The final role of a polymer therapeutic is to release the therapeutic agent upon 
cellular internalization. This is typically desired following escape from the endosome to 
avoid unwanted degradation by endosomal and lysosomal enzymes. For example, when 
delivering siRNA, release is preferred in the cytoplasm where it can then directly enter 
into the RNA interference (RNAi) pathway. Therefore, a number of approaches have 
been developed to promote release of therapeutic agents at a desired location within the 
cell. 
 A common strategy for intracellular-induced therapeutic release is to conjugate 
the therapeutic agent to a polymer scaffold using a degradable linkage. The most 
common types of degradable linkages used for intracellular drug release cleave in 
response to changes in pH, redox potential, or enzymatic degradation. Acid-labile 
linkages include esters, carbonates, carbamates, acetals, and hydrazones among others,58–
63 while enzymatically-degradable linkers comprised of specific ester- or peptide-
containing sequences are selectively cleaved by esterases or peptidases, respectively, 
facilitating intracellular therapeutic release.64–66 Disulfide linkages are the primary 
example of a chemical linkage that cleaves upon experiencing a change in redox 
potential.67–69 Glutathione, the most abundant non-protein peptide in mammalian cells, is 
an efficient reducing agent meant to maintain the redox potential inside of the cell by 
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reducing reactive oxygen species but also has been shown to effectively reduce most 
forms of disulfide bonds.70 This type of bond cleavage occurs readily and almost 
exclusively inside of the cytoplasm, which would promote therapeutic release from the 
polymeric carrier only after escaping the endosome. Also, higher levels of glutathione are 
observed in a number of cancer cell types compared to concentrations present in healthy 
tissues, which further promotes the likelihood of disulfide bond cleavage in these cancer 
cells.71 
 After the polymer “vehicle” has delivered its therapeutic payload to the 
appropriate location within the cell, it must be reabsorbed or eliminated from the body to 
avoid toxic in vivo accumulation. This can be accomplished using a polymer therapeutic 
in which the polymer component is partially or entirely degradable, or small enough to be 
excreted whole by the body. Examples of biodegradable polymers include poly(L-
lactide/glycolide),72 polypeptides,73 and polysaccharides.74 These polymers are capable of 
being completely degraded, or can be used as part of larger polymeric scaffolds which are 
reduced in size upon partial degradation of lactide or glycolide linkages, thus facilitating 
polymer clearance from the body. Polymers that are to be secreted based upon size are 
removed by renal filtration in the kidneys and typically must have hydrodynamic 
diameters less than ~15 nm for adequate removal without renal accumulation.75 Thus, 
adequate control over the size of the delivery vehicle is necessary to avoid both rapid 
clearance from the body and to prevent perpetual accumulation by being too large for 
long term elimination to occur. 
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Reversible Addition-Fragmentation Chain Transfer Polymerization 
 The development of reversible-deactivation radical polymerization (RDRP) 
techniques including nitroxide-mediated polymerization (NMP),76,77 atom transfer radical 
polymerization (ATRP),78–81 and reversible addition-fragmentation chain transfer 
(RAFT)82–87 polymerization has made possible the synthesis of polymers with precise 
compositions, predetermined molecular weights, and advanced architectures comprised 
of monomers possessing a wide variety of functional groups. RAFT polymerization is 
arguably the most versatile of the RDRP techniques owing to the increased tolerance of 
protic functional groups and solvents allowing for the polymerization of styrenics, 
(meth)acrylates, (meth)acrylamides, acrylonitriles, vinyl esters, and vinyl amides, in 
organic or aqueous media under homogeneous or heterogeneous conditions. In particular, 
the development of aqueous RAFT (aRAFT) polymerization has allowed for the direct 
synthesis of polymers containing biologically relevant functional groups such as amines, 
carboxylates, phosphates, sulfonates, and betaines among others.88–98 For these reasons, 
RAFT is an ideal polymerization method for the synthesis of advanced polymer-based 
therapeutics. 
The RAFT Mechanism 
 The mechanism of RAFT polymerization is fundamentally different from the 
mechanisms of NMP and ATRP in that the main active/dormant equilibrium is 
established by degenerative chain transfer between active (propagating) and dormant 
chain ends rather than reliance upon the persistent radical effect. Successful degenerative 
chain transfer is achieved when the product of chain transfer is also a chain transfer agent 
of equal or similar reactivity. Operating under these conditions, RAFT polymerization 
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exhibits similarities to pseudo-living polymerizations in that narrow molecular weight 
distributions can be obtained while molecular weight progresses linearly with monomer 
conversion and high chain-end fidelity is maintained throughout the reaction such that 
sequential monomer addition results in the formation of block copolymers. 
 
 
Scheme 1.1. Proposed mechanism of RAFT polymerization. 
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 Like classical free radical polymerization, the first stage in the RAFT process 
involves decomposition of initiator into radicals (Scheme 1.1). However, the fate of 
initiator-derived radicals differs significantly during RAFT polymerization due to the 
presence of a thiocarbonylthio-containing chain transfer agent (CTA). The initiation/pre-
equilibrium stage of RAFT consists of multiple kinetically distinct chain transfer 
reactions. During this period, initiator-derived radicals 1 can either initiate 
polymerization by direct addition to monomer to form the propagating species 3, or add 
directly to CTA 2 to afford the radical intermediate 4. Although the formation of 4 is also 
reversible, eventual fragmentation of the R-group yields a new initiator-derived CTA 9 
and R-group-derived radical 7 capable of adding to monomer to form the propagating 
species 8. Similarly, the initiator-derived propagating species 3 can add to CTA 2 with a 
rate constant kadd to yield the radical intermediate 5. This intermediate can fragment in 
the reverse direction with rate constant k-add or in the forward direction with rate constant 
k to form the macro-CTA 6 and the R-group-derived radical 7, which can add to 
monomer forming the propagating species 8. The pre-equilibrium period is complete 
when CTA 2 has been converted into the corresponding macro-CTA 6. Similar to the 
initiation stage of other controlled/”living” polymerizations where Ri > Rp must be met to 
achieve narrow molecular weight distributions, it is important that the duration of the pre-
equilibrium period during RAFT be suitably short relative to the timescale of propagation 
such that the majority of polymer chains start growing at the same time. 
  Prolonged periods of little or no monomer conversion have often been observed 
during the pre-equilibrium stage of RAFT polymerizations.99 Like conventional radical 
polymerizations, inhibition of RAFT is possible due to the presence of oxygen or other 
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impurities (e.g. thiol impurities originating from the CTA) that consume radicals early in 
the polymerization. Extended pre-equilibrium or inhibition periods in RAFT can also 
occur for certain CTA-monomer combinations because of slow reinitiation by R· due to 
preferred addition to the CTA thiocarbonyl (high k-) rather than addition to monomer 
(low ki).
90,91,100–105 The cause of this initialization phenomena was first elucidated by 
McCleary, Klumperman, and coworkers using in situ 1H NMR analysis during the 2-
cyano-2-propyl dithiobenzoate-mediated polymerization of styrene.106 As seen in Figure 
1.4, complete conversion of the initial dithiobenzoate species (AD) to the corresponding 
single monomer unit adduct (ASD) was required before reaching the main RAFT 
equilibrium and thus observed as a period of minimal monomer conversion. Suppression 
or elimination of prolonged initialization periods can be accomplished by selection of 
CTA R- and Z-groups which favor fragmentation and reinitiation by R· (i.e. R-groups 
that are structurally similar to the propagating radical Pn·). 
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Figure 1.4. Percentage of dithiobenzoate species present during the AIBN-initiated 
polymerization of styrene in the presence of 2-cyano-2-propyl dithiobenzoate (AD).106 
 
 Propagation during the main RAFT equilibrium occurs as it does during 
conventional free radical polymerization where the rate of propagation (Rp) is expected to 
be first order with respect to both the concentration of monomer [M] and propagating 
radicals [Pn·] while independent of [CTA] as seen in equation 1. RAFT polymerizations 
often exhibit pseudo-first-order kinetic behavior when a steady state radical concentration 
is reached where Ri ≈ Rt, allowing for simplification of equation 1 to equation 2 where 
kapp is the apparent propagation rate constant equal to kp[Pn·]. 
 𝑅𝑝 = 𝑘𝑝[𝑃𝑛 ·][𝑀] (1) 
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 𝑅𝑝 = 𝑘𝑎𝑝𝑝[𝑀] (2) 
 
Degenerative chain transfer during RAFT polymerization allows for the total number of 
polymer chains to greatly exceed the number of propagating radicals. This is a 
cornerstone feature of any RDRP technique since reducing [Pn·] by a factor of 10 will 
result in a 10-fold reduction in Rp but a 100-fold reduction in the rate of bimolecular 
radical termination (Rt) due to the second order dependence of Rt on [Pn·] (equation 3). 
 𝑅𝑡 = 𝑘𝑡[𝑃𝑛 ·]
2 (3) 
 
 In theory, the introduction of CTA (RAFT agent) to a conventional free radical 
polymerization should have no effect on Rp as seen in equation 1. However, in practice 
Rp during RAFT polymerization is significantly reduced compared to the analogous free 
radical polymerization conducted in the absence of CTA with much debate over the exact 
cause of rate retardation.107–110 One possible explanation for the differences in observed 
polymerization rates between conventional and RAFT polymerizations is due to extended 
lifetimes of the intermediate radical 11, such that [Pn·] is lower than what would be 
predicted based upon the total radical concentration resulting from initiator-derived 
radicals.111 While the intermediate radical 11 has been observed by electron spin 
resonance (ESR) spectroscopy, the observed concentrations were too low to completely 
explain the reduction in Rp for RAFT polymerizations.
112–115 Radical trapping or “sink” 
theories which suggest intermittent and reversible coupling of the transient species 11 
with other radical species including Pn·, I·, and 11 have also been proposed with some 
spectroscopic evidence provided for the formation of these intermediates using 
electrospray ionization mass spectrometry (ESI-MS) and nuclear magnetic resonance 
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(NMR) spectroscopy, however, there is still much debate as to the exact cause of 
propagation rate retardation in RAFT polymerizations.116–118 
Molecular Weight Control in RAFT Polymerization 
 In RAFT polymerization, the theoretical number average degree of 
polymerization (Xn,th) can be determined based upon the molar ratio of consumed 
monomer to the number of polymer chains formed during polymerization such that: 
 𝑋𝑛,𝑡ℎ =
[𝑀]0𝜌
[𝐶𝑇𝐴]0 + 2𝑓[𝐼]0(1 − 𝑒−𝑘𝑑𝑡)
 (4) 
        
where [M]0 is the initial monomer concentration,  is the fractional monomer conversion, 
[CTA]0 is the initial CTA concentration, f is the initiator efficiency, [I]0 is the initial 
initiator concentration, kd is the initiator dissociation constant, and t is the reaction time. 
In a typical RAFT polymerization, the [CTA]0:[I]0 is suitably high such that the total 
number of initiator-derived polymer chains is negligible allowing for omission of the 
second term in the denominator of equation 4.110 The theoretical number average 
molecular weight (Mn,th) can then be calculated according to: 
 𝑀𝑛,𝑡ℎ = 𝑋𝑛,𝑡ℎ𝑀𝑀𝑊 + 𝐶𝑇𝐴𝑀𝑊 =
[𝑀]0𝜌
[𝐶𝑇𝐴]0
𝑀𝑀𝑊 + 𝐶𝑇𝐴𝑀𝑊 (5) 
 
where MMW and CTAMW are the molecular weights of monomer and CTA respectively. It 
is worth noting that equation 5 assumes 100% of CTA results in formation of a polymer 
chain and has been shown to underestimate Mn,th compared to experimentally determined 
Mn (Mn,exp) during RAFT polymerizations where incomplete consumption of CTA occurs 
during the pre-equilibrium period or due to CTA degradation during polymerization.119 
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RAFT Agent Design 
 Chain transfer agents possessing thiocarbonylthio functional groups (RAFT 
agents) have been utilized to mediate the polymerization of a wide variety of monomer 
types including styrenics, (meth)acrylates, (meth)acrylamides, acrylonitriles, vinyl esters, 
and vinyl amides among others. As shown in Figure 1.5, the RAFT agent consists of a 
reactive C=S double bond capable of addition to propagating radicals, a weak S-R bond 
to promote rapid fragmentation and reinitiation by the R-group, and Z-group that 
influences the stability of the intermediate radical. The R-group is only involved during 
the initialization period while the Z-group is present on the -terminus of dormant RAFT 
chains throughout the entire polymerization. Consequently, the Z-group has the greatest 
influence over polymerization control and must be chosen in accordance with monomer 
type. For this reason a number of Z-groups including dithioesters,82 trithiocarbonates,120 
xanthates,121 and dithiocarbamates122 have been utilized to polymerize a range of 
monomers from “more activated monomers” (MAM) such as methyl methacrylate to 
“less activated monomers” (LAM ) such as vinyl acetate. Furthermore, “universal” or 
“switchable” RAFT agents based upon 4-pyridinyl dithiocarbamates (Figure 1.5) have 
been designed to polymerize a wider range of monomers.123–125 In the presence of acid, 
the pyridine ring is protonated and elelctron withdrawing, allowing for control over 
polymerization of MAMs. Alternatively, use of 4-pyridinyl dithiocarbamates in the 
electron donating neutral form facilitates polymerization control of LAMs. General 
guides for RAFT agent R- and Z-group selection for a given monomer-type are also now 
available as shown in Figure 1.6. 
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Figure 1.5. General structures of commonly used RAFT agents. 

 
Figure 1.6. Guidelines for RAFT agent Z-group, R-group, and monomer selection based 
upon previously reported experimental results.87 Dashed lines indicate marginal 
polymerization control. 
 
End Group Functionalization of RAFT Polymers 
 It is often desirable or necessary to control polymer end group functionality. 
Inherent to polymers synthesized by RAFT is retention of the RAFT agent R-group on 
the -terminus and the thiocarbonylthio moiety and Z-group on the -terminus (Figure 
1.7). Accordingly, preparation of functional telechelic RAFT polymers is readily 
accomplished by incorporating the desired functionalities onto the RAFT agent R- and Z-
groups.126–129 However, precise control over end group functionality not directly 
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obtainable through R- and Z-group selection necessitates the use of post-polymerization 
end group transformations. Extensive efforts have thus been made toward end group 
functionalization of RAFT polymers by exploiting the latent reactivity of the 
thiocarbonylthio moeity.130–137 
 
Figure 1.7. R/Z-group approach toward the synthesis of ,-telechelic polymers by 
RAFT. 
 
 While the reactive thiocarbonylthio -terminus of RAFT polymers functions as a 
useful chemical “handle” for subsequent end group transformations, the instability of this 
group may be undesirable depending upon the end-use of the RAFT polymer. Bulmus 
and coworkers recently studied the effect of RAFT agent type on cytotoxicity of the 
biocompatible polymer pHPMA. In-vitro cell viability assays showed that 
dithiobenzoate-functional pHPMA was significantly more toxic than analagous 
trithiocarbonate-terminated pHPMA.138 This is likely due to the hydrolytic instability of 
dithiobenozoates relative to trithiocarbonates, with hydrolysis byproducts responsible for 
the decreased cell viability. A number of methods now exist whereby the reactive 
thiocarbonylthio moiety can be converted to a benign end group to minimize unintended 
consequences of RAFT agent reactivity.139–142 
Stimuli-Responsive Polymers 
 Of particular interest in the field of polymeric drug carriers is the ability to design 
stimuli-responsive behavior into the delivery “vehicle” such that autonomous functions 
can be performed in-vivo that elicit a therapeutic effect. For example, the acidic 
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environment of tumoral tissue may be used as an environmental trigger for polymer-
bound drug release.143 Stimuli-responsive polymers in solution can exhibit changes in 
chain conformation, size, or solubility in response to biologically relevant stimuli such as 
changes in pH, redox potential, temperature, ionic strength, or specific molecular 
interactions.144 Furthermore, externally applied stimuli such as electromagnetic radiation, 
changing magnetic fields, and mechanical forces (sonication) have also been used to 
elicit changes in polymer physical and chemical properties.145 Such stimuli-responsive 
polymer properties can be exploited to passively/actively target polymeric drug carriers, 
promote cell-specific internalization, endosomal escape, site-specific drug release, trigger 
drug carrier degradation/elimination from the body, and allow polymers to function as 
combined therapeutic/diagnostic (theranostic) agents. It is therefore becoming ever more 
pertinent to design multipli-responsive polymeric carriers that can exhibit rapid and 
reversible changes in physical and chemical properties in response to discrete changes in 
orthogonal biologically relevant stimuli. 
pH-Responsive Polymers 
 Polymers comprised of weakly acidic or basic functional groups (polyacids or 
polybases) make up a class of polyelectrolytes that exhibit pH-dependent aqueous 
solution properties and have been used extensively in a variety of applications including 
drug delivery.97,146–157 A change in solution pH results in a corresponding change in the 
degree of ionization of the polyelectrolyte and subsequently its hydration state. This can 
ultimately lead to aggregation or self assembly of polyelectrolyte-containing polymers. 
Polyacids exist predominantly in the ionized form when the solution pH (pHsol) is greater 
than the pKa of the poly acid. Accordingly, polyacids are protonated and therefore neutral 
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(or nearly neutral) in charge and less hydrophilic when pHsol < pKa. Conversely, 
polybases are ionized and therefore water soluble when pHsol < pKa and neutrally charged 
and less water soluble when pHsol > pKa. It is therefore possible to dictate whether 
increasing or decreasing the solution pH will increase or decrease polymer solubility 
depending upon whether the polymer is a weak polyacid or polybase Figure 1.8 shows 
some of the more common acid- and base-functional acrylic monomers that are readily 
polymerizable by RDRP techniques such as RAFT to afford the corresponding pH-
responsive polymers. 
 
Figure 1.8. Common pH-responsive monomers polymerizable by RDRP techniques.144 

Temperature-Responsive Polymers 
 Temperature-responsive polymers are those which exhibit a volume phase 
transition at a critical temperature. In solution, the influence of temperature on polymer 
solubility can be explained by the mutual influences of the enthalpy (H) and entropy 
(S) of mixing on the total free energy of mixing (G) according to equation 6. Polymers 
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which exhibit a decrease in solubility in a given solvent upon heating possess a lower 
critical solution temperature (LCST), above which polymer-solution phase separation 
occurs. For these systems, S is negative and an increase in temperature results in a 
corresponding increase in G with the temperature at which G = 0 defined as the LCST. 
Polymers that exhibit increased solubility in a given solvent upon heating possess an 
upper critical solution temperature (UCST) owing to a positive S of mixing. In aqueous 
systems, entropic effects are driven by the ordering or disordering of water molecules at 
the polymer-water interface whereas the enthalpy of mixing is influenced by hydrogen 
bonding, dipole interactions, and hydrophobic effects. 
 𝐺 = 𝐻 − 𝑇𝑆 (6) 
 
 Figure 1.9 shows the more commonly used temperature-responsive monomers 
that have been polymerized by RAFT. The most extensively studied temperature-
responsive polymers for biological applications are those derived from N-
isopropylacrylamide (NIPAM) owing to the LCST of poly(NIPAM) (~32 °C) being near 
that of physiological temperature (37 °C).158–161 A number of other N-substituted 
(meth)acrylamides have also been polymerized by RAFT to afford the corresponding 
temperature-responsive polymers and have seen applications in polymer-facilitated drug 
delivery.146,162–166 
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Figure 1.9. Common temperature-responsive monomers polymerizable by RDRP 
techniques.144 
 
Redox-Responsive Polymers 
 Polymers exhibiting redox-responsive chemical and physical properties are 
actively being explored as stimuli-responsive drug carriers. Glutathione (GSH), the most 
abundant non-protein peptide in mammalian cells, is largely responsible for the reductive 
intracellular environment within cells.71,167 The intracellular concentration of GSH (5-10 
mM) is significantly higher than that outside of the cell (2- 20μM) resulting in a 
difference in redox potential that can be exploited as an intracellular-specific stimulus. 
Redox-responsive polymers for drug delivery are almost exclusively based upon disulfide 
linkages which are chemically stable in the oxidative extracellular environment while 
being rapidly reduced to the corresponding thiols by GSH upon cellular 
internalization.46,168–174 Consequently, redox-responsive polymers differ from pH- and 
temperature-responsive polymers in that the “response” is cleavage of covalent disulfide 
linkages rather than a thermodynamic change in polymer hydration/solubility. This 
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makes possible the triggered release of covalently bound therapeutics such as thiol-
functional siRNA as was recently demonstrated by York et al.46 There are a number of 
reviews that address the potential applications of redox-responsive disulfide-containing 
polymer therapeutics.168,171,172,174–176 
Advanced Macromolecular Architectures 
 While imparting stimuli-responsive behavior into polymer-drug conjugates 
through careful selection of monomer-type and end group functionality has the potential 
to address many of the barriers to drug delivery in a single delivery “vehicle,” it is 
evident that multipli-responsive polymer therapeutics will likely be needed thus 
necessitating the use of branched or block copolymers where discrete blocks of the 
polymer are designed to respond to different stimuli. Furthermore, issues such as 
therapeutic agent protection, vascular circulation, tumoral accumulation, and ultimate 
polymer clearance from the body can be accomplished by controlling polymer 
architecture. Upon the advent of controlled/”living” polymerization techniques, a number 
of polymer architectures are now possible including 
alternating/statistical/gradient/multiblock copolymers, functional telechelics, stars, 
hyperbranched polymers, dendrimers, and molecular brushes (Figure 1.10).177–185 
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Figure 1.10. Polymer architectures accessible through the use of controlled/”living” 
polymerization techniques. 
 
 Highly branched architectures with tailorable shapes and sizes are of particular 
interest for polymer therapeutics. Compared to analogous linear polymers, highly 
branched polymers have been shown to exhibit increased vascular circulation and 
tumoral tissue accumulation.186 While self-assembled polymer structures such as micelles 
and vesicles share many of the benefits of branched polymers, in-vivo usage is limited 
due to dilution-induced disassembly caused by polymer concentrations falling below the 
critical micelle concentration (CMC).89,187 Consequently, branched polymer architectures 
that are assembled using permanent or reversible covalent linkages are desired. 
Molecular Brush Copolymers 
 Molecular brush or “bottle-brush” copolymers are comprised of polymeric side-
chains attached to a polymer backbone and can exhibit highly branched spherical or 
cylindrical morphologies with minimal intermolecular chain entanglement owing to the 
volume-exclusion interactions between sterically crowded polymeric side-chains.188,189 
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Molecular brush architectures are of particular interest as drug delivery “vehicles” due to 
their unique branched topology and readily tailorable dimensions. As stated previously, 
large, highly branched, and cylindrical polymer architectures exhibit increased in-vivo 
circulation times, enhanced accumulation in tumoral tissue due to the EPR effect, and 
improved biocompatibility compared to analogous linear polymers.186 Molecular brush 
copolymers therefore represent an attractive polymer architecture that has the potential to 
simultaneously address numerous issues associated with drug delivery. 
 In general, molecular brush synthesis is accomplished by one of three routes 
referred to as “grafting from,” “grafting onto,” and “grafting through” (Figure 1.11). 
“Grafting from” molecular brush synthesis involves initial preparation of a 
multifunctional backbone (macroinitiator) followed by side chain growth from initiator 
side groups. Controlled polymerization techniques such as RAFT, ATRP, NMP, and 
ROP have been used to prepare molecular brush backbones, which typically require 
additional post-polymerization modification in order to attach the desired initiator groups 
along the backbone.190–194 Side chain growth is most often accomplished using RDRP 
techniques such as ATRP. Limited use of RAFT polymerization to afford side chain 
growth is due in part to difficulties in attaching the RAFT agent to the brush backbone by 
post-polymerization modification and also because of the fragmentation-chain transfer 
nature of RAFT requiring that either a polymer side chain fragment from the backbone in 
order to propagate or necessitating the unlikely collision of sterically restricted polymer 
end groups in order for degenerate chain transfer to occur.194 While there are some 
limitations regarding the synthesis of molecular brushes using “grafting from” 
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approaches, purification of molecular brushes synthesized in this fashion is typically 
simpler since the resulting molecular brush is the only polymeric product of the reaction. 
 
 
Figure 1.11. “Grafting from,” “grafting onto,” and “grafting through” synthetic routes 
toward molecular brush synthesis. 
 
 “Grafting onto” methods allow for preparation of molecular brush back bone and 
side chains separately.195–197 Side chains are then grafted onto the brush backbone using 
efficient coupling or “click” type reactions to ensure high side chain grafting density. 
This approach makes possible the synthesis of well-defined side chains and backbones 
first, such that molecular brushes with predetermined backbone and side chain lengths are 
easier to prepare. In addition to covalent means of “grafting onto” molecular brush 
synthesis, supramolecular brushes based upon noncovalent interactions have been 
demonstrated which rely upon coordination bonding, hydrogen bonding, or ionic 
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interactions between side chains and backbones.198–200 This type of supramolecular brush 
assemblage occurs naturally in proteoglycan aggregates found in cartilage tissues which 
are comprised of a positively charged polypeptide backbone electrostatically bound to 
glycosaminoglycan side chains.201 While practical, the primary drawback to “grafting 
onto” methods is the near impossibility of achieving 100 % grafting density of the 
molecular brush backbone due to kinetic and thermodynamic restrictions resulting from 
steric exclusion of side chains as grafting density increases. 
 The third and arguably most versatile molecular brush synthetic route is referred 
to as “grafting through.” This method relies upon first using a controlled polymerization 
technique to synthesize macromonomers (MMs) which possess polymerizable end groups 
that can then be reacted by a second polymerization technique to afford the 
corresponding molecular brush.202–205 “Grafting through” is the only approach that 
affords molecular brushes with 100 % side chain graft density since each brush backbone 
repeat unit is inherently attached to a polymer side chain. However, this method often 
results in kinetically limited reactions with low MM conversions due to the steric 
constraints arising from the use of MMs and the low concentration of polymerizable end 
groups typically ranging from 0.01-0.1 M. 
 To overcome these issues, ring opening metathesis polymerization (ROMP)206–209 
has recently been used to successfully synthesize molecular brushes from norbornene-
functional MMs while achieving near quantitative conversion of norbornene end groups 
owing to the high reactivity and functional group tolerance of the current generation of 
ruthenium-based metathesis catalysts (Figure 1.12).189,202,210–217 This approach has since 
been used to synthesize a variety of molecular brushes with block-backbone and block-
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side chain subarchitectures from a wide range of MMs derived from controlled 
polymerization techniques. While ROMP of MMs overcomes the previous limitations 
associated with “grafting through” molecular brush synthetic routes, the facile synthesis 
of norbornene-functional MMs still represents an ongoing challenge. 
 
 
Figure 1.12. Ruthenium-based metathesis catalysts. 

 Synthesis of MMs can be accomplished by either “direct-growth” (DG-MM) or 
“growth-then-coupling” (GC-MM) methods as described recently by Xia and coworkers 
(Figure 1.13).218 DG-MM synthesis has been accomplished through the use of 
norbornene-functional initiators during ROP, NMP, ATRP, and through the use of 
norbornene-functional chain transfer agents during RAFT polymerization.202,219–226 The 
use of reversible deactivation radical polymerization techniques to synthesize MMs is 
particularly advantageous due to the wide variety of vinyl monomers available and ease 
of controlling end group functionality. However, DG-MM synthesis by RDRP techniques 
requires polymerization optimization for a given monomer to minimize radical addition 
to the norbornene olefin during polymerization.214 Furthermore Xia and coworkers have 
demonstrated that even trace amounts of difunctional macromonomer impurities resulting 
from bimolecular radical coupling of α-norbornene-functional polymers can result in 
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undesired molecular brush branching and broadened molecular weight distributions.218 
Therefore, facile and efficient growth-then-coupling methods to synthesize RDRP-based 
MMs are needed. 
 
Figure 1.13. Norbornene-functional macromonomer synthesis by direct-growth (DG-
MM) and growth-then-coupling (GC-MM) synthetic routes. 
 
 Due to recent improvements in molecular brush synthetic methods, a number of 
drug delivery applications have been developed that readily exploit the discrete sizes and 
highly branched morphologies of molecular brushes. Johnson, Grubbs and coworkers 
recently demonstrated the synthesis of drug-loaded, bivalent molecular brush copolymers 
that were synthesized using “grafting through” ROMP methodologies developed in the 
same lab (Figure 1.14).212 Molecular brushes were comprised of polynorbornene 
backbones and PEG side chains with anticancer drugs doxorubicin (DOX) and 
camptothecin (CT) attached to the brush backbone using a photocleavable 
nitrobenzyloxycarbonyl linker. Subsequently, photolysis of the degradable linkages using 
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365 nm UV light afforded rapid release of DOX and CT with 50% drug release observed 
in 3.1 min and 10 min for each drug respectively. When irradiated with UV light, the 
molecular brush-cancer drug conjugates were shown to have similar half-maximum 
inhibitory concentrations to the free drugs whereas the PEG-based drug-bound molecular 
brushes showed minimal influence on cell viability due to steric shielding of the 
covalently attached anticancer drugs. 
 
 
Figure 1.14. Drug-loaded, bivalent molecular brush polymers synthesized using “grafting 
through” ROMP of norbornene-functional macromonomers.212 
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CHAPTER II 
OBJECTIVES OF RESEARCH 
 The original “depot” model proposed by Ringsdorf in 1975 was the first attempt 
at addressing the issues of drug delivery using a single macromolecular architecture. 
Initially, limitations in the available synthetic methods prevented the synthesis of well 
defined polymers comprised of functionally diverse monomers and advanced 
architectures such as block, star, and molecular brush copolymers. Upon the advent of 
controlled/”living” polymerization techniques such as reversible-deactivation radical 
polymerization (RDRP), facile preparation of (co)polymers with tailorable architectures, 
predetermined molecular weights, and of narrow molecular weight distributions has made 
possible the synthesis of a wide variety of interpretations of the Ringsdorf “depot” model. 
However, limitations still exist regarding the facile synthesis of polymers aimed at 
specifically addressing the issues of drug delivery. 
 The main work described in this dissertation focuses on the development of 
synthetic approaches toward novel stimuli-responsive polymers and advanced polymer 
architectures that specifically address the issues of in vivo drug delivery. Particular 
attention is given to understanding the fundamentals of the underlying chemistry used to 
synthesize the polymers discussed in this work. 
The specific objectives of this research are to: 
1. Synthesize a library of methacryloyl sulfonamide (MSA) monomers with pKa 
values in the biologically relevant regime. 
2. Develop conditions to control the RAFT polymerization of MSA monomers. 
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3. Investigate the tunable pH- and CO2-responsive aqueous solution properties of 
MSA RAFT polymers. 
4. Investigate temperature-dependent trithiocarbonate chain-end degradation 
observed during RAFT polymerization of N-arylmethacrylamides. 
5. Synthesize RAFT polymer small molecule analogs by single monomer unit 
insertion in order to study the byproducts of trithiocarbonate degradation. 
6. Use in situ 1H NMR analysis to study the mechanism of N-arylmethacrylamide 
promoted trithiocarbonate chain-end degradation. 
7. Develop complimentary mechanistic and kinetic models to explain the observed 
effects of N-arylmethacrylamide substitution on amide nucleophilicity. 
8. Systematically investigate the effects of nucleophilic catalyst, reducing agent, and 
solvent on “one-pot” aminolysis/thiol-maleimide end-group functionalization of 
RAFT polymers. 
9. Identify and prevent detrimental nucleophile-promoted thiol-maleimide side 
reactions. 
10. Elucidate the mechanism(s) of base catalyzed maelimide polymerization initiated 
by thiols and thiol-maleimide adducts. 
11. Optimize “one-pot” aminolysis/thiol-maleimide end-group functionalization 
reaction conditions to afford selective and quantitative end group 
functionalization efficiency of RAFT polymers with N-substituted maleimides. 
12. Synthesize thiol-reactive maleimide- and methanethiosulfonate-functional 
oxanorbornenes. 
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13. Synthesize -oxanorbornenyl macromonomers by end-group modification of 
RAFT polymers with thiol-reactive oxanorbornenes. 
14. Develop polymerization conditions for the controlled ROMP of RAFT-polymer 
derived macromonomers. 
15. Demonstrate reduction-induced disassembly of disulfide-containing molecular 
brushes. 
 The work addressing these objectives is divided into four main sections. The first 
section is concerned with the synthesis of a novel class of tunable pH-responsive 
polymers by RAFT polymerization. These polymers are to be synthesized using a library 
of sulfadrug-based methacryloyl sulfonamide monomers possessing pKa values in the 
range of the early-to-late endosomes (pH = 5-7). Future work regarding these polymers is 
aimed at developing pH-responsive endolytic polymers that could be incorporated into 
polymer therapeutics to aid in endosomal escape, which is often cited as the “bottle neck” 
of drug delivery. 
 Section 2 is concerned with investigating the poor RAFT polymerization control 
of methacryloyl sulfonamide monomers despite using “standard” methacrylamide 
polymerization conditions. Consequently, work in this section aims to provide an 
understanding of the factors influencing RAFT agent degradation during MSA 
polymerization by systematically studying the effects of methacrylamide structure and 
polymerization temperature on the rates and mechanisms of RAFT polymer chain-end 
degradation. In addition, on-going work regarding the development of a mechanistic and 
kinetic theory aimed at explaining the unique influence of N-arylsubstitution on amide 
nucleophilicity is further discussed in Appendix B. 
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 Control over polymer end group functionality is typically necessary when 
synthesizing highly branched polymer architectures such as molecular brushes. Section 3 
details the identification and prevention of deleterious side reactions that we observed 
during “one-pot” aminolysis/thiol-maleimide end group functionalization reactions of 
RAFT polymers. The effects of solvent, nucleophilic catalyst, reducing agent, and 
reagent order of addition on RAFT polymer end-group functionalization efficiency are 
investigated. Particular attention is also given to finding suitable reagents and reaction 
conditions that favor quantitative end group functionlization of RAFT polymers with N-
substituted maleimides with minimal side reactions. 
 Section 4 is concerned with developing a facile synthetic route towards molecular 
brush copolymers derived from RAFT polymers for potential use as drug delivery 
“vehicles.” This work is particularly focused on synthesizing RAFT polymer-derived 
macromonomers using optimized end group functionalization techniques as discussed in 
Section 3. Furthermore, this work aims to develop a facile synthetic route towards 
molecular brushes capable of intracellular-induced disassembly via the incorporation of 
disulfide linkages between the molecular brush backbone and side chain. Macromonomer 
polymerization control by ROMP and reduction-induced molecular brush disassembly 
are discussed. 
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CHAPTER III 
EXPERIMENTAL SECTION 
Materials 
 Methacryloyl chloride (Aldrich, 97%), N,N-dimethylacrylamide (Aldrich, 99%), 
styrene (Aldrich, 99%), aniline (Aldrich, 99%), benzylamine (Aldrich, 98%), and furan 
(Aldrich, 99%) were vacuum distilled and stored under N2 at -10 °C prior to use. 4,4-
Azobis(4-cyanovaleric acid) and azobisisobutyronitrile (AIBN) (Aldrich, 98%) were 
recrystallized from methanol and stored at -10 °C. N,N’-dimethylformamide (Acros, 
extra dry w/ sieves) was stirred under vacuum at room temperature for 60 min prior to 
use in order to remove traces of dimethylamine. The following were used as received: 2, 
2’-Azobis(4-methoxy-2-4-dimethyl valeronitrile) (V-70) (Wako, 96%); sulfacetamide 
(Aldrich, >98%); sulfamethazine (Aldrich, >99%); sulfamethizole (Aldrich, >99%); 
sulfadimethoxine (Aldrich, >98.5%); sulfadoxine (Aldrich, >95%); sulfabenzamide (TCI, 
>98%); trimesic acid (Aldrich, 95%); 1-dodecanethiol (Aldrich, 98%); ethane thiol 
(Aldrich, 97%); carbon disulfide (Aldrich, 99.9%); 2-bromoisobutyryl bromide (TCI, 
98%); triethylamine (Aldrich, 99.5%); NaH (Aldrich, 95%); maleic anhydride (Aldrich, 
99%); acetic anhydride (Fisher, 99.2%); sodium acetate (Fisher, anhydrous); N-
methylmaleimide (Aldrich, 97%); ethyl 2-mercaptopropionate (Aldrich, >95%); benzyl 
mercaptan (Fluka, >99%); hexylamine (Aldrich, 99%); 1,8-diazabicyclo[5.4.0]undec-7-
ene (DBU) (Aldrich >99.0%); triethylamine (Aldrich, >99.5%); tributylphosphine 
(Aldrich, 97%); trimethylphosphite (Aldrich, >99%); 2nd generation Grubbs catalyst 
(Aldrich); ethylenediamine (Aldrich > 99.5%); di-tert-butyl dicarboante (Aldrich, > 
99%); maleimide (Aldrich, 99%); methylchlroformate (Aldrich, 99%); 4-
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methylmorpholine (Aldrich, redist., > 99.5%); trifluoroacetic acid (Aldrich, 99%); 3-
bromopropylamine hydrobromide (Aldrich, 98%); sodium methane sulfinate (Alfa Aesar, 
95%); 0.1 N NaOH (Alfa Aesar, standardized); and 0.05 N HCl (Alfa Aesar, 
standardized); CDCl3 (Cambridge Isotopes, 99.8%); acetone-d6 (Cambridge Isotopes, 
99.9%); N, N’-dimethylformamide-d7 (Cambridge Isotope, 99.5%); dimethylsulfoxide-d6 
(Cambridge Isotopes, 99.9%); acetonitrile-d3 (Cambridge Isotopes, 99.8%); methylene 
chloride-d2 (Cambridge Isotopes, 99.8%); Ethanol-D (Cambridge Isotopes, D 99%, <6% 
D2O); and Deuterium Oxide (Aldrich, 99.9%). All other chemicals were purchased from 
Aldrich in the highest available purity and used as received. 
Characterization 
 NMR spectra for structural analysis and monomer conversions were obtained 
using a Varian INOVA 300 MHz NMR spectrometer. Polymer molecular weights and 
molecular weight distributions (Mw/Mn) were determined by size exclusion 
chromatography (SEC) using DMF 20 mM LiBr as the eluent at a flow rate of 1.0 
mL/min in combination with two Agilent PolarGel-M columns heated to 50 °C and 
connected in series with a Wyatt Optilab DSP interferometric refractometer and Wyatt 
DAWN EOS multiangle laser light scattering (MALLS) detector (λ = 633 nm). Absolute 
molecular weights and Mw/Mn were calculated using a Wyatt ASTRA SEC/LS software 
package. The dn/dc values for each polymer derivative in the above eluent at 35 °C were 
determined offline using a Wyatt Optilab DSP interferometric refractometer and Wyatt 
ASTRA dn/dc software. 
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Chapter IV Section 1 Experimental 
Dithiobenzoic acid 21 
 
 Magnesium (1.22 g, 50.0 mmol) was washed in anhydrous diethyl ether and dried 
in an oven prior to addition to a 250 mL round bottomed flask equipped with stir bar. The 
flask was flame dried under vacuum and backfilled with argon followed by the addition 
of anhydrous THF (25 mL). Bromobenzene (5.0 mL, 47.8 mmol) was then added 
dropwise via syringe over 15 min, upon which 75 mL of THF was added and the 
resulting Grignard solution transferred via cannula to a flame-dried 3-neck round 
bottomed flask equipped with condenser and heated to reflux (40 °C). Carbon disulfide 
(2.89 mL, 47.8 mmol) was then added dropwise over 15 min and the reaction stirred at 40 
°C for an additional 2 h. Ice cold 0.5 N HCl (50 mL) was then added to the reaction 
followed by removal of approximately 75% of the THF/Et2O by rotary evaporation. The 
pH of the aqueous solution was then adjusted to pH < 2 with 12 N HCl and transferred to 
a separatory funnel and extracted with diethyl ether (2 x 100 mL). The light pink aqueous 
layer was discarded and the dark pink/red ether layer kept in the separatory funnel, to 
which was added ice cold 10 wt. % NaOH (100 mL). Upon formation of distinct phases, 
the aqueous layer was removed and further washed with Et2O (3 x 100 mL). The aqueous 
layer was again acidified (pH < 2) with 12 N HCl and the dithiobenzoic acid extracted 
into ether (2 x 100 mL) while discarding the aqueous layer. The Et2O layer was dried 
over MgSO4 and the solvent removed via rotary evaporation to give 21 as a purple oil 
(3.47 g, 47%). 
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Bis(thiobenzoyl)disulfide 22 
 
 Dithiobenzoic acid 21 (3.47 g, 22.5 mmol) was dissolved in 2 N NaOH (150 mL) 
and transferred to a 1 L round bottomed flask equipped with stir bar. A solution of 
K3FeCN6 (15 g, mmol) in H2o (300 mL) was added dropwise over 1 h followed by 
stirring at room temperature for an additional hour. The resulting solids were removed by 
filtration and the solvent removed by rotary evaporation. 22 was further purified by 
recrystallization form EtOH to give deep purple crystals (1.71 g, 57%). 
4-Cyanopentanoic acid dithiobenzoate 23 
 
 A solution of bis(thiobenzoyl)disulfide 22 (1.71 g, 5.6 mmol) and 4,4’-azobis(4-
cyanopentanoic acid) (2.35 g, 8.4 mmol) in EtOAc (100 mL) was prepared in a 3-necked 
round bottomed flask equipped with stir bar and condenser. The reaction was degassed by 
purging with N2 for 40 min prior to heating to reflux (77 °C) for 18 h. The reaction was 
quenched by exposure to air and freezing in liquid N2 followed by solvent removal via 
rotary evaporation. The crude RAFT agent was purified by column chromatography 
(59:40:1 EtOAc:hexanes:AcOH). To remove residual AcOH, column fractions containing 
23 were combined and transferred to a separatory funnel and washed with 0.05 N HCl (2 
x 150 mL), brine (1 x 150 mL) and dried over MgSO4 followed by solvent removal by 
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rotary evaporation to give 23 as a purple solid (2.22 g, 71%). 1H NMR (300 MHz, 
CDCl3): δ 7.91 (d, 2H), 7.57 (t, 1H), 7.40 (t, 2H), 2.77-2.40 (m, 4H), 1.94 (s, 3H). 
Sodium ethyl trithiocarbonate 24 
 
 A suspension of NaH (2.11 g, 83.5 mmol) in anhydrous diethyl ether (150 mL) 
was cooled to 0 °C using an ice bath; ethane thiol (5.73 g, 92.3 mmol) was then added 
dropwise over 15 min accompanied by vigorous evolution of hydrogen gas. The reaction 
was stirred for an additional 15 min at 0 °C followed by dropwise addition of CS2 (7.03g, 
92.3 mmol) over 5 min and the reaction mixture stirred for an additional 60 min at room 
temperature and then diluted with pentane (100 mL). The resulting yellow precipitate was 
isolated by vacuum filtration before drying in-vacuo yielding 24 (12.07 g, 90%) as a 
hygroscopic yellow solid. 1H NMR (300 MHz, D2O): δ 3.15 (q, 2H), 1.27 (t, 3H). 13C 
NMR δ: 35.36, 12.39. 
Bisethyl trithiocarbonate 25 
 
 Sodium ethyl trithiocarbonate 24 (7.74 g, 48.3 mmol) was dissolved in H2O (50 
mL) in a 250 mL round bottomed flask equipped with magnetic stir bar. A solution of I2 
(13.49 g, 53.1 mmol) and potassium iodide (8.82 g, 53.1 mmol) in H2O (100 mL) was 
subsequently added dropwise over 30 min to the stirred solution of sodium ethyl 
trithiocarbonate. The reaction mixture was stirred for an additional 60 min and 
transferred to a separatory funnel and extracted with ether (3 x 75 mL). The ether layers 
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were combined and washed with H2O (2 x 150 mL), 5% Na2S2O3 (2 x 150 mL) and brine 
(1 x 150 mL) before drying over MgSO4 followed by solvent removal by rotary 
evaporation to give 25 as a yellow oil (6.29 g, 95%). 1H NMR (300 MHz, CDCl3): δ 3.30 
(q, 4H), 1.35 (t, 6H). 
4-cyano-4-(ethylsulfanylthiocarbonylsulfanyl)pentanoic acid 26 
 
 A solution of bisethyl trithiocarbonate 25 (5.00 g, 18.2 mmol) and 4,4’-azobis(4-
cyanopentanoic acid) (7.66 g, 27.3 mmol) in EtOAc (250 mL) was prepared in a 500 mL 
3-necked flask equipped with stir bar and condenser. The solution was purged with N2 for 
40 min prior to heating at reflux for 18 h. The reaction was then quenched via exposure to 
air and cooled to room temperature. The solvent was removed by rotary evaporation and 
the crude RAFT agent purified by column chromatography (60:35:5 
hexanes:EtOAc:AcOH). To remove residual AcOH, column fractions containing 26 were 
combined and transferred to a separatory funnel and washed with 0.05 N HCl (2 x 150 
mL), brine (1 x 150 mL) and dried over MgSO4 followed by solvent removal by rotary 
evaporation to give 26 as a yellow solid (7.10 g, 74%).1H NMR (300 MHz, CDCl3): δ 
3.37 (q, 2H), 2.70 (t, 2H), 2.60-2.30 (m, 2H) 1.89 (s, 3H), 1.36 (t, 3H). 
General Procedure for Methacryloyl Sulfonamide Synthesis 
 Using a modified procedure, sulfa drug (40.0 mmol) was dissolved in 160 mL of a 
1:1 (v:v) mixture of acetone and 0.5 N aqueous NaOH and stirred while cooling in an ice 
bath. Methacryloyl chloride (4.10 mL, 42.0 mmol) was then added dropwise over 30 min 
followed by removing the ice bath and stirring the reaction at room temperature for an 
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additional 60 min. The acetone was removed by rotary evaporation, followed by 
adjusting the solution to pH = 2 with 6 N HCl. The resulting solids were isolated using 
vacuum filtration and washed with 100 mL of dilute HCl (0.01 N) prior to drying in-
vacuo for 48 h, yielding the desired monomers as colorless to off-white solids. The 
synthesis of methacryloyl sulfadoxine 30 required the use of 240 mL of a 1:2 (v:v) 
mixture of acetone and 0.5 N aqueous NaOH. 
Methacryloyl sulfacetamide 27 
 
Yield: (10.29 g, 91%); mp 203-205 °C dec. 1H NMR (300 MHz, DMSO-d6): δ 11.99 (s, 
1H), 10.20 (s, 1H), 8.11 – 7.65 (m, 4H), 5.84 (s, 1H), 5.58 (s, 1H), 1.93 (s, 3H), 1.89 (s, 
3H). 13C NMR (75 MHz, DMSO-d6) δ 168.69, 167.34, 143.72, 139.99, 133.13, 128.67, 
121.03, 119.50, 23.22, 18.63. 
Methacryloyl sulfabenzamide 28 
 
43 
 
 
Yield: (12.89 g, 94%); mp 228-229 °C dec. 1H NMR (300 MHz, DMSO-d6): δ 12.46 (s, 
1H), 10.22 (s, 1H), 8.02 – 7.87 (m, 4H), 7.83 (d, J = 7.2 Hz, 2H), 7.60 (t, J = 7.4 Hz, 1H), 
7.47 (t, J = 7.6 Hz, 2H), 5.84 (s, 1H), 5.58 (s, 1H), 1.93 (s, 3H). 13C NMR (75 MHz, 
DMSO-d6) δ 167.36, 165.38, 143.79, 139.99, 133.24, 133.15, 131.54, 128.93, 128.61, 
128.40, 121.03, 119.50, 18.62. 
Methacryloyl sulfamethazine 29 
 
Yield: (13.39 g, 97%); mp 234-235 °C dec. 1H NMR (300 MHz, DMSO-d6): δ 11.47 (s, 
1H), 10.10 (s, 1H), 7.86 (dd, J = 28.3, 8.6 Hz, 4H), 6.74 (s, 1H), 5.81 (s, 1H), 5.55 (s, 
1H), 2.23 (s, 6H), 1.92 (s, 3H). 13C NMR (75 MHz, DMSO) δ 167.61, 156.65, 143.19, 
140.43, 135.08, 129.49, 121.24, 119.42, 113.97, 23.37, 19.04. 
Methacryloyl sulfamethizole 30 
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Yield: (12.42 g, 91%); mp 215-217 °C dec. 1H NMR (300 MHz, DMSO-d6): δ 13.90 (s, 
1H), 10.12 (s, 1H), 7.77 (dd, J = 37.4, 8.4 Hz, 4H), 5.82 (s, 1H), 5.56 (s, 1H), 2.44 (s, 
3H), 1.92 (s, 3H). 13C NMR (75 MHz, DMSO-d6) δ 167.80, 167.20, 154.46, 142.65, 
140.03, 136.05, 126.71, 120.83, 119.70, 18.65, 16.10. 
Methacryloyl sulfadimethoxine 31 
 
Yield: (14.72 g, 97%); mp 216-218 °C dec. 1H NMR (300 MHz, DMSO-d6): δ 11.50 (s, 
1H), 10.17 (s, 1H), 7.86 (m, 4H), 5.92 (s, 1H), 5.82 (s, 1H), 5.57 (s, 1H), 3.77 (s, 3H), 
3.73 (s, 3H), 1.92 (s, 3H). 13C NMR (75 MHz, DMSO-d6) δ 171.67, 167.30, 164.26, 
159.90, 143.41, 139.98, 133.68, 128.30, 120.96, 119.64, 84.57, 54.54, 53.81, 18.59. 
Methacryloyl sulfadoxine 32 
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Yield (14.10 g, 93%); mp 198-199 °C. 1H NMR (300 MHz, DMSO-d6): δ 11.09 (s, 1H), 
10.17 (s, 1H), 8.12 (s, 1H), 5.84 (s, 1H), 5.59 (s, 1H), 3.90 (s, 3H), 3.70 (s, 3H), 1.95 (s, 
3H). 13C NMR (75 MHz, DMSO-d6) δ 167.32, 161.63, 150.43, 143.14, 140.06, 134.61, 
129.88, 128.61, 127.21, 120.92, 119.40, 60.28, 54.08, 18.64. 
General Procedure for RAFT Polymerization of Methacryloyl Sulfonamides 
 Briefly, methacryloylsulfonamide (5.0 x 10-3 mol, 150 equiv), CTA (23 or 26) 
(3.3 x 10-5 mol, 1 equiv), initiator (V-70 or V-501) (6.7 x 10-7 mol, 0.2 equiv), and 
trimesic acid (50 mg, 1H NMR internal standard) were combined in a 10 mL graduated 
cylinder and DMF added to bring the final solution volume to 5.0 mL ([M]0 = 1 M) or 6.0 
mL (0.83 M) depending upon monomer solubility as indicated in Table 1. The solution 
was then transferred to a 10 mL test tube equipped with a magnetic stir bar and rubber 
septum followed by purging with N2 for 40 mins. An initial aliquot (200 μL) was taken 
prior to heating the reaction vessel at the indicated temperature with subsequent aliquots 
taken at timed intervals and analyzed by 1H NMR (DMSO-d6) to determine monomer 
conversion by comparing the relative integral areas of the trimesic acid aromatic protons 
(8.64 ppm, 3H) to the monomer vinyl proton (5.84 ppm, 1H). SEC-MALLS (95% 
DMF/5% CH3COOH, 20 mM LiBr) was used to monitor the progression of molecular 
weight and molecular weight distribution (Mw/Mn) throughout each polymerization. 
Polymers isolated for solubility studies were purified by precipitating the reaction 
mixture into a 10-fold excess of MeOH followed by isolating the resulting solids by 
ultracentrifugation. The isolated polymers were precipitated a total of three times from 
DMF into MeOH before drying overnight in-vacuo. 
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Methacryloyl Sulfonamide Monomer Titrations 
 Monomer stock solutions (1mM) were prepared by weighing each MSA (0.1 
mmol) into separate 100 mL volumetric flasks, followed by the addition of 2.00 mL of 
0.1 N NaOH (0.2 mmol) to each flask. Once the monomers were completely dissolved, 
DI H20 (18.2 MΩ resistance) was added to each volumetric flask to achieve a final 
volume of 100 mL. Twenty-five mL of each stock solution was transferred to a 100 mL 
beaker containing a stir bar and titrated against 0.05 N HCl in volume increments of 5 μL 
at 25 °C using a Metrohm 848 Titrino Plus autotitrator. All titrations were performed in 
triplicate. 
pH-dependent Polymer Solubility 
 Polymer solutions were first prepared by dissolving each pMSA derivative (1 eq. 
sulfonamide, 2.5 x 10-5 mol sulfonamide functional groups) in 1.00 mL 0.05 N NaOH (2 
eq., 5 x 10-5 mol)) followed by dilution with DI H2O (18.2 MΩ resistance) to a final 
volume of 2.50 mL ([SO2NH] = 10 mM). The polymer solution was transferred into a 
quartz cuvette and the solution pH adjusted incrementally by adding 1-10 μL of 0.2 N 
HCl followed by measuring the % transmittance at λ = 500 nm using a UV-Vis 
spectrophotometer. 
CO2-dependent Polymer Solubility 
 In a 20 mL vial equipped with magnetic stir bar and pierceable cap, pMSA (1 eq. 
sulfonamide, 2.0 x 10-5 mol sulfonamide functional groups) was dissolved in 400 μL of 
0.05 N NaOH (1.25 eq., 2.5 x 10-5 mol) and subsequently diluted to a final volume of 
3.00 mL ([SO2NH] = 6.7 mM) with DI H2O (18.2 MΩ resistance). CO2-dependent 
polymer solubility was examined between purge cycles by transferring the solutions to a 
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quartz cuvette and measuring the percent transmittance at 500 nm. Purge cycles consisted 
of purging the solution with CO2 for 10 s or N2 for 25 min. 
Chapter IV Section 2 Experimental 
N-Phenylmethacrylamide 33 
 
 Methacryloyl chloride (11.83 mL, 121 mmol) was added dropwise over 15 min to 
a stirred solution of aniline (12.00 g, 121 mmol) and triethylamine (12.86 g, 127 mmol) 
in CH2Cl2 (250 mL) that was previously cooled using an ice bath. Upon complete 
addition of methacryloyl chloride, the reaction was stirred at 0 °C for 30 min followed by 
stirring at room temperature for an additional 60 min. The reaction mixture was then 
transferred to a separatory funnel and washed with 0.1 N HCl (1 × 200 mL), saturated 
NaHCO3 (1 × 200 mL), and saturated NaCl (brine) (1 × 200 mL) before drying over 
MgSO4. The solvent was removed via rotary evaporation and the isolated solids 
recrystallized from hot hexanes:THF (95:5) to yield 33 (17.52 g, 90%) as colorless 
needle-like crystals. mp 80-81 °C. 1H NMR (300 MHz, CDCl3): δ 7.60 (s, 1H), 7.57 (d, 
2H), 7.32 (t, 2H), 7.11 (t, 1H), 5.78 (s, 1H), 5.44 (s, 1H), 2.05 (s, 3H). 13C NMR (CDCl3): 
δ 166.87, 141.05, 137.95, 129.15, 124.57, 120.24, 120.04, 18.96. 
N-Benzylmethacrylamide 34 
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 A synthetic procedure analogous to that described for 33 was used to prepare N-
benzylmethacrylamide. The product was recrystallized from hot hexanes:THF (90:10) to 
yield 34 (17.88 g, 91%) as colorless needle-like crystals. mp 78-79 °C. 1H NMR (300 
MHz, CDCl3): δ 7.30 (m, 5H), 6.13 (s, 1H), 5.71 (s, 1H), 5.34 (s, 1H), 4.50 (d, 2H), 1.97 
(s, 3H). 13C NMR (CDCl3): δ 168.43, 140.03, 138.41, 128.87, 127.97, 127.67, 119.89, 
43.86, 18.89. 
Sodium dodecyl trithiocarbonate 35 
 
 1-Dodecanethiol (15.0 g, 74.1 mmol) was added dropwise over 30 min to a stirred 
suspension of NaH (1.68 g, 70.0 mmol) in anhydrous diethyl ether (350 mL) resulting in 
slow evolution of hydrogen gas. The reaction mixture was vented and stirred overnight 
(12 h) at room temperature after which carbon disulfide (5.64 g, 74.1 mmol) was added 
dropwise over 10 min, followed by stirring at room temperature for 60 min. The reaction 
mixture was subsequently diluted with pentane (100 mL) and the solids isolated by 
vacuum filtration and further dried in-vacuo to yield 35 (18.55 g, 83%) as a yellow solid. 
1H NMR (300 MHz, DMSO-d6): δ 2.97 (t, 2H), 1.49 (m, 2H), 1.23 (b, 18H), 0.85 (t, 3H). 
13C NMR (DMSO-d6): δ 31.79, 29.55, 29.51, 29.27, 29.21, 29.14, 22.59, 14.45. 
 
Bisdodecyl trithiocarbonate 36 
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 To a suspension of sodium dodecyl trithiocarbonate 35 (18.55 g, 61.7 mmol) in 
diethyl ether (200 mL) at room temperature was added solid I2 (8.62 g, 34.0 mmol) over 
5 min. The reaction was stirred for 60 min at room temperature followed by removal of 
the precipitated NaI salts by vacuum filtration. The filtrate was transferred to a separatory 
funnel and washed with 5% Na2S2O4 (1 × 150 mL), H2O (1 × 150 mL), and brine (1 × 
150 mL) before drying over MgSO4. The solvent was removed via rotary evaporation to 
yield 36 (16.36 g, 96%) as a yellow oil that solidified upon cooling to -10 °C. 1H NMR 
(300 MHz, CDCl3): δ 3.28 (t, 4H), 1.68 (m, 4H), 1.24 (b, 36H), 0.87 (t, 6H). 13C NMR 
(CDCl3): δ 221.74, 38.52, 32.13, 29.85, 29.77, 29.64, 29.57, 29.31, 29.16, 27.57, 22.91, 
14.36. 
2-Cyano-2-propyl dodecyl trithiocarbonate 37 
 
 Bisdodecyl trithiocarbonate 36 (7.88 g, 14.2 mmol) and AIBN (2.33 g, 14.2 
mmol) were dissolved in EtOAc (250 mL) and the solution purged with N2 for 40 min 
before heating to 77 °C. After 12 h, a degassed solution of AIBN (2.33 g, 14.2 mmol) in 
EtOAc (100 mL) was subsequently added and the reaction stirred for an additional 12 h 
at 77 °C. Purification by column chromatography (95:5 Hexanes:EtOAc) yielded 37 
(7.36 g, 75%) as a yellow oil that solidified upon cooling to 0 °C. 1H NMR (300 MHz, 
CDCl3): δ 3.32 (t, 2H), 1.86 (s, 6H), 1.68 (m, 2H), 1.25 (b, 18H), 0.87 (t, 3H). 13C NMR 
(CDCl3): δ 217.96, 120.66, 42.54, 37.13, 32.11, 29.82, 29.74, 29.62, 29.54, 29.27, 29.12, 
27.91, 27.25, 22.90, 14.35. 
2-(Ethylthiocarbonylthio)-2-methylpropionic acid 38 
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 Ethane thiol (12.4 g, 0.200 mol), acetone (96.4 g, 1.66 mol), and 
trioctylmethylammonium chloride (aliquat 336) (3.23 g, 8.00 mmol) were charged into a 
500 mL round bottomed flask equipped with magnetic stir bar and the solution cooled to 
0-5 °C using an ice bath. 50 wt. % NaOH (16.8 g, 0.210 mol) was then added dropwise 
over 20 min, followed by the dropwise addition of a solution of carbon disulfide (15.2 g, 
0.200 mol) in acetone (20.0 g, 0.344 mol) over 20 min. The reaction mixture was stirred 
at 0 °C for 20 min, upon which chloroform (35.8 g, 0.300 mol) was added in a single 
portion immediately followed by the dropwise addition of 50 wt. % NaOH (80.0 g, 1.00 
mol) over 30 min. The ice bath was then removed and the reaction mixture stirred 
overnight (18 h) at room temperature, after which the remaining acetone was removed by 
rotary evaporation. The resulting viscous residue was diluted with 250 mL H2O and 
cooled with an ice bath before acidification with 12 N HCl to pH = 2. Upon acidification, 
the aqueous component was transferred to a separatory funnel and extracted with hexane 
(4 x 250 mL) and the aqueous layer discarded. The combined hexane layers were 
subsequently washed with 0.1 N HCl (1 x 250 mL), brine (1 x 250 mL), and dried over 
Na2SO4 before isolating the crude product by rotary evaporation. Purification by column 
chromatography (60:38:2 Hexanes:EtOAc:AcOH, Rf = 0.33) yielded a dark yellow oil 
that was further purified by recrystallization from hot hexanes to give 38 (16.01 g, 36%) 
as bright yellow crystals. 1H NMR (300 MHz, CDCl3) δ 3.31, 1.73, 1.34. 
2-Bromoisobutyranilide 39 
51 
 
 
 
 2-Bromoisobutyryl bromide (15.00 mL, 124 mmol) was added dropwise over 15 
min to a stirred solution of aniline (12.03 g, 124 mmol) and triethylamine (12.28 g, 124 
mmol) in CH2Cl2 (500 mL) that was previously cooled using an ice bath. Upon complete 
addition of 2-bromoisobutyryl bromide, the reaction was stirred at 0 °C for 30 min 
followed by stirring at room temperature for an additional 60 min. The reaction mixture 
was then transferred into a separatory funnel and washed with 0.1 N HCl (1 × 400 mL), 
saturated NaHCO3 (1 × 400 mL), and brine (1 × 400 mL) before drying over MgSO4 and 
removal of the solvent by rotary evaporation. The isolated solids were recrystallized from 
hot hexanes to yield 39 (29.13 g, 97%) as colorless needle-like crystals. mp 82-23 °C. 1H 
NMR (300 MHz, CDCl3): δ 8.45 (s, 1H), 7.55 (d, 2H), 7.35 (t, 2H), 7.14 (t, 1H), 2.04 (s, 
6H). 13C NMR (CDCl3): δ 170.12, 137.53, 129.24, 125.06, 120.11, 63.37, 32.75. 
N-phenyl-2-(ethylsulfanylthiocarbonylsulfanyl)propanamide 40 
 
 A solution of sodium ethyl trithiocarbonate 24 (1.32 g, 8.3 mmol), 2-
bromoisobutyrylanilide 39 (2.00 g, 8.3 mmol), and NaI (0.124 g, 0.83 mmol) in absolute 
EtOH (10 mL) was prepared and stirred at 22 °C for 48 h. The reaction mixture was then 
precipitated twice into water (100 mL) and the precipitate isolated by vacuum filtration 
and further purified by recrystallization from absolute EtOH resulting in large needle-like 
crystals. The product, isolated by recrystallization, was determined to be 5,5-dimethyl-3-
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phenyl-2-thioxothiazolidin-4-one (40).227 Conducting the reaction at 60 °C for 12 h 
allowed for isolation of 40 in higher yields for use in additional studies. mp 108-110 °C. 
1H NMR (300 MHz, CDCl3): δ 7.50 (m, 3H), 7.22 (d, 2H), 1.79 (s, 6H). 13C NMR 
(CDCl3) δ 199.80, 179.64, 135.43, 129.82, 129.70, 128.54, 55.59, 27.55. 
Synthesis of 41 
 
 A solution of 2-cyano-2-propyl dodecyl trithiocarbonate 37 (3.41 g, 9.9 mmol), 
33 (1.59 g, 9.9 mmol), and V-70 (0.609 g, 2.0 mmol) in DMF (35 mL) was prepared in a 
round bottomed flask equipped with magnetic stir bar and the reaction degassed via three 
freeze-pump-thaw cycles and backfilled with argon. The reaction mixture was heated at 
30 °C in an oil bath for 48 h, followed by exposure to air and freezing in liquid N2. The 
reaction mixture was then diluted with EtOAc (250 mL) and transferred to a separatory 
funnel and washed with 75% brine (1 × 200 mL), H2O (1 × 200 mL), brine (1 × 200 mL), 
and dried over MgSO4. The crude product was then purified by column chromatography 
(8:2 Hexanes:EtOAc, Rf = 0.30) yielding 41 (0.511 g, 10%) as a yellow solid. 
1H NMR 
(300 MHz, CDCl3): δ 8.44 (s, 1H), 7.45 (d, 2H), 7.32 (t, 2H), 7.12 (t, 1H), 3.26 (t, 2H), 
2.55 (q, 2H), 2.02 (s, 3H), 1.64 (m, 2H), 1.47 (s, 3H), 1.46 (s, 3H), 1.23 (b, 18H), 0.87 (t, 
3H). 13C NMR (CDCl3): δ 219.02, 169.43, 137.45, 129.02, 124.83, 120.51, 60.48, 45.13, 
37.33, 31.91, 30.45, 29.62, 29.54, 29.42, 29.35, 29.10, 29.07, 28.90, 28.69, 27.62, 23.81, 
22.70, 14.15. 
Synthesis of 42 
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 A solution of 2-cyano-2-propyl dodecyl trithiocarbonate 37 (2.00 g, 5.8 mmol), 
34 (1.01 g, 5.8 mmol), and AIBN (0.190 g, 1.2 mmol) in DMF (20 mL) was prepared in a 
round bottomed flask equipped with magnetic stir bar and degassed via three freeze-
pump-thaw cycles and backfilled with argon. The reaction mixture was heated at 60 °C in 
an oil bath for 24 h, followed by exposure to air and freezing in liquid N2. The reaction 
mixture was then diluted with EtOAc (150 mL) and transferred to a separatory funnel and 
washed with 75% brine (1 × 150 mL), H2O (1 × 150 mL), brine (1 × 150 mL), and dried 
over MgSO4. The crude product was first purified by column chromatography (8:2 
Hexanes:EtOAc, Rf = 0.25) followed by recrystallization from MeOH:H2O (98:2) at -10 
°C yielding 42 (0.475 g, 16%) as yellow crystals. 1H NMR (300 MHz, CDCl3): δ 7.31 
(m, 5H), 6.79 (t, 1H), 4.42 (q, 2H), 3.25 (t, 2H), 2.56 (q, 2H), 1.96 (s, 3H), 1.64 (m, 2H), 
1.47 (s, 3H), 1.45 (s, 3H), 1.27 (b, 18H), 0.89 (t, 3H). 13C NMR (CDCl3): δ 219.32, 
171.33, 137.62, 128.87, 128.38, 127.84, 125.04, 60.16, 45.04, 37.28, 32.12, 30.66, 29.84, 
29.76, 29.64, 29.55, 29.47, 29.29, 29.14, 28.72, 27.87, 24.16, 22.90, 14.35. 
RAFT Polymerization of 33 and 34 
 Briefly, monomer (33 or 34) (10.0 mmol, 200 equiv), 37 (5.0 × 10-5 mol, 1 equiv), 
initiator (V-70 or V501) (1.0 × 10-5 mol, 0.2 equiv), and trimesic acid (50 mg, 1H NMR 
internal standard) were combined in a 10 mL graduated cylinder and DMF added to bring 
the final solution volume to 5.0 mL ([M]0 = 2 M). The solution was then transferred to a 
10 mL test tube equipped with a magnetic stir bar and rubber septum, degassed via three 
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freeze-pump-thaw cycles, and backfilled with argon. An initial aliquot (200 μL) was 
taken prior to heating the reaction vessel at the indicated temperature with subsequent 
aliquots taken at timed intervals and analyzed by 1H NMR (DMSO-d6) to determine 
monomer conversion by comparing the relative integral areas of the trimesic acid 
aromatic protons (8.64 ppm, 3H) to the vinyl proton of 33 (5.86 ppm, 1H) or 34 (5.79 
ppm, 1H). SEC-MALLS (DMF 20 mM LiBr) analysis of aliquots was used to monitor 
molecular weight and molecular weight distribution progression throughout each 
polymerization. 
Trithiocarbonate Degradation Analysis by UV-Vis Spectroscopy 
 Reactions (final volume = 2500 μL) were performed using [37]0 = 5 × 10-3 M and 
[M]0:[37]0:[V501]0 = 10:1:0.2 in DMF. A typical procedure was as follows: 34 (250 μL 
of an 87.6 mg/mL stock soln. in DMF, 10 equiv), 37 (250 μL of a 17.3 mg/mL stock soln. 
in DMF, 1 equiv), V501 (25 μL of a 28.0 mg/mL stock soln. in DMF, 0.2 equiv), and 
DMF (1975 μL) were combined in a 4 mL test tube equipped with magnetic stir bar and 
rubber septum. The reaction was then degassed via 4 freeze-pump-thaw cycles and 
backfilled under argon. An initial aliquot (50 μL) was taken using an argon-purged gas-
tight syringe and subsequently diluted into a quartz cuvette containing 2500 μL of 
acetonitrile before measuring the absorbance at λ = 320 nm using a Lambda 35 UV-vis 
spectrometer. Subsequent aliquots (50 μL) were taken and analyzed in the same manner. 
In situ 1H NMR Analysis 
 Samples of 41 and 42 (2 × 10-2 M) in DMF-d7 were prepared immediately prior to 
analysis by first adding DMF-d7 (0.60 mL) into an NMR tube equipped with pierceable 
rubber septum and the solvent degassed by two freeze-pump-thaw cycles to remove 
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possible traces of dimethyl amine. The appropriate amount of 41 or 42 was then added as 
a solid directly into the NMR tube containing the previously degassed DMF-d7 and the 
resulting solution degassed by two additional freeze-pump-thaw cycles and backfilled 
with argon. 1H NMR spectra were acquired at 70 °C using a Bruker Ascend™ 600 MHz 
spectrometer. 
Chapter IV Section 3 Experimental 
Reactions of N- and P-based Nucleophiles with N-Methylmaleimide 
 A solution of N-methylmaleimide (25.0 mg, 2.23 × 10-4 mol, 10 eq.) and CH2Cl2 
(10 μL, 1H NMR internal standard) in DMSO-d6 (1.00 mL) was prepared in an NMR 
tube in the presence of air. An initial 1H NMR spectrum was taken upon which the 
appropriate nucleophile (2.23 × 10-5 mol, 1 eq.) was added to the NMR tube and the 
solution mixed by inverting three times. Subsequent spectra were taken at timed intervals 
and the fractional change in maleimide concentration measured by comparing the relative 
integrated peak areas of the maleimide olefin protons (DMSO-d6, 7.02 ppm, 2H) to the 
CH2Cl2 protons (DMSO-d6, 5.76 ppm, 2H). 
Reaction of Ethyl 2-Mercaptopropionate with N-Methylmaleimide 
 A solution of N-methylmaleimide (25.0 mg, 2.23 × 10-4 mol, 10 eq.), 
triethylamine (3.13 μL, 2.23 × 10-5 mol 1.0 eq.) and CH2Cl2 (10 μL, 1H NMR internal 
standard) in DMSO-d6 (1.00 mL) was prepared in an NMR tube in the presence of air. An 
initial 1H NMR spectrum was taken upon which ethyl 2-mercaptopropionate () was added 
to the NMR tube and the solution mixed by inverting three times. Subsequent spectra 
were taken at timed invervals and the fractional change in maleimide concentration 
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measured by comparing the relative integrated peak areas of the maleimide olefin protons 
(DMSO-d6, 7.02 ppm, 2H) to the CH2Cl2 protons (DMSO-d6, 5.76 ppm, 2H). 
Synthesis of 3-Benzylsulfanyl-1-Methylmaleimide 43 
 
 An initially colorless solution of benzylmercaptan (2.64 g, 21.2 mmol) and N-
methylmaleimide (2.36 g, 21.2 mmol) in MeCN (50 mL) was first prepared at room 
temperature followed by the addition of TEA (0.281 mL, 2.12 mmol) via syringe. The 
resulting red solution was stirred at room temperature for 30 min followed by quenching 
with acetic acid (1.0 mL) resulting in the solution becoming colorless. The solvent was 
removed by rotary evaporation and the crude reaction mixture redissolved in diethyl ether 
(100 mL) and washed with 0.1 M HCl (100 mL), H2O (100 mL), and saturated NaCl (100 
mL). The product was further purified by column chromatography (65:35 
hexanes:EtOAc, Rf = 0.35), yielding 43 (4.55 g, 91%) as a colorless viscous oil that 
solidified into a waxy solid after 7 days; mp 47-52 °C. 1H NMR (600 MHz, DMSO-d6): δ 
7.31 (m, 4H), 7.24 (m, 1H), 3.93 (dd, J = 62.3, 13.1 Hz, 2H), 3.76 (dd, J = 9.0, 3.9 Hz, 
1H), 3.06 (dd, J = 18.5, 9.0 Hz, 1H), 2.78 (s, 3H), 2.45 (dd, J = 18.5, 3.9 Hz, 1H). 
Reaction of 43 with N-Methylmaleimide. 
 A solution of N-methylmaleimide (25.0 mg, 2.23 × 10-4 mol, 10 eq.), 43 (5.29 
mg, 2.23 × 10-5 mol, 1.0 eq.), and CH2Cl2 (10 μL, 1H NMR internal standard) in DMSO-
d6 (1.00 mL) was prepared in an NMR tube in the presence of air. An initial 
1H NMR 
spectrum was taken upon which TEA (3.13 μL, 2.23 × 10-5 mol, 1 eq) was added to the 
NMR tube and the solution mixed by inverting three times. Subsequent spectra were 
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taken at timed intervals and the fractional change in maleimide concentration measured 
by comparing the relative integrated peak areas of the maleimide olefin protons (DMSO-
d6, 7.02 ppm, 2H) to the CH2Cl2 protons (DMSO-d6, 5.76 ppm, 2H). 
Hydrogen-Deuterium Exchange Kinetics of 43 
 NMR Spectra were recorded with a Bruker Ascend™ 600 MHz spectrometer at 
23 °C. Briefly, a solution of 7 (10.0 mg, 4.25 × 10-5, 1 eq) and D2O (100 μL, 5.54 mmol, 
130 eq) in DMSO-d6 (0.600 mL) was prepared in an NMR tube in the presence of air and 
an initial 1H NMR spectrum was acquired (t = 0 min). TEA (5.93 μL, 1 eq) was then 
added to the NMR tube and the solution mixed by inverting three times. Subsequent 
spectra were acquired at timed intervals and the fractional change in peak area (At/A0) of 
protons Ha (3.80 – 3.75 ppm, 1H), Hb (3.10 – 3.00 ppm, 1H), and Hc (2.50 – 2.40 ppm, 
1H) were measured relative to the peak area of the benzylsulfanyl aromatic protons (7.30 
- 7.20 ppm, 5H). 
2-cyano-2-propyl benzodithioate 44 
 
 A solution of bis(thiobenzoyl)disulfide 22 (1.00 g, 3.3 mmol) and AIBN (1.07 g, 
6.6 mmol) in EtOAc (40 mL) was prepared in a 3-necked round bottomed flask equipped 
with stir bar and condenser. The reaction was degassed by purging with N2 for 40 min 
prior to heating to reflux (77 °C) for 18 h. The reaction was quenched by exposure to air 
and freezing in liquid N2 followed by solvent removal via rotary evaporation. The crude 
RAFT agent was purified by column chromatography (9:1 hexanes:EtOAc, Rf = 0.25) to 
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give 44 as a dark red oil that solidified upon cooling to - 10 °C (0.87 g, 60%). 1H NMR 
(200 MHz, CDCl3): δ 7.90 (d, 2H), 7.57 (t, 1H), 7.40 (t, 2H), 1.94 (s, 6H). 
Synthesis of pDMA-CPDB 45 
 
 N,N-dimethylacrylamide (28.0 g, 282 mmol), 2-cyano-2-propyl benzodithioate 44 
(298.0 mg, 1.34 mmol), AIBN (44.1 mg, 0.27 mmol), and benzene (100 mL) were 
combined in a 250 mL round bottomed flask equipped with magnetic stir bar and sealed 
with a rubber septum before purging with N2 for 45 mins. The reaction vessel was then 
heated in an oil bath at 60 °C for 5 h, upon which the reaction was quenched via exposure 
to air and freezing in liquid nitrogen. The solvent was removed by rotary evaporation and 
the polymer precipitated 4 times into pentane, redissolving in a minimal amount of 
CH2Cl2 between precipitations. The final product 45 was dried overnight in-vacuo before 
characterizing via 1H NMR (D2O) and SEC-MALLS (DMF 20 mM LiBr). Mn(NMR) = 
3220 g/mol, Mn(SEC) = 3360 g/mol, Ð = 1.06. 
N-Benzylmaleimide 46 
 
 A solution of maleic anhydride (20.00 g, 204 mmoL) in anhydrous diethyl ether 
(250 mL) was first prepared at room temperature in a 3-necked 1L round bottom flask 
equipped with magnetic stir bar, condenser, and addition funnel. A solution of 
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benzylamine (21.86 g, 204 mmol) in anhydrous diethyl ether (100 mL) was added 
dropwise via addition funnel over 30 mins such that the exothermic reaction produced a 
mild reflux of the solvent. The reaction mixture was stirred for 1 h at room temperature 
before isolating the resulting solids by vacuum filtration followed by washing with 
anhydrous diethyl ether (100 mL). The resulting N-benzylmaleamic acid intermediate 
was dried in-vacuo and used without further purification (40.70 g, 97%). 
 N-benzylmaleamic acid (40.70 g, 198 mmol) was added as a solid to a stirred 
solution of acetic anhydride (90.00 g, mmol) and anhydrous sodium acetate (13.00 g, 
mmol) and the reaction heated at 100 °C for 30 min resulting in formation of a dark 
brown homogenous solution. The reaction mixture was then poured into a vigorously 
stirred solution of ice cold water (600 mL) and stirred for 30 min. The resulting brown 
precipitate was isolated by vacuum filtration and washed with water (3 × 100 mL). The 
solids were resuspended in water (500 mL) and stirred vigorously for 30 min before 
isolation again by vacuum filtration. The crude compound was further purified by 
recrystallization from EtOH:H2O (2:1, v:v) to afford 46 (27.02 g, 73%) as fine beige 
crystals; mp 67-69 °C. 1H NMR (300 MHz, CDCl3): δ 7.22 (b, 5H), 6.64 (s, 2H), 4.61 (s, 
2H). 13C NMR (CDCl3): δ 170.41, 136.17, 134.19, 128.69, 128.38, 127.86, 41.42. 
Simultaneous “One-Pot” Aminolysis/Thiol-Maleimide End Group Modification of 45 
with 46 (Method 1) 
 A representative procedure is as follows: 45 (100.0 mg, 3.10 × 10-5 mol, 1 eq) and 
N-benzylmaleimide (29.0 mg, 1.55 × 10-4 mol, 5 eq) were measured into a 5 mL test tube 
equipped with rubber septum and dissolved in 1.00 mL of DMSO. The reaction mixture 
was degassed via three freeze-pump-thaw cycles and backfilled with argon. 100 μL of a 
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solution of hexylamine in DMSO (102 μL/mL, 7.75 × 10-5 mol, 2.5 eq) and 100 μL of a 
solution of DBU in DMSO (40.0 μL/mL, mol, 1 eq) were then added via gas tight syringe 
and the reaction stirred for 12 h at room temperature (23 °C). End-modified pDMA was 
purified by precipitation into diethyl ether (3 × 50 mL) and dried overnight in-vacuo. End 
group analysis was performed using 1H NMR (D2O) by comparing the integrated peak 
area of the benzyl aromatic protons (7.50 - 7.15 ppm, 5H) to the integrated peak area of 
the pDMA N,N-dimethyl side chain and methyne backbone protons (3.30 – 2.20 ppm, 
213.22H). NMR samples were filtered through a 0.20 μm Millex PTFE filter prior to 
analysis. 
Sequential “One-Pot” Aminolysis/Thiol-Maleimide End Group Modification of 45 with 
46 (Method 2) 
 A representative procedure is as follows: 45 (100.0 mg, 3.10 × 10-5 mol, 1 eq) and 
trimethylphosphite (18.3 μL, 1.55 × 10-4 mol, 5 eq) were measured into a 5 mL test tube 
equipped with rubber septum and dissolved in 1.00 mL of DMSO. The reaction mixture 
was degassed via three freeze-pump-thaw cycles and backfilled with argon. 100 μL of a 
solution of hexylamine in DMSO (102 μL/mL, 7.75 × 10-5 mol, 2.5 eq) was then added 
via gas tight syringe and the reaction stirred for 30 min at room temperature (23 °C) upon 
which a previously degassed solution of 46 (29.0 mg, 1.55 × 10-4 mol, 5 eq) in DMSO 
(0.5 mL) was added and the reaction stirred for 12 h at room temperature. End-modified 
45 was purified by precipitation into diethyl ether (3 × 50 mL) and dried overnight in-
vacuo. End group analysis was performed using 1H NMR (D2O) by comparing the 
integrated peak area of the benzyl aromatic protons (7.50 - 7.15 ppm, 5H) to the 
integrated peak area of the 45 N,N-dimethyl side chain and methyne backbone protons 
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(3.30 – 2.20 ppm, 213.22H). NMR samples were filtered through a 0.20 μm Millex PTFE 
filter prior to analysis. 
Chapter IV Section 4 Experimental 
tert-butyl 2-aminoethylcarbamate 47 
 
 To a 1 L flask equipped with a magnetic stir bar was added 1,2-diaminoethane 
(7.7 mL, 114 mmol) and dichloromethane (450 mL). The solution was cooled using an 
ice bath, upon which a solution of di-tert-butyl dicarbonate (5.00 g, 22.9 mmol) in 
dichloromethane (50 mL) was added dropwise via addition funnel over 2 h. Following 
complete addition, the ice bath was removed and the reaction stirred at room temperature 
for 12 h, after which the solution was filtered of solids and the filtrate concentrated via 
rotary evaporation to ~250 mL. The filtrate was then washed with half saturated brine (3 
x 150 mL), brine (1 x 150 mL), dried using MgSO4, and the solvent removed via rotary 
evaporation to yield the desired compound 47 as a colorless oil (3.25 g, 89%). 1H NMR 
(300 MHz, CDCl3): δ 3.12 (dd, J = 11.6, 5.8 Hz, 2H), 2.75 (t, J = 5.9 Hz, 2H) 1.40 (s, 
9H). 
N-(methoxycarbonyl) maleimide 48 
 
 A solution of maleimide (7.00 g, 72.1 mmol) in dichloromethane (250 mL) was 
prepared and cooled using an ice bath. A solution of N-methylmorpholine (7.92 mL, 72.1 
mmol) in dichloromethane (50 mL) was added dropwise to the solution of maleimide 
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over 10 min while stirring. Subsequently, a solution of methylchloroformate (6.69 mL, 
86.5 mmol) in dichloromethane (50 mL) was added dropwise over 1 h, upon which the 
ice bath was removed and the reaction stirred for 1 h at room temperature. The 
heterogeneous solution was then poured into a separatory funnel and washed with 1 x 250 
mL each of saturated NaHCO3, water, and brine, before drying over MgSO4. The solvent 
was removed via rotary evaporation and the product further dried in vacuo to yield 48 as 
an off white solid ( 10.26 g, 92%). 1H NMR (300 MHz, CDCl3): δ 6.80 (s, 2H), 3.88 (s, 
3H). 
tert-Butyl N-[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl]carbamate 49 
 
 A solution of 47 (3.25 g, 20.3 mmol) in saturated NaHCO3 (120 mL) was 
prepared and stirred at room temperature for 10 min before vacuum filtering to remove 
the resulting solids. The filtrate was subsequently cooled using an ice bath followed by 
the solid addition of finely ground N-(methoxycarbonyl) maleimide 48 (3.15 g, 20.3 
mmol). After 30 min, the ice bath was removed and the reaction stirred at room 
temperature for an additional 30 min. The resulting precipitate was filtered, washed with 
100 mL water, and dried overnight in vacuo to yield the desired compound 49 as a white 
solid (3.87 g, 79%). 1H NMR (300 MHz, CDCl3): δ 6.69 (s, 2H), 3.78 – 3.53 (m, 2H), 
3.31 (dd, J = 11.1, 5.8 Hz, 2H), 1.38 (s, 9H). 
tert-Butyl N-{2-[(2R,6S)-3,5-dioxo-10-oxa-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl]ethyl} 
carbamate 50 
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 A round bottomed flask equipped with a magnetic stir bar and condenser was 
charged with 49 (3.87 g, 16.1 mmol), freshly distilled furan (20 mL, 275 mmol), and 
benzene (80 mL) and heated to reflux for 12 h, upon which the reaction was concentrated 
via rotary evaporation and further dried in vacuo resulting in isolation of 50 as a white 
solid that required no further purification (4.65 g, mmol, 96%). 1H NMR (300 MHz, 
CDCl3): δ 6.49 (s, 2H), 5.24 (s, 2H), 3.75 – 3.51 (m, 2H), 3.28 (dd, J = 11.1, 5.3 Hz, 2H), 
2.83 (s, 2H), 1.40 (s, 9H). 
2-[(2R,6S)-3,5-dioxo-10-oxa-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl]ethan-1-amonium 
trifluoroacetate 51 
 
 N-bocethyl oxanorbornene 50 (4.60 g, 14.9 mmol) was dissolved in 
dichloromethane (40 mL) and cooled using an ice bath. Trifluoroacetic acid (10 mL) was 
then added via syringe over 10 min followed by stirring of the reaction overnight (12 h) 
at room temperature. Diethyl ether (250 mL) was then added to the reaction and the 
heterogeneous solution cooled using an ice bath for 30 min before isolating the resulting 
precipitate by vacuum filtration. The isolated solids were further dried in vacuo, yielding 
51 as a white solid (4.64 g, 97%). 1H NMR (300 MHz, D2O): δ 6.64 (s, 2H), 5.36 (s, 2H), 
3.84 (t, J = 5.8 Hz, 2H), 3.23 (t, J = 5.9 Hz, 2H), 3.19 (s, 2H). 
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(2R,6S)-4-[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl]-10-oxa-4 
azatricyclo[5.2.1.02,6] dec-8- ene-3,5-dione 52 
 
 Oxanorbornene ethylamine TFA 51 (4.72 g, 14.6 mmol) was dissolved in 
saturated NaHCO3 (200 mL) and cooled using an ice bath.  The solution was stirred while 
purging with N2 for 10 min at 0 °C to dispel any dissolved CO2. Subsequently, finely 
ground N-(methoxycarbonyl) maleimide 48 (2.27 g, 14.6 mmol) was then added as a 
solid to the solution of 51, followed by stirring for 30 min at 0 °C, upon which the ice 
bath was removed and the reaction stirred for an additional 3 h at room temperature. The 
resulting precipitate was isolated via vacuum filtration and the filtrand washed with water 
(50 mL) before drying overnight in vacuo to yield the desired compound 52 as an off-
white solid (2.09 g, 48%). 1H NMR (300 MHz, CDCl3): δ 6.65 (s, 2H), 6.47 (d, J = 0.7 
Hz, 2H), 5.19 (t, J = 0.8 Hz, 2H), 3.84 – 3.59 (m, 4H), 2.81 (s, 2H). 
N-(3-bromopropyl)maleimide 53 
 
 3-Bromopropylamine hydrobromide (2.00 g, 9.1 mmol) was dissolved in 
saturated NaHCO3 (100 mL) and cooled using an ice bath. The solution was allowed to 
stir for 10 min at 0 °C while purging with N2 to dispel any dissolved CO2. Subsequently, 
finely ground N-(methoxycarbonyl) maleimide 48 (1.42 g, 9.1 mmol) was added as a 
solid to the solution of 3-bromopropylamine, followed by stirring for 30 min at 0 °C, 
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upon which the ice bath was removed and the reaction stirred for an additional 1 h at 
room temperature. The resulting precipitate was isolated via vacuum filtration and the 
filtrand washed with water (50 mL) before drying overnight in vacuo to yield the desired 
compound 53 as a white solid (1.23 g, 62%). Note: after ~1 hr, additional 53 formed in 
the filtrate as colorless plate-like crystals. This additional product was isolated by 
vacuum filtration followed by drying in-vacuo. 1H NMR (300 MHz, CDCl3): δ 6.70 (s, 
2H), 3.65 (t, J = 6.9 Hz, 2H), 3.34 (t, J = 6.6 Hz, 2H), 2.15 (p, J = 6.7 Hz, 2H). 
(2R,6S)-4-(3-bromopropyl)-10-oxa-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione 54 
 
 A round bottomed flask equipped with a magnetic stir bar and condenser was 
charged with 3-bromopropyl maleimide 53 (5.16 g, 23.7 mmol), freshly distilled furan 
(30 mL, 413 mmol), and benzene (150 mL) and heated to reflux for 12 h, upon which the 
reaction was concentrated via rotary evaporation and further dried in vacuo resulting in 
isolation of 54 as a white solid that required no further purification (6.16 g, 91%). 1H 
NMR (300 MHz, CDCl3): δ 6.49 (s, 2H), 5.25 (s, 2H), 3.61 (t, J = 6.9 Hz, 2H), 3.31 (t, J 
= 6.7 Hz, 2H), 2.83 (s, 2H), 2.12 (p, J = 6.8 Hz, 2H). 
Sodium Methanethiosulfonate 55 
 
 Sodium methanesulfinate (5.00 g, 49 mmol) and elemental sulfur (1.57 g, 49 
mmol) were combined in anhydrous methanol (500 mL) and heated to reflux. After 30 
min, a homogenous solution was observed and the reaction cooled to room temperature, 
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followed by solvent removal via rotary evaporation. The resulting crude solid was 
triturated with absolute ethanol (2 x 30 mL) and further dried in vacuo yielding 55 as a 
white crystalline solid (6.27 g, 95%) m.p. 271-272 °C (lit. 272-273 °C) 1H NMR (300 
MHz, D2O): δ 3.36 (s, 3H). 
(2R,6S)-4-[3-(methanesulfonylsulfanyl)propyl]-10-oxa-4-azatricyclo[5.2.1.02,6]dec-8-
ene-3,5-dione 56 
 
 Oxanorbornene propylbromide 54 (5.24 g, 18.3 mmol) and sodium 
methanethiosulfonate 55 (3.69 g, 27.5 mmol) were dissolved in DMF (40 mL) and heated 
at 50 °C for 18 h. Most of the solvent was removed via rotary evaporation and the crude 
product was dissolved in EtOAc (100 mL) and washed with water (2 x 50 mL) and brine 
(1 x 50 mL) before drying over MgSO4. The solvent was then removed in vacuo to yield 
the product 56 as a yellow solid (5.00 g, 86%). 1H NMR (300 MHz, CDCl3): δ 6.50 (s, 
2H), 5.25 (s, 2H), 3.61 (t, J = 6.5 Hz, 2H), 3.31 (s, 3H), 3.07 (t, J = 7.3 Hz, 2H), 2.84 (s, 
2H), 2.15 – 1.99 (m, 2H). 
Synthesis of 57 
 
 Styrene (15.00 g, 120 eq.), 44 (246.0 mg, 1 eq.), and AIBN (29.6 mg, 0.15 eq.) 
were combined in a 25 mL Schlenk tube equipped with magnetic stir bar and sealed 
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before degassing by three freeze-pump-thaw cycles and backfilled under argon. The 
reaction vessel was then heated in an oil bath at 65 °C for 5.25 h, upon which the reaction 
was quenched via exposure to air and freezing in liquid nitrogen. The polymer was 
precipitated 3 times in to methanol, redissolving in a minimal amount of CH2Cl2 between 
precipitations. The final product 57 was dried overnight in-vacuo before characterizing 
via NMR and DMF SEC-MALLS. Mn(NMR) = 3090 g/mol, Mn(SEC) = 2980 g/mol, Ð = 
1.03, dn/dc = 0.160 mL/g. 
Synthesis of 58 
 
 N,N-dimethylacrylamide (28.0 g, 282 mmol), 44 (298.0 mg, 1.34 mmol), AIBN 
(44.1 mg, 0.27 mmol), and benzene (100 mL) were combined in a 250 mL round 
bottomed flask equipped with magnetic stir bar and sealed with a rubber septum before 
purging with N2 for 45 mins. The reaction vessel was then heated in an oil bath at 60 °C 
for 6 h, upon which the reaction was quenched via exposure to air and freezing in liquid 
nitrogen. The solvent was removed by rotary evaporation and the polymer precipitated 4 
times into pentane, redissolving in a minimal amount of CH2Cl2 between precipitations. 
The final product 58 was dried overnight in-vacuo before characterizing via 1H NMR 
(D2O) and SEC-MALLS (DMF 20 mM LiBr). Mn(NMR) = 3700 g/mol, Mn(SEC) = 3630 
g/mol, Ð = 1.05, dn/dc = 0.086 mL/g. 
End group functionalization of 57 with 52 (59) 
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 57 (600 mg, 1.94 × 10-4 mol, 1 eq), THF (2.00 mL) and trimethylphosphite (114.4 
μL, 9.69 × 10-4 mol, 5 eq) were measured into a 10 mL test tube equipped magnetic stir 
bar and sealed with a rubber septum. The reaction mixture was degassed via three freeze-
pump-thaw cycles and backfilled with argon. Propylamine (39.9 μL, 4.85 × 10-4 mol, 2.5 
eq) was then added via gas tight syringe and the reaction stirred for 60 min at room 
temperature upon which a previously degassed solution of 52 (280.0 mg, 9.69 × 10-4 mol, 
5 eq) in THF (4.0 mL) was added and the reaction stirred for 12 h at room temperature. 
59 was purified by precipitation into MeOH (3 × 50 mL) and dried overnight in-vacuo. 
End group analysis was performed using 1H NMR (acetone-d6) by comparing the 
integrated peak area of the norbornene bridgehead methyne protons (5.25 – 4.95 ppm, 
2H) to the integrated peak area of the polystyrene aromatic side chain protons (7.50 – 
6.25 ppm, 137.92 H). 
End group functionalization of 57 with 56 (60) 
 
 57 (500 mg, 1.6 × 10-4 mol, 1 eq), 56 (307 mg, 9.7 × 10-4 mol, 6 eq), and THF (2 
mL) were combined in a 5 mL test tube equipped with magnetic stir bar and sealed with a 
rubber septum. The reaction mixture was degassed via three freeze-pump-thaw cycles 
and backfilled with argon. Propylamine (200 μL, 2.4 × 10-3 mol, 15 eq) was then added 
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by gas-tight syringe and the reaction stirred for 12 h at room temperature. 60 was purified 
by precipitation into MeOH (3 x 50 mL) and dried overnight in-vacuo. End group 
analysis of 60 was performed in analogous fashion to that described for analysis of 58. 
End group functionalization of 58 with 52 (61) 
 
 58 (500 mg, 1.35 × 10-4 mol, 1 eq), THF (2.00 mL) and trimethylphosphite (79.5 
μL, 7.74 × 10-4 mol, 5 eq) were measured into a 10 mL test tube equipped magnetic stir 
bar and sealed with a rubber septum. The reaction mixture was degassed via three freeze-
pump-thaw cycles and backfilled with argon. Hexylamine (35.4 μL, 4.85 × 10-4 mol, 2.0 
eq) was then added via gas tight syringe and the reaction stirred for 30 min at room 
temperature upon which a previously degassed solution of 52 (194.0 mg, 7.74 × 10-4 mol, 
5 eq) in THF (4.0 mL) was added and the reaction stirred for 12 h at room temperature. 
The reaction mixture was then dialyzed against water (3 x 200 mL), changing the water 
every hour. The aqueous solution was reclaimed from the dialysis bag and filtered 
through a 0.2 uM Millipore filter and then further dialyzed against MeOH (5 x 100 mL), 
changing the solvent every hour. 61 was subsequently isolated by rotary evaporation as a 
colorless solid. End group analysis was performed using 1H NMR (D2O) by comparing 
the integrated peak area of the norbornenyl olefin protons (6.65 – 6.55 ppm, 2H) to the 
integrated peak area of the pDMA N,N-dimethyl side chain and methyne backbone 
protons (3.30 – 2.20 ppm, 246.26H). 
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End group functionalization of 58 with 56 (62) 
 
 58 (500 mg, 1.6 × 10-4 mol, 1 eq), 56 (307 mg, 9.7 × 10-4 mol, 6 eq), and THF (2 
mL) were combined in a 5 mL test tube equipped with magnetic stir bar and sealed with a 
rubber septum. The reaction mixture was degassed via three freeze-pump-thaw cycles 
and backfilled with argon. Propylamine (200 μL, 2.4 × 10-3 mol, 15 eq) was then added 
by gas-tight syringe and the reaction stirred for 12 h at room temperature. The reaction 
mixture was then dialyzed against water (3 x 200 mL), changing the water every hour. 
The aqueous solution was reclaimed from the dialysis bag and filtered through a 0.2 uM 
Millipore filter and then further dialyzed against MeOH (5 x 100 mL), changing the 
solvent every hour. 62 was isolated by rotary evaporation as an off-white solid. End 
group analysis of 62 was performed in analogous fashion to that described for analysis of 
61.  
 
Synthesis of 3rd Generation Grubbs Catalyst 19 
 
 Grubbs 2nd generation catalyst (500 mg, 0.12 mmol) was weighed into a 
scintillation vial containing a small magnetic stir bar followed by the addition of pyridine 
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(0.474 mL, 5.88 mmol) in the presence of air. After 5 min, pentane (20 mL) was added to 
the vial resulting in precipitation of a bright green solid. The vial was placed in the 
refrigerator (5 °C) overnight upon which the green 3rd generation Grubbs catalyst 19 was 
isolated by vacuum filtration and washed with pentane (20 mL) before drying in-vacuo. 
19 was subsequently stored under argon in the dark at 5 °C. Yield: 400 mg, 93%. 
ROMP of RAFT-Derived Macromonomers 58, 59, 60, or 61 
 
 A representative procedure is as follows: A stock solution of 19 (1 eq.) in CH2Cl2 
(degassed by 4 x freeze-pump-thaw cycles and backfilled with argon) was measured into 
a vial that was previously degassed with argon. A separate vial containing 59 (100.0 mg, 
50 eq,) was evacuated and backfilled with argon. Degassed CH2Cl2 (200 uL) was added 
to the vial of 59, upon which the solution was transferred by gas tight syrige to the vial of 
19. The reaction was stirred for 6 h at room temperature before being terminated via the 
addition of one drop of ethyl vinyl ether followed by precipitation in MeOH. 
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CHAPTER IV 
RESULTS AND DISCUSSION 
Section 1. Tunable pH- and CO2-Responsive Sulfonamide-Containing  
Polymers by RAFT Polymerization 
Overview 
 Lately, extensive research efforts have been directed toward the synthesis of well-
defined (co)polymers capable of rapid and reversible changes in solubility and/or 
conformation in response to external stimuli including pH,144,228,229 temperature,230,231 or 
ionic strength,232 among others.233–235 Of particular interest are “smart” nanocarriers for 
drug and gene delivery that exploit discrete changes in physiological pH to elicit the 
desired therapeutic effect.236–240 Designing such polymeric systems requires that the 
morphological transitions occur over a very narrow designated pH range. Commonly, this 
specificity is achieved by the selection of a monomer with a pKa at or near the target 
transition pH; however, polymer design is accordingly restricted by the limited choice in 
monomers and their respective pKa values. Consequently, a facile method of specifically 
tuning polymer pH-responsiveness while maintaining a narrow transition range is needed. 
 
Scheme 4.1. pH-dependent solubility of pMSAs. 
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 A number of attempts have been made to systematically vary the pH-
responsiveness of polymers.57,241 One versatile approach towards modification of 
polymer pKa was reported by Ringsdorf in seminal work in which a library of 
sulfonamide-containing polymers derived from sulfa drugs was synthesized by classical 
free radical or Michael-addition techniques.242 Variation of the sulfonamide R-group 
afforded facile, tunable control over polymer pKa and subsequent pH-dependent 
solubility (Scheme 4.1). Recently, Bae and coworkers further demonstrated this 
versatility in pKa selection for a variety of polymer-based therapeutic applications.
237,243–
245 However, until now the uncontrolled nature of the polymerization methods used to 
prepare such polymers has limited the ability to attain well-defined polymer architectures 
with the specific molecular weights and narrow molecular weight distributions required 
for responsive nanotherapeutics. 
 Reversible-deactivation radical polymerization (RDRP) techniques such as 
nitroxide-mediated polymerization (NMP), atom transfer radical polymerization (ATRP), 
and reversible addition-fragmentation chain transfer (RAFT) polymerization have made 
possible the synthesis of (co)polymers of a wide variety of architectures with predictable 
molecular weights and narrow molecular weight distributions.76,246,247 In particular, 
RAFT has been used to directly polymerize a variety of cationic, anionic, and other 
functional monomers in organic or aqueous media without the necessity of protecting 
group chemistries or post-polymerization modification.89,247 The facility of 
polymerization and excellent functional group tolerance of RAFT polymerization have 
driven our current objectives of synthesizing sulfonamide-containing polymers in a 
controlled fashion. 
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 In this chapter we report, to our knowledge, the first controlled RAFT 
polymerization of a library of methacryloyl sulfonamide (MSA) monomers possessing 
pKa values in the biologically relevant regime (pH = 4.5-7.4). In this work we show that 
temperature has a significant influence on the polymerization of MSAs, with lower 
reaction temperatures affording improved molecular weight control and functional chain 
end retention. Varying the sulfonamide R-group is shown to be an effective means of 
adjusting monomer pKa and subsequently the pH-dependent solubility of the resulting 
polymethacryloyl sulfonamides (pMSAs). During our study of the weakly acidic/basic 
nature of the MSA derivatives chosen, we found a remarkably facile and reversible CO2-
induced solubility transition in aqueous solutions. The demonstrated control over RAFT 
polymerization of MSAs now allows new routes for the synthesis of advanced polymer 
architectures with tunable pH- and CO2-responsive properties for ultimate use in 
biological and therapeutic applications. 
RAFT Polymerization of Methacryloyl Sulfonamides (MSAs) at 70 °C 
 The MSA monomers 27-32 (R-groups shown in Scheme 4.2) were targeted for 
this work based upon their respective pKa values (Table 4.3) that reside within the 
biologically relevant pH range of 4.5-7.4. Utilizing a modified literature procedure,237 
high monomer yields (>90%) were obtained from the reaction of methacryloyl chloride 
and the appropriate sulfa drug precursor, as outlined in the experimental section. 
 Achieving controlled RAFT polymerization of a given monomer requires 
appropriate choice of CTA and polymerization conditions. Previously, our group 
successfully utilized the trithiocarbonate 4-cyano-4-
(ethylsulfanylthiocarbonylsulfanyl)pentanoic acid (26) and the dithioester 4-
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cyanopentanoic acid dithiobenzoate (23) to polymerize a wide variety of 
(meth)acrylamide monomers in aqueous or organic media in a controlled fashion.153,248 
Based on that work, we have investigated the RAFT polymerization of MSAs using 26 
and 23 as outlined in Scheme 4.2. It is worth noting that although these monomers are 
water soluble, polymerizations were conducted in DMF in order to avoid CTA hydrolysis 
or aminolysis.119 
 
Scheme 4.2. Synthetic pathway for the 23- or 26-mediated RAFT polymerization of 
MSAs in DMF. 
 
 Initially, 26- and 23-mediated RAFT polymerizations of methacryloyl 
sulfacetamide (27) were carried out at 70 °C in DMF using V-501 as the initiator at molar 
ratios of [M]0:[CTA]0:[I]0 = 150:1:0.2. As illustrated in Figure 4.1, a near linear pseudo-
first-order kinetic plot is observed for the polymerization of 27 with 26 at 70 °C. After an 
initialization period of approximately 30 min, monomer conversion reached 81% after 
600 min. The 23-mediated polymerization of 27 at 70 °C under analogous conditions was 
significantly slower, reaching only 12% monomer conversion after 600 min. Retardation 
in rate of dithiobenzoate-mediated polymerizations as compared to analogous reactions 
mediated by trithiocarbonates has been observed previously for styrenics, acrylates, and 
acrylamides with some monomers failing to polymerize in the presence of a 
dithiobenzoate RAFT agent.107,249 
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Figure 4.1. Kinetic plots for the 23- and 26-mediated RAFT polymerization of 27 at 70 
°C in DMF ([M]0:[CTA]0:[I]0 = 150:1:0.2). 
 
 Despite near ideal linear pseudo-first-order kinetic behavior, the 26-mediated 
polymerization of 27 at 70 °C produced polymers with Mw/Mn of 1.27 or higher (Table 
4.1). Similarly, the polymerization of 27 with 23 yielded polymers with Mw/Mn >1.20. 
The increased conversions achieved during the 26-mediated polymerization of 27 
prompted our use of this CTA to polymerize each monomer derivative in order to 
ascertain what influences the sulfonamide R-group might have on conversion, molar 
mass, and molecular weight distribution (Table 4.1). As with the 26-mediated 
polymerization of 27 at 70 °C, each substituted monomer derivative also yielded 
moderately broad molecular weight distributions, typically increasing with conversion, 
and indicative of limited polymerization control. 
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Table 4.1 
Conversion, molar mass, and molecular weight distribution data for the RAFT 
polymerization of MSAs in DMF at 70 °C.a 
 
entry monomer CTA 
time 
(min) 
conv.b 
(%) 
[M]0 
(mol/L) 
Mntheoryc 
(g/mol) 
Mnexpd 
(g/mol) 
Mw/Mnd 
1a 27 23 120 7 1.0 3200 4400 1.19 
1b 27 23 360 10 
 
4500 5800 1.18 
1c 27 23 600 12 
 
5400 6200 1.27 
2a 27 26 120 22 1.0 9400 14 600 1.27 
2b 27 26 360 67 
 
28 500 26 400 1.41 
2c 27 26 600 81 
 
34 700 29 700 1.44 
3a 28 26 120 13 1.0 7000 7400 1.27 
3b 28 26 360 48 
 
25 000 22 000 1.24 
3c 28 26 600 66 
 
34 200 28 100 1.26 
4a 29 26 120 16 0.83 8800 13 900 1.22 
4b 29 26 360 51 
 
26 800 29 800 1.27 
4c 29 26 600 69 
 
36 300 35 500 1.29 
5a 30 26 120 35 1.0 18 000 22 000 1.55 
5b 30 26 420 79 
 
40 600 34 900 1.78 
5c 30 26 600 85 
 
43 300 35 200 1.81 
6a 31 26 120 12 0.83 6900 15 100 1.23 
6b 31 26 360 47 
 
26 800 34 600 1.20 
6c 31 26 600 73 
 
41 900 44 400 1.28 
7a 32 26 120 15 0.83 8800 11 100 1.10 
7b 32 26 420 62 
 
35 500 25 900 1.45 
7c 32 26 600 67 
 
38 500 27 100 1.47 
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aSulfonamide monomers were polymerized at 70 °C in DMF ([M]0:[CTA]0:[I]0 = 150:1.0:0.2) using V-501 as the initiator. 
bConversions were determined by 1H NMR (DMSO-d6) by comparing the relative integral areas of trimesic acid (internal standard) 
aromatic protons (8.64 ppm, 3H) to the vinyl proton of the sulfonamide monomer (5.84 ppm, 1H). cTheoretical number average 
molecular weights were calculated according to the following equation: Mn=(ρ·MWmon·[M]/[CTA]) + MWCTA where ρ is the 
fractional monomer conversion, MWmon is the molecular weight of the monomer, and MWCTA is the molecular weight of the CTA.  
dAs determined by SEC-MALLS (95:5 (v:v) DMF:CH3COOH 20 mM LiBr). 
Chain Extension of P27 macroCTA at 70 °C 
 The degree of “living” chain end retention was investigated by synthesizing and 
isolating a P27 macroCTA using 26 (P27-26) (Mn = 7 300 g/mol, Mw/Mn = 1.35), 
followed by chain extension with 27 to yield the corresponding chain extended polymer 
(P27-b-P27-26). Figure 4.2 shows the SEC traces of both the initial monomodal P27-26 
macroCTA and the corresponding P27-b-P27-26 polymer after chain extension with 27. 
The latter exhibits multimodality and broad molecular weight distribution, indicating 
extensive loss of “living” polymer chain ends during the initial polymerization of the P27 
macroCTA. Loss of “living” polymer chains is most often attributed to irreversible 
radical termination, undesirable chain transfer events, or degradation of the 
thiocarbonylthio chain ends. During the 23- and 26-mediated polymerizations of MSAs at 
70 °C, we observed a loss of the characteristic color of 23 (pink) and 26 (yellow) after 
extended polymerization times, qualitatively indicating degradation of the dithiobenzoate 
and trithiocarbonate moieties, respectively. 
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Figure 4.2. SEC traces of P27 macroCTA (Mn = 7300 g/mol, Mw/Mn = 1.35) and P27-b-
P27 after chain extension at 70 °C in DMF. 
 
RAFT Polymerization of Methacryloyl Sulfonamides at 30 °C 
 Hypothesizing that a deleterious side reaction was competing with chain 
extension during the CTA-mediated polymerization, we lowered the reaction 
temperature. Such approaches have been previously successful in RAFT polymerizations, 
yielding well-defined copolymers that maintained a high degree of chain end 
functionality.158,250,251 Figure 4.3 shows the comparative SEC chromatograms of the 26-
mediated polymerizations of 27 at 70 °C and 30 °C under the polymerization conditions 
outlined in Table 4.1. It should be noted that the 30 °C reaction utilized the low 
decomposition temperature initiator 2,2’-azobis(4-methoxy-2-4-dimethyl valeronitrile) 
(V-70). While both reactions produced polymers with similar number average molecular 
weights, the resulting molecular weight distribution of the polymer synthesized at 30 °C 
(58 % conversion, Mn = 29 700 g/mol, Mw/Mn = 1.05) was substantially lower than the 
polymer prepared at 70 °C (67% conversion, Mn = 26 400 g/mol, Mw/Mn = 1.41). 
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Figure 4.3. DMF SEC RI traces of P27 polymerized at 30 °C and 70 °C using V-70 and 
V-501, respectively. 
 
 Figure 4.4a shows the kinetic plots for the respective 26- and 23-mediated 
polymerizations of 27 at 30 °C. The former exhibited a longer pre-equilibrium 
(initialization) period (~60 min) as compared to polymerization at 70 °C; however, linear 
pseudo-first-order kinetic behavior was observed up to 600 min. Deviation from linearity 
at longer times in this particular case is possibly due to the reduced radical flux observed 
as the initiator concentration decreases substantially at prolonged reaction times, as we 
have previously reported.95 Figure 4.4b shows the SEC chromatogram overlay at 
specified times during the 30 °C polymerization of 27 with 26. The progression of the 
polymer traces to lower elution volumes with corresponding increases in RI intensity, 
without high molecular weight shouldering, is indicative of controlled polymerization 
behavior and thus maintenance of thiocarbonylthio functionality. This is further indicated 
by the narrow molecular weight distributions (Figure 4.4c) and linear progression of Mn 
vs. monomer conversion (Figure 4.4d) observed for the 30 °C polymerization of 27. 
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While Mn increases in a linear fashion during the RAFT polymerization of 27 at 30 °C, 
experimentally determined molecular weights (Mnexp) are marginally higher than those 
theoretically predicted (Mntheory) based upon monomer conversion. The higher than 
expected molecular weights determined by MALLS directly of aliquots taken from the 
polymerization could be indicative of irreversible coupling of CTA intermediate radicals 
during the initialization stage.106,252,253 
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Figure 4.4. a) Pseudo-first-order kinetic plots for the 26- and 23-mediated RAFT 
polymerization of 27 at 30 °C in DMF ([M]0:[CTA]0:[I]0 = 150:1:0.2). b) SEC overlay 
for 26-mediated polymerization of 27 at 30 °C in DMF. c) Mw/Mn versus conversion. d) 
Mn versus conversion. 
 
 Table 4.2 summarizes the conversion, molar mass, and molecular weight 
distribution data for the RAFT polymerization of each MSA derivative in DMF at 30 °C 
using either 26 or 23 as the RAFT agent and V-70 as the initiator. Reducing the 
polymerization temperature to 30 °C results in Mw/Mn values typically below 1.10 for all 
monomer derivatives. Mn values determined by DMF SEC-MALLS are in reasonable 
agreement with theoretical values calculated from monomer conversion; however, Mnexp 
exceeds Mntheory in a similar manner to that discussed earlier. Furthermore, all 
polymerizations conducted at 30 °C maintained the characteristic color of the parent 
CTA, indicating limited degradation as compared to that at 70 °C. 
 The 23-mediated polymerization of 27 conducted at 30 °C resulted in 34% 
monomer conversion after 710 min and narrow molecular weight distributions even after 
1500 min of polymerization (53% conversion, Mn = 20 500 g/mol, Mw/Mn = 1.03) (Table 
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4.2) with the Mn values determined by DMF SEC-MALLS agreeing well with the 
theoretical values. The analogous reaction conducted at 70 °C yielded 12% monomer 
conversion after 600 min and relatively broad molecular weight distributions (Mn = 6 200 
g/mol, Mw/Mn = 1.27) (Table 4.1). The strikingly higher rate of polymerization observed 
for the 23-mediated polymerization of 27 performed at 30 °C as compared to 70 °C is 
consistent with effectively minimizing (though not completely eliminating) competing 
dithioester degradation and limiting the accumulation of potentially rate-retarding 
degradation byproducts. 
Table 4.2 
Conversion, molar mass, and molecular weight distribution data for the RAFT 
polymerization of MSAs in DMF at 30 °C.a 
 
entry monomer CTA 
time 
(min) 
conv.b 
(%) 
[M]0 
(mol/L) 
Mntheoryc 
(g/mol) 
Mnexpd 
(g/mol) 
Mw/Mnd 
1a 27 23 350 19 1.0 8300 9500 1.02 
1b 27 23 710 34 
 
14 700 16 700 1.01 
1c 27 23 1500 53 
 
22 700 20 500 1.03 
2a 27 26 350 26 1.0 11 300 16 300 1.08 
2b 27 26 710 58 
 
24 800 29 700 1.05 
2c 27 26 1500 81 
 
34 600 37 500 1.03 
3a 28 26 350 10 1.0 5600 8100 1.19 
3b 28 26 710 30 
 
15 900 14 500 1.12 
3c 28 26 1500 69 
 
36 000 28 600 1.02 
4a 29 26 350 11 0.83 5700 10 300 1.12 
4b 29 26 710 35 
 
18 200 22 100 1.06 
4c 29 26 1500 61 
 
32 200 35 400 1.06 
5a 30 26 240 8 1.0 4200 8100 1.16 
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Table 4.2 (continued). 
entry monomer CTA time 
(min) 
conv.b 
(%) 
[M]0 
(mol/L) 
Mntheoryc 
(g/mol) 
Mnexpd 
(g/mol) 
Mw/Mnd 
5b 30 26 360 14 
 
7500 12 200 1.06 
5c 30 26 780 54 
 
28 200 33 200 1.05 
6a 31 26 240 7 0.83 6300 10 800 1.11 
6b 31 26 360 13 
 
14 800 16 700 1.05 
6c 31 26 780 44 
 
35 500 43 800 1.04 
7a 32 26 240 11 0.83 4200 8700 1.10 
7b 32 26 360 26 
 
7500 11 800 1.06 
7c 32 26 780 62 
 
25 000 30 100 1.07 
 
aSulfonamide monomers were polymerized at 30 °C in DMF ([M]0:[CTA]0:[I]0 = 150:1.0:0.2) using V-70 as the initiator. 
bConversions were determined by 1H NMR (DMSO-d6) by comparing the relative integral areas of trimesic acid (internal standard) 
aromatic protons (8.64 ppm, 3H) to the vinyl proton of the sulfonamide monomer (5.84 ppm, 1H). cTheoretical number average 
molecular weights were calculated according to the following equation: Mn=(ρ·MWmon·[M]/[CTA]) + MWCTA where ρ is the 
fractional monomer conversion, MWmon is the molecular weight of the monomer, and MWCTA is the molecular weight of the CTA.  
dAs determined by SEC-MALLS (95:5 (v:v) DMF:CH3COOH 20 mM LiBr). 
Chain Extension of P27macroCTA at 30 °C 
 To further demonstrate the controlled RAFT polymerization of MSAs at low 
temperatures, a P27macroCTA was prepared at 30 °C using V-70 as the initiator and 
isolated before chain extending with additional 27 at 30 °C. Figure 4.5 shows the SEC 
chromatogram of the P27 macroCTA (Mn = 25 100 g/mol, Mw/Mn = 1.09) and a distinct 
decrease in elution volume of the chain-extended polymer (P27-b-P27) (Mn = 49 600 
g/mol, Mw/Mn = 1.07). The monomodal SEC chromatogram and absence of low 
molecular weight tailing at higher elution volumes of the chain extended polymer is 
additional evidence of improved chain end retention during the polymerization of MSAs 
at 30 °C as compared to the analogous chain extension conducted at 70 °C (Figure 4.2). 
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Figure 4.5. SEC traces of P27 macroCTA (Mn= 25 100 g/mol, Mw/Mn = 1.09) and P27-
b-P27 (Mn = 49 600 g/mol, Mw/Mn = 1.07) after chain extension in DMF. Both 
polymerizations were conducted at 30 °C. 
 
Methacryloyl Sulfonamide Monomer pKa Studies 
 MSA monomer titrations were performed to determine the pKa of each monomer 
derivative after converting the respective sulfa drug precursors into the corresponding 
methacrylamides. The pKa of the sulfonamide (SO2NH) group of each monomer 
derivative was determined by equation 7 where pHEP1/2 is the pH corresponding to the 
half equivalence point (EP1/2) of the titration curve. The volume of HCl titrant required to 
reach the EP1/2 (VolEP1/2) was determined by equation 8 where VolEP is the volume of HCl 
titrant required to reach the equivalence point of the titration curve, [SO2NH] is the 
sulfonamide concentration, [HCl] is the concentration of HCl titrant used, and Volsol is 
the initial volume of the monomer solution being titrated. Figure 4.6 shows the positions 
of EP and EP1/2 on the titration curve for 27. 
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 𝑝𝐾𝑎 = 𝑝𝐻𝐸𝑃1/2 (7) 
      
 𝑉𝑜𝑙𝐸𝑃1/2 =  𝑉𝑜𝑙𝐸𝑃 +
1
2
[𝑆𝑂2𝑁𝐻]
[𝐻𝐶𝑙]
𝑉𝑜𝑙𝑠𝑜𝑙 (8) 
Table 4.3 contains the pKa values for each monomer calculated using equation 1 along 
with the literature reported pKa values for the corresponding sulfa drug precursors. A 
general trend is observed whereby the pKa of the MSA is lower than that of the sulfa drug 
precursor which is consistent with the decrease in pKa observed upon acetylation of the 
p-amino group of sulfa drugs.254 
 
Figure 4.6. EP and EP1/2 locations on the titration curve of 27 (1 mM) titrated against 
HCl (0.05 N) at 25 °C using a Metrohm 848 Titrino Plus autotitrator. 
 
pH-dependent Solubility of Poly(methacryloyl sulfonamides) 
 The titration curves (Figure 4.7) demonstrate the facility by which the pH-
dependent solubility of pMSAs can be “tuned” by simply varying the sulfonamide R-
group of the monomer. The changes in polymer solubility occur over a very narrow range 
of typically 0.5 pH units. Table 4.3 summarizes the pH-dependent solubility of each 
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MSA derivative. The critical onset of precipitation (pH*), is defined as the pH 
corresponding to 90% light transmittance. For each of the MSA derivatives, pH* of the 
polymer is greater than the pKa of the corresponding monomer. The pH* of a particular 
pMSA is dependent upon the monomer pKa and the relative hydrophobicity of the 
monomer derivative, both influenced by the sulfonamide R-group. The mutual influence 
of these two parameters is readily apparent by comparing the pH* and pKa values for P27 
and P28 (Table 4.3). While the pKa of 28 (4.51) is lower than that of 27 (4.88), the pH* 
for P28 (5.3) is higher than that of P27 (5.1) due to the greater hydrophobicity of the 
benzoyl R-group. 
Table 4.3 
MSA monomer and polymer titration data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
polymer 
Mnexp 
(g/mol) 
Mw/Mn 
sulfadrug 
pKa 
monomer 
pKa 
pH* 
P27 31 400 1.04 5.38 4.88 ± 0.01 5.3 
P28 27 500 1.03 4.57 4.51 ± 0.01 5.7 
P29 32 000 1.05 5.29 5.19 ± 0.03 6.3 
P30 24 400 1.03 6.16 5.44 ± 0.01 6.7 
P31 43 800 1.04 6.70 5.75 ± 0.01 7.5 
P32 34 400 1.08 7.49 7.33 ± 0.02 7.9 
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Figure 4.7. Substituent effects on pH-dependent solubility transitions of sulfonamide-
containing polymers. Percent transmittance was measured using a UV-Vis 
spectrophotometer (λ = 500 nm). 
 
CO2-dependent Solubility of Poly(methacryloyl sulfonamides) 
 To date, CO2-responsive polymers rely almost exclusively upon protonation of 
amine or amidine functional groups by carbonic acid (produced upon dissolution of CO2 
in water) that alters polymer solubility and conformation in solution.235,255 However, 
there are very few examples of CO2-responsive polymers based upon acidic functional 
groups.256 In order for acid-functional polymers to exhibit CO2-induced changes in phase 
or conformation, the pKa of the acidic functional group and more importantly the pH* of 
the corresponding polymer, must be greater than the pH of the solution upon production 
of carbonic acid via dissolution of CO2. Therefore, weakly acidic polyacids that exhibit 
pH-responsive behaviors above pH = 4 (the pH of an aqueous solution in equilibrium 
with 1 atm of CO2 at 25 °C) should also exhibit similar changes in properties upon CO2-
induced solution acidification. 
 The weakly acidic pMSA derivatives we report here exhibit pH* values above pH 
= 5.0, making these ideal candidates as CO2-responsive polymers. To demonstrate the 
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reversible CO2-responsiveness of pMSAs, polymethacryloyl sulfamethazine (P29) (Mn = 
34 400 g/mol, Mw/Mn = 1.08) (1 eq sulfonamide functional group) was dissolved in 0.05 
N NaOH (1.25 eq) and diluted with DI H2O to yield a final [SO2NH] = 6.7 mM and 
[NaOH] = 8.4 mM. The solution was purged with CO2 (10 s) and then N2 (25 min) and 
the % transmittance (λ = 500 nm) of the polymer solution measured before and after each 
purge cycle using a UV-Vis spectrophotometer. Figure 4.8 shows % transmittance as a 
function of purge cycle and illustrates the reversible CO2-triggered change in aqueous 
solubility of P29. 
 
Figure 4.8. Reversible solubility of P29 in response to presence or absence of CO2. 
Solutions were purged with either CO2 for 10 s (shaded regions) or N2 for 25 min 
(unshaded regions) and % transmittance measured using a UV-Vis spectrophotometer (λ 
= 500 nm). 
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Section 2. Mechanistic Insights into Temperature-Dependent Trithiocarbonate Chain-End 
Degradation during the RAFT Polymerization of N-Arylmethacrylamides 
Overview 
 The acknowledged utility of reversible-deactivation radical polymerization 
(RDRP) is the facile synthesis of polymers with precise compositions, predetermined 
molecular weights, and well-defined architectures while incorporating monomers 
possessing a wide variety of functional groups.76,89,246,247 The success of any RDRP 
technique depends greatly upon maintaining “living” chain end fidelity. In particular, the 
reversible addition-fragmentation chain transfer (RAFT) process must retain 
thiocarbonylthio end groups in order to maintain the active/dormant equilibrium 
necessary for polymerization control. While thiocarbonylthio reactivity has often been 
exploited as a facile means of post-polymerization end group modification of RAFT 
polymers,257–263 a number of deleterious side reactions involving the thiocarbonylthio 
moiety can occur including hydrolysis,119 aminolysis,95,119 thermolysis,264 oxidation,265,266 
and irreversible coupling of intermediate radicals.252,267,268 It is therefore important to 
fully understand the nature of any degradative reactions involving thiocarbonylthio end 
groups in order to extend the current capabilities of RAFT polymerization. 
 Recently, we reported the RAFT polymerization of a library of pH-responsive 
methacryloyl sulfonamide (MSA) monomers derived from sulfa drugs.97 Loss of chain 
end functionality was observed during the polymerization of MSAs at the commonly 
used temperature of 70 °C as evidenced, in part, by broad molecular weight distributions 
(Mw/Mn > 1.3) and failure to successfully chain extend a poly(MSA) macro chain transfer 
agent (macroCTA). However, narrow molecular weight distributions and controlled 
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molecular weights were ultimately achieved by conducting the polymerizations at 30 °C. 
The poor polymerization control of MSAs at 70 °C surprisingly contrasts numerous 
literature reports of successful RAFT polymerizations of (meth)acrylamides in organic 
and aqueous media at temperatures greater than 60 °C,91,95,100,269–271 thus prompting our 
current investigation. 
  Since our initial report,97 we have conducted the RAFT polymerization of N-
phenylmethacrylamide (33), an MSA analog lacking the sulfonamide functional group 
(vide infra). Notably, the trithiocarbonate-mediated polymerization of 33 at 70 °C also 
results in relatively broad molecular weight distributions (Mw/Mn = 1.30), indicating that 
the sulfonamide functional group is not the primary cause for chain end degradation 
during polymerization of MSAs. Previous reports regarding the atom transfer radical 
polymerization (ATRP) of (meth)acrylamides attributed loss of “living” chain ends to 
nucleophilic displacement of the terminal bromine by the penultimate amide unit.272–274 
Similarly, oxazolone formation during peptide synthesis occurs by an amide “back-
biting” reaction.275 There is also literature precedent for the effects of N-aryl substitution 
on the cyclization of (thio)carbamoyl derivatives formed during sequencing of peptides 
by Edman’s degradation276 as well as the cyclization of -bromobutyranilides.277 From 
these observations, we have hypothesized that a similar reaction involving nucleophilic 
attack on the ω-thiocarbonyl by the terminal methacrylamide unit may be responsible for 
thiocarbonylthio degradation during the RAFT polymerization of N-
arylmethacrylamides. 
 In this contribution we report the influences of methacrylamide structure and 
reaction temperature on trithiocarbonate degradation during the RAFT polymerization of 
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N-substituted methacrylamides. A detailed study of the trithiocarbonate-mediated 
polymerizations of 33 and N-benzylmethacrylamide (34) using SEC-MALLS and UV-vis 
spectroscopy has now provided a clear understanding of the influence of methacrylamide 
structure on CTA degradation. Furthermore, in situ 1H NMR analysis of RAFT polymer 
small molecule analogs, prepared by single monomer unit insertion, affords additional 
mechanistic insight into the specific degradation pathway. 
33 and 34 Polymerization Kinetics 
 To our knowledge, there are no reports detailing the effects of N-aryl substitution 
on RAFT-mediated polymerization control of (meth)acrylamides. To this end, we chose 
to compare the RAFT polymerizations of 33 and 34 under analogous conditions (Scheme 
4.3). 34 was chosen based upon its structural similarity to 33 while lacking direct N-aryl 
substitution. 
 
Scheme 4.3. Synthetic route for 37-mediated polymerization of 33 and 34 in DMF at 70 
or 30 °C. 
 
  Table 4.4 summarizes the conversion, molar mass, and molecular weight 
distribution data for the polymerizations of 33 and 34 in DMF at 70 and 30 °C, using the 
RAFT agent 2-cyano-2-propyl dodecyl trithiocarbonate (37). The effect of 
methacrylamide structure on polymerization control is initially apparent by comparing 
the increase in molecular weight distribution of P33 (Mw/Mn = 1.30) relative to that of 
P34 (Mw/Mn = 1.15) synthesized under identical reaction conditions. Limited molecular 
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weight control during polymerization of 33 at 70 °C can also be seen in the Mn vs 
conversion plot (Figure A1, Appendix A) which shows a decrease in Mn,exp relative to 
Mn,th at higher conversions. By contrast, for the polymerization of 34 at 70 °C, Mn,exp 
values mirror Mn,th values, indicating that the number of active/dormant chain ends 
remain constant during polymerization (Figure A2, Appendix A). 
Table 4.4 
Conversion, Molar Mass, and Molecular Weight Distribution Data for the RAFT 
Polymerizations of 33 and 34 in DMF at 70 and 30 °C.a 
 
entry monomer 
temp. 
(°C) 
time 
(min) 
conv.b 
(%) 
Mn,thc 
(g/mol) 
Mn,expd 
(g/mol) 
Mw/Mnd 
1a 33 70 240 37 12400 14800 1.09 
1b 33 70 360 48 16000 17300 1.16 
1c 33 70 480 55 18200 18100 1.24 
1d 33 70 600 59 19500 18900 1.30 
2a 34 70 240 24 8900 11700 1.06 
2b 34 70 360 32 11500 13400 1.11 
2c 34 70 480 37 13400 15000 1.15 
2d 34 70 600 41 14600 16100 1.15 
3a 33 30 300 9 3200 6000 1.07 
3b 33 30 420 14 4900 7400 1.05 
3c 33 30 600 23 7800 10500 1.02 
3d 33 30 1380 50 16600 18800 1.02 
4a 34 30 300 7 2700 3400 1.13 
4b 34 30 420 10 3700 4100 1.07 
4c 34 30 600 14 5100 5900 1.05 
4d 34 30 1380 29 10400 11200 1.04 
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aPolymerizations were conducted at 70 or 30 °C in DMF ([M]0:[CTA]0:[I]0 = 200:1.0:0.2) using V501 or V-70 as the initiators 
respectively. bConversions were determined by 1H NMR (DMSO-d6) by comparing the relative integral areas of trimesic acid (internal 
standard) aromatic protons (8.64 ppm, 3H) to the vinyl proton of 33 (5.86 ppm, 1H) or 34 (5.79 ppm, 1H). cTheoretical Mn values 
were calculated according to the equation Mn,th=(ρMWmon[M]0/[CTA]0) + MWCTA where ρ is the fractional monomer conversion, 
MWmon is the molecular weight of the monomer, and MWCTA is the molecular weight of the CTA.  
dExperimental Mn and Mw/Mn 
values were determined by SEC-MALLS (DMF 20 mM LiBr). 
 
 Figure 4.9 shows the kinetic plots for the 70 °C polymerizations of 33 (black) and 
34 (red); each plot shows an initialization period of approximately 30 min followed by 
pseudo-first-order kinetic behavior up to 300 min with the differences in slope of the 
curves indicative of the relative propagation rate coefficients (kp) for each monomer 
derivative. Similar initialization periods were observed previously for the 
trithiocarbonate-mediated polymerizations of N-aryl MSAs and are indicative of slow 
fragmentation/reinitiation by the RAFT agent R-group.97,106 Interestingly, the first-order 
kinetic plots for the homopolymerizations of 33 and 34 at 70 °C show similar minimal 
decreases in slope beyond 300 min despite limited molecular weight control observed 
during the same time period for the polymerization of 33. It might be expected that RAFT 
agent degradation during polymerization of 33 would result in a decrease in the slope 
(kp[Pn·]) of the pseudo-first-order kinetic plot due to chain transfer to thiol-containing 
degradation byproducts. However, efficient chain transfer can take place without 
influencing the rate of polymerization if the rate of reinitiation by thiyl radicals is greater 
than the rate of propagation (i.e. kiT > kp).
278 The decrease in Mn,exp relative to Mn,th 
throughout the 70 °C polymerization of 33 (Figure A1, Appendix A) is evidence of an 
increasing number of polymer chains resulting from efficient chain transfer. 
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Figure 4.9. Kinetic plot for the 37-mediated polymerization of 33 and 34 in DMF at 70 
°C ([M]0 = 2.0 M, [M]0:[CTA]0:[I]0 = 200:1:0.2). 
 
 Recently we demonstrated that improved chain end retention and narrow 
molecular weight distributions can be achieved during the RAFT polymerization of N-
aryl MSAs by reducing the reaction temperature.97 Likewise, as seen in Figure 4.10, the 
molecular weight distribution of P33 synthesized at 30 °C (Mw/Mn = 1.02, Mn = 18800) 
was markedly narrower than that of P33 synthesized under analogous conditions at 70 °C 
(Mw/Mn = 1.30, Mn = 18900). Reduced polymerization temperature also afforded 
improved molecular weight control during the polymerization of 33 as evidenced by the 
linear progression of Mn,exp with conversion and good correlation between Mn,exp and 
Mn,th values (Figure A3, Appendix A). As shown in Table 4.4, narrower molecular weight 
distributions were also obtained during the polymerization of 34 at 30 °C (Mw/Mn < 1.10) 
but the additional decrease was minimal due to already narrow Mw/Mn achieved during 
polymerization at 70 °C. 
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Figure 4.10. SEC RI chromatogram showing the effect of temperature on molecular 
weight distribution for the 37-mediated RAFT polymerization of 33 at 70 and 30 °C. 
 
 The kinetic plots for the 37-mediated polymerizations of 33 and 34 at 30 °C 
(Figure 4.11) exhibit initialization times of 100 min and 60 min respectively, while 
demonstrating near pseudo-first-order kinetic behavior up to at least 1380 min. The 
increase in initialization time with decreasing temperature for the RAFT polymerizations 
of 33 and 34 is consistent with observations made by McLeary et al.106 The improved 
linearity of the first-order kinetic plots is also consistent with previous low temperature 
RAFT polymerizations of (meth)acrylamides and is generally attributed to increased 
thiocarbonylthio chain end retention.158,250 
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Figure 4.11. Kinetic plot for the 37-mediated polymerization of 33 and 34 in DMF at 30 
°C ([M]0 = 2.0 M, [M]0:[CTA]0:[I]0 = 200:1:0.2). 
 
Trithiocarbonate Degradation during the 37-mediated Polymerizations of 33 and 34 
 It is evident from the molecular weight data summarized in Table 4.4 that chain 
end degradation is likely occurring during the 70 °C polymerization of 33. Meanwhile, 
polymerization of 34 at the same temperature affords narrower molecular weight 
distributions with good correlation between Mn,th and Mn,exp values. In order to ascertain 
the influences of each polymerization component (i.e. solvent, monomer, and initiator) on 
temperature-dependent trithiocarbonate degradation, reactions were performed in DMF 
using combinations of 37, monomer (33 or 34), and initiator (V501) at relative 
concentrations of [37]0:[M]0:[I]0 = 10:1.0:0.2 as illustrated in the figures of Figure 4.12. 
The fractional change in total trithiocarbonate (TTC) concentration ([TTC]/[TTC]0) was 
measured by comparing the absorbance (λ = 320 nm) of diluted aliquots taken at timed 
intervals to that of an initial aliquot at t = 0. It is worth noting that only minimal change 
in the molar extinction coefficient (ε) of 37 at λ = 320 nm occurs after covalent addition 
of 33 or 34, allowing for accurate measurement of the total [TTC] during polymerization. 
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Figure A5 in Appendix A shows the Beer-Lambert plots and ε values at λ = 320 nm for 
37 (ε320 = 9380 M-1 cm-1) and the corresponding single monomer unit insertion (SMUI) 
adducts of 37 and 33 (41) (ε320 = 9560 M-1 cm-1) and the SMUI adduct of 37 and 34 (42) 
(ε320 = 10300 M-1 cm-1). 
 Examination of Figure 4.12a reveals no measureable influences of DMF (▼), 33 
(▲), or V501 (●) independently on [TTC]/[TTC]0 at 70 °C. However, a 60 % decrease in 
[TTC]/[TTC]0 is observed after 12 h when 37, 33, and V501 are combined at 70 °C (■) 
such that monomer addition to 37 takes place. This result supports terminal monomer 
unit-induced degradation in which the ultimate methacrylamide unit is in a favored 
orientation for O-5 or N-5 nucleophilic attack on the terminal thiocarbonyl (Scheme 4.4). 
In this case “5” denotes the number of atoms between the amide oxygen or nitrogen and 
the thiocarbonyl carbon. By contrast, identical experiments performed with 34 showed 
minimal trithiocarbonate degradation during polymerization with only a 3 % decrease in 
[TTC]/[TTC]0 observed after 12 h (Figure 4.12b). 
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Figure 4.12. Individual and combined influences of solvent, initiator, and monomer on 
the time-dependent change in [TTC]/[TTC]0 as measured by UV-Vis spectroscopy 
([M]0:[CTA]0:[I]0 = 10:1:0.2). Trithiocarbonate degradation experiments were performed 
using (a) 33 or (b) 34 as the monomer. 
 
 
Scheme 4.4. Proposed trithiocarbonate degradation by O-5 or N-5 nucleophilic attack by 
the terminal methacrylamide unit. 
 
 Previously, we attributed the substantially improved polymerization control of 
MSAs and 33 at 30 °C to increased chain end retention.97 As seen in Figure 4.13, the 
effect of temperature on trithiocarbonate degradation was confirmed by measuring 
[TTC]/[TTC]0 during polymerization of 33 at 30 °C under analogous conditions used for 
experiments in Figure 4.12a. At 30 °C, only 8 % trithiocarbonate degradation was 
observed after 720 min compared to 60 % degradation for the same time period at 70 °C. 
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Figure 4.13. Trithiocarbonate degradation during the 37-mediated polymerization of 33 
([M]0:[CTA]0:[I]0 = 10:1:0.2) at 70 and 30 °C using V501 and V-70 as initiators 
respectively. 
 
Small Molecule Analog Synthesis 
 In order to better study the mechanism and byproducts of N-arylmethacrylamide-
promoted trithiocarbonate degradation, we attempted to synthesize a small molecule 
analog of trithiocarbonate-terminated poly(N-phenylmethacrylamide). According to 
Scheme 4.5, the desired product 40a should result from the SN1 reaction of sodium ethyl 
trithiocarbonate (24) and 2-bromoisobutyrylanilide (39). Despite the reaction being 
performed at room temperature (22 °C), isolation of 40a proved unsuccessful. 
Recrystallization of the crude reaction mixture afforded 5,5-dimethyl-3-phenyl-2-
thioxothiazolidin-4-one (40), the N-5 cyclization product of 40a (Scheme 4.5). The 
structure of 40 was confirmed in part by analysis of the 1H NMR spectrum (Figure 4.14) 
which is absent of ethylsulfanyl –SCH2CH3 and amide -N-H 1H resonances. The 1H and 
13C chemical shifts of 40 also match those reported previously.227 1H NMR analysis of 
aliquots sampled during the reaction (Scheme 4.5) showed rapid formation of 40, 
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indicating that under these conditions, N-5 cyclization/elimination of the transient species 
40a occurs even at temperatures below 30 °C. 
 
Scheme 4.5. Synthetic route for small molecule analog 40a. 
 
 
Figure 4.14. 1H NMR (300 MHz, CDCl3) spectrum of isolated N-5 
cyclization/elimination product 40. 
 
Small Molecule Analog Synthesis via Single Monomer Unit Insertion 
 Minimal degradation of 37 during the polymerization of 33 at 30 °C indicates that 
covalent adducts of 33 and 37 are stable at low temperatures and can be formed by free 
radical processes. Recently, single monomer unit insertion279,280 has become a facile 
method for CTA synthesis, exploiting the “initialization” phenomenon previously 
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described by McLeary, Klumperman, and coworkers.106 We found that the SMUI adduct 
of 37 and 33 (41) could be marginally favored by stoichiometric control of monomer, 
CTA, and initiator at 30 °C as outlined in Scheme 4.6. The SMUI adduct of 37 and 34 
(42) was synthesized at 60 °C using AIBN as the initiator owing to the lower 
nucleophilicity of the N-benzylamide at higher temperatures as previously demonstrated. 
The labeled 1H NMR spectra of 41 and 42 are shown in Figures 4.15a and 4.15b 
respectively. 
 
Scheme 4.6. Synthesis of 41 and 42 by single monomer unit insertion. 
 
 
Figure 4.15. 1H NMR (300 MHz, CDCl3) spectra of (a) 41 and (b) 42 SMUI adducts. 
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In situ 1H NMR Analysis of 41 and 42 Degradation at 70 °C 
 In situ 1H NMR analysis was used to gain further insight into the mechanism and 
kinetics of 41 and 42 degradation. The labeled 1H NMR spectra at select time points 
during the degradation analysis of 41 at 70 °C in DMF-d7 are shown in Figure 4.16. After 
5 min, only the 1H resonances 41 are observed. Subsequently, new signals in the aromatic 
(7.4-7.7 ppm) and aliphatic (1.5-2.7 ppm) regions corresponding to degradation 
byproducts appear and increase in intensity with time. Comparison of the 1H NMR 
chemical shifts of the degradation byproducts (Figure 4.16) with those of 1-dodecanethiol 
and 5,5-dimethyl-3-phenyl-2-thioxothiazolidin-4-one (40) (Figures A6, A7 and A8, 
Appendix A) indicates that the byproducts of 41 degradation are those formed 
exclusively by N-5 cyclization/elimination. Labeled resonances corresponding to N-5 
cyclization/elimination degradation byproducts are given prime designation in the NMR 
spectrum (Figure 4.16) obtained at 491 min. 
 
Figure 4.16. 1H NMR (600 MHz, DMF-d7) overlay following the time-dependent 
degradation of 41 at 70 °C. 
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 Degradation of 42 at 70 °C (Figure 4.17) was also monitored using in situ 1H 
NMR analysis. After 491 min, minimal degradation was observed as shown in the 
expanded regions of the 1H NMR spectrum in Figure 4.17 corresponding to the 3-benzyl-
2-thioxothiazolidin-4-one methylene (peak i’) and the cyclized benzylmethacrylamide 
methyl (peak e’). Also visible is the characteristic methylene of 1-dodecanethiol (peak d’) 
which is additional evidence of degradation by N-5 cyclization/elimination. 
 
Figure 4.17. 1H NMR (600 MHz, DMF-d7) overlay following the time-dependent 
degradation of 42 at 70 °C. 
 
 Kinetic analysis of 41 degradation also provides additional evidence for exclusive 
N-5 cyclization/elimination. As shown in Scheme 4.7, intramolecular N-5 nucleophilic 
attack of the trithiocarbonate by adjacent methacrylamide can occur by either 
cyclization/elimination (pathway A) or rearrangement (pathway B) depending upon 
which C-S bond is cleaved.  The total rate of degradation of 41 by pathways A and B is 
equal to the rate of change in area of the phenyl 1H resonances (Figure 4.16, peaks i, j, 
and k) as N-5 nucleophilic attack results in loss of the N-phenylamide. The exclusive rate 
of N-5 cyclization/elimination (pathway A) is equal to the rate of change in area of the –
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CH2-S- 
1H resonance (Figure 4.16, peak d) as elimination of 1-dodecanethiol occurs. As 
shown in Figure 4.18a, the fractional changes in area (At/A0) of peaks i (7.70 ppm) and d 
(3.39 ppm) are essentially identical throughout the 491 min experiment indicating that 
pathway A is responsible for the degradation of 41 at 70 °C. 
 
Scheme 4.7. Possible N-5 nucleophilic attack degradation pathways. 
 
 Kinetic analysis of 42 degradation (Figure 4.18b) additionally supports the 
proposed degradation pathway of N-5 cyclization/elimination as shown by the 
comparable change in At/A0 of peaks i (4.42 ppm) and d (3.37 ppm) (Peak assignments in 
Figure 4.17). 
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Figure 4.18. Time-dependent fractional change in the area of select 1H chemical shifts 
during the degradation of (a) 41 and (b) 42 in DMF-d7 at 70 °C. 
 
 As seen in Figure 4.19, excellent agreement is observed between the time-
dependent fractional changes in [TTC] measured during the 37-mediated polymerizations 
of 33 and 34 by UV-Vis spectroscopy (open data points) and during 41 and 42 
degradation measured by in situ 1H NMR analysis (solid data points). The half lives (t1/2) 
of 41 and 42 at 70 °C in DMF were calculated to be t1/2 = 7.18 h and t1/2 = 78.5 h 
respectively based upon the degradation rates measured using 1H NMR. 
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Figure 4.19. Time-dependent change in [TTC]/[TTC]0 at 70 °C in DMF as measured by 
UV-vis spectroscopy during polymerization (open circles) and as measured by in situ 1H 
NMR during SMUI adduct degradation analysis (closed circles). 
 
 It is important to note that while we have determined that significant 
trithiocarbonate degradation occurs by N-5 cyclization/elimination during the RAFT 
polymerization of 33 at 70 °C, this work does not specifically address the influence of N-
phenyl substitution on increased amide nucleophilicity and how this affects the observed 
reaction mechanism. We are currently examining the influences of N-aryl substitution on 
both reaction mechanism and rate of N-5 cyclization/elimination and will report this in a 
future manuscript. 
Influence of 3-phenyl-2-thioxothiazolidin-4-one Chain Ends on the RAFT Polymerization 
of 33 
 Typically, RAFT agent degradation during polymerization results in the loss of 
active thiocabonylthio chain ends affording “dead” polymer chains that can no longer 
participate in the RAFT process. However, we have shown that trithiocarbonate 
degradation by N-5 cyclization/elimination during the polymerization 33 results in 
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formation of a new cyclic thiocarbonylthio end group. To date, there are few examples of 
RAFT polymerizations mediated by cyclic thiocarbonylthio compounds.281–283 However, 
Zhan and coworkers recently reported the RAFT polymerization of vinyl acetate using 40 
as the RAFT agent, which resulted in incorporation of thiocarbonylthio functionality into 
the polymer backbone.227 Similarly, it is plausible that the 3-phenyl-2-thioxothiazolidin-
4-one chain ends formed as a result of N-5 cyclization/elimination could participate 
during the RAFT polymerization of 33 as shown in Scheme 4.8. 
 
Scheme 4.8. Proposed mechanism for radical addition to 3-phenyl-2-thioxothiazolidin-4-
one chain ends during RAFT polymerization of 33 at 70 °C. 
 
 We investigated the possibility of 3-phenyl-2-thioxothiazolidin-4-one chain ends 
participating in the RAFT process by conducting the polymerization of 33 at 70 °C in the 
presence of 40, a small molecule analogue of N-5 cyclized poly(N-
phenylmethacrylamide) chain ends. Figure 4.20a shows the kinetic plot for the 40-
mediated polymerization of 33 in DMF at 70 °C. Linear pseudo-first-order kinetic 
behavior was observed up to 140 min with no initialization period. By contrast, the 37-
mediated polymerization of 33 under identical conditions exhibited a 30 min initialization 
period, consistent with similar results first reported by Klumperman and coworkers.106 
While the linear pseudo-first-order kinetic behavior indicates a constant kp[Pn·], the SEC 
RI overlay shown in Figure 4.20b demonstrates that molecular weight control is not 
achieved during the 40-mediated polymerization of 33 at 70 °C. The intensities of the 
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SEC RI chromatograms shown in Figure 4.20b increase with conversion but the 
unchanging peak elution volumes, which occur at the exclusion limit of the SEC system 
(~11.0 mL), are representative of uncontrolled polymerization behavior where Mn does 
not scale linearly with monomer conversion. While the polymers presented in Figure 
4.20b were too large to characterize by our SEC-MALLS system, it is worth noting that a 
polyvinylpyridine standard of Mn = 475,000 g/mol (Mw/Mn = 1.06) elutes at a volume of 
11.5 mL. These results suggest that 3-phenyl-2-thioxothiazolidin-4-one-terminated 
polymers do not participate in the normal CTA-mediated RAFT polymerization of 33 at 
70 °C. 
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Figure 4.20. (a) Kinetic plot and (b) SEC RI chromatogram overlay for the 40-mediated 
polymerization of 33 in DMF at 70 °C ([33]0 = 2.0 M, [33]0:[40]0:[V501]0 = 200:1.0:0.2). 
 
Section 3. “One-Pot” Aminolysis/Thiol-Maleimide End Group Functionalization of 
RAFT Polymers: Identifying and Preventing Michael Addition Side Reactions 
Overview 
 Reversible addition-fragmentation chain transfer (RAFT) polymerization has 
made possible the synthesis of functionally-diverse polymers with predetermined 
molecular weights and low dispersities (Ð) using a wide variety of monomer types and 
polymerization conditions (e.g. aqueous and organic media).89,284,285 The versatility of 
RAFT in synthesizing tailor-made polymers also stems from the fidelity by which 
polymer end-functionality can be controlled. Such end-functionalized polymers have 
been used to prepare advanced macromolecular architectures including block 
copolymers,286 star copolymers,287 molecular brushes,202,213 and polymer 
bioconjugates.172,288 Telechelic RAFT polymers can be synthesized directly by 
controlling the RAFT agent R- and Z-group functionality263 or by post-polymerization 
end group modification.289–291 The latter approach often exploits the inherent reactivity of 
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the residual thiocarbonylthio moiety present on RAFT polymers, allowing for 
simultaneous removal and replacement of the unstable RAFT agent with a benign or 
functional end group. 
 In recent years, reduction or aminolysis of thiocarbonylthio-terminated RAFT 
polymers to the corresponding polymeric thiol has afforded a myriad of thiol “click” end 
group functionalization routes including thiol-isocyanate,292 thiol-epoxy,293 thiol-
halogen,294 thiol-disulfide,295,296 and thiol-ene reactions.257,258,262,297–299 Particularly 
advantageous are thiol-maleimide Michael addition reactions which proceed to near 
quantitative conversions at room temperature in the presence of oxygen and water and 
typically occur much more rapidly than analogous thiol-acrylate or thiol-acrylamide 
reactions.260,300–305 Furthermore, thiol-maleimide end group modification of RAFT 
polymers can be performed as “one-pot” reactions without isolation of the intermediate 
polymeric thiol (Scheme 4.9). 
 
Scheme 4.9. “One-pot” aminolysis/thiol-maleimide end group functionalization of RAFT 
polymers. 
 
  To ensure quantitative polymer end group functionalization, an excess of 
maleimide relative to polymeric thiol is required. It is therefore desirable to optimize the 
reaction conditions to favor rapid and efficient polymer conjugation with minimal excess 
of maleimide, especially when using costly biologic, therapeutic, or diagnostic agents. 
One potential way to maximize end group functionalization efficiency while minimizing 
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the required excess of maleimide is through the use of nucleophilic catalysts. Thiol-
Michael addition reactions typically employ a base catalyst (e.g. tertiary amine) to 
generate the nucleophilic thiolate species.305 However, nucleophilic catalysts such as 
phosphines, amines, and amidines have been used to initiate Michael addition reactions 
and can increase reaction rates of these reactions by several orders of magnitude 
compared to analogous base-catalyzed reactions.300,306–312  The proposed mechanism of 
nucleophile-initiated thiol-maleimide Michael addition is illustrated in Scheme 4.10.312 
Rather than direct deprotonation of thiol, conjugate addition of the nucleophile to the 
maleimide double bond 60 forms the zwitterionic enolate 61, which in turn functions as a 
strong base (pKa ≈ 25) capable of generating the nucleophilic thiolate species while also 
forming a nucleophile-succinimide byproduct 62. In this regard, the nucleophile does not 
function as a catalyst which would be regenerated during each catalytic cycle, but rather 
serves as an initiator that generates the steady state enolate/thiolate concentration 
necessary for the thiol-ene chain transfer mechanism to operate. Subsequent propagation 
occurs by thiolate addition to maleimide forming the corresponding enolate 63, which 
abstracts a proton from thiol, regenerating the thiolate along with the desired thiol-
maleimide Michael addition product 64. 
 
Scheme 4.10. Mechanism of nucleophile-initiated thiol-maleimide Michael addition. 
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 Recently, while investigating the use of nucleophilic initiators to improve the 
efficiency of RAFT polymer end group functionalization with N-substituted maleimides, 
we discovered that in certain instances, nucleophilic initiators reduced the degree of end 
group functionalization compared to reactions performed using only a base catalyst. 
Reagent order of addition and solvent-type were also determined to have marked effects 
on end group functionalization efficiency (vide infra). These observations have prompted 
this study aimed at understanding the influences of nucleophile type, solvent, and 
reaction conditions on the efficacy of “one-pot” aminolysis/thiol-maleimide end group 
functionalization of RAFT polymers. Furthermore, the results discussed herein offer 
mechanistic insights into potentially detrimental side reactions that can occur during 
thiol-maleimide Michael addition reactions. 
Nucleophile-Promoted Michael Addition Side Reactions 
 Preliminary efforts in our lab to catalyze the “one-pot” aminolysis/thiol-
maleimide end group modification of acrylamido RAFT polymers in DMSO using the 
amidine 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) resulted in i) low end group 
functionalization efficiencies compared to reactions performed in the absence of DBU, ii) 
quantitative maleimide consumption, and iii) the formation of high molecular weight 
impurities observable by SEC-MALLS. From these observations we hypothesize that a 
low polymeric thiol concentration relative to maleimide concentration in the presence of 
a strong nucleophile (DBU), results in anionic propagation of maleimide occuring faster 
than the desired thiol-maleimide Michael addition. It is also possible that other 
nucleophiles (e.g. amines and phosphines) commonly used during “one-pot” 
aminolysis/thiol-maleimide modification of RAFT polymers could promote similar side 
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reactions. Azechi et al. showed that 1°, 2°, and 3° amines can initiate the anionic 
polymerization of N-substituted maleimides in highly polar aprotic solvents (DMSO and 
DMF) whereas no polymerization was observed in less polar solvents (THF).313 Also, 
phosphines have been used as initiators for the anionic polymerizations of methylene 
malonic esters,314 cyanoacrylates,315 and N-substituted maleimides.316 It is therefore 
plausible that during “one-pot” aminolysis/thiol-maleimide modification of RAFT 
polymers, amine- and phosphine-initiated polymerization of maleimide could also 
outcompete the desired thiol-maleimide Michael reaction and account for the poor end 
group functionalization efficiencies observed under certain reaction conditions. 
Reaction of N- and P-Based Nucleophiles with N-Methylmaleimide 
 A number of nucleophile types including amines (aminolysis), phosphines 
(reducing agent), and amidines (nucleophilic initiator) can be present during “one-pot” 
aminolysis/thiol-maleimide end group reactions of RAFT polymers. Accordingly, we 
chose to first investigate the effect of solvent on the reactions of representative N- and P-
based nucleophiles with N-methylmaleimide (65) in the absence of thiol as outlined in 
Figure 4.21. A stoichiometric excess of maleimide relative to nucleophile ([Nu]0:[Mal]0 = 
1.0:10) was chosen to reflect the relative concentrations of these reagents used during 
“one-pot” RAFT polymer aminolysis/thiol-maleimide reactions and to make apparent 
whether or not maleimide polymerization is occurring. In situ 1H NMR analysis was used 
to monitor the time-dependent fractional change in maleimide concentration 
([Mal]/[Mal]0) by comparing the area of the maleimide olefin peak to the peak area of an 
internal standard (CH2Cl2). 
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Figure 4.21. Effect of solvent on the time-dependent fractional change in [Mal]/[Mal]0 
upon reaction of 65 with representative nucleophiles a) hexylamine (HexAM), b) 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU), c) tributylphosphine (TBP), and d) 
trimethylphosphite (TMP) as measured by in situ 1H NMR analysis. 
 
 Figure 4.21a shows the time-dependent [Mal]/[Mal]0 plots for the reactions of 
hexylamine (HexAM) with 65 in different solvents with the dashed line ([Mal]/[Mal]0 = 
0.9) representing the theoretical decrease in [Mal]/[Mal]0 predicted for the reaction of 
HexAM and 65 via single aza-Michael addition. Reactions conducted in MeCN, EtOH, 
and CH2Cl2 show decreases in [Mal]/[Mal]0 to a value of 0.9, beyond which no change in 
[Mal]/[Mal]0 is observed up to 12 h, indicating exclusive aza-Michael addition takes 
place in these solvents. Conversely, reaction of HexAM with 65 in DMSO results in rapid 
maleimide consumption, corresponding to 7.5 maleimides consumed on average per 
amine within the first 3 min. Subsequently, no change in [Mal]/[Mal]0 is observed up to 
12 h. These results are consistent with those reported by Azechi et al.313 and confirm that 
HexAM can initiate the anionic polymerization of 65 in polar solvents such as DMSO 
whereas exclusive aza-Michael addition takes place in less polar solvents. Furthermore, 
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the effect of solvent polarity on the reaction of HexAM with 65 is readily observed in 
Figure 4.21a by noting the increase in reaction rate with increasing solvent polarity in the 
order of CH2Cl2 (ε = 8.93) < EtOH (ε = 24.5) < MeCN (ε = 37.5) < DMSO (ε = 46.7). 
 The time-dependent [Mal]/[Mal]0 plots for the reactions of DBU and 65 are 
shown in Figure 4.21b. Reaction rate increases with increasing solvent polarity with 100 
% 65 conversion reached in < 10 min in DMSO. Quantitative consumption of 65 was 
also observed for reactions performed in EtOH and MeCN while 71% maleimide 
conversion was measured in CH2Cl2 after 12 h. Interestingly, the kinetic plots in Figure 
4.21b do not rapidly reach a constant value of [Mal]/[Mal]0 as was observed during the 
reaction of HexAM and 65 in Figure 4.21a. Unlike protic nucleophiles (e.g. 1°, 2° 
amines, and thiols), aprotic nucleophiles such as DBU cannot undergo complete Michael 
addition due to the lack of a transferable hydrogen from the nucleophile. Therefore, if an 
active hydrogen-containing compound (e.g. thiol) is in low concentration or completely 
absent, the nucleophile-derived zwitterionic enolate 61 can undergo reaction with 
additional maleimide without enolate termination by proton transfer, allowing for a 
“living-like” polymerization process to occur. Noteworthy is that precipitation was 
observed during the reaction of DBU and 65 in CH2Cl2 after ~30 min. Limited solubility 
of the propagating macro zwitterionic enolate in CH2Cl2 likely prevents the propagating 
chain-end from reacting with 65 in solution, accounting for the non-quantitative 
maleimide conversion obtained in this solvent. Nonetheless, these results indicate that 
DBU-initiated polymerization of 65 occurs rapidly and extensively in both polar and 
nonpolar solvents. 
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 Similarly, the aprotic nucleophile tributylphosphine (TBP) was shown to initiate 
polymerization of 65 in all solvents tested (Figure 4.21c). Reaction rates increase with 
solvent polarity with 95% maleimide conversion reached within 2.5 min in DMSO. 
Precipitation was also observed during reactions performed in EtOH and CH2Cl2 after ~5 
min following the addition of TBP. Poor solubility of the propagating phosphonium 
zwitterionic enolate is again a likely explanation for the non-quantitative maleimide 
conversions achieved in EtOH and CH2Cl2 during the time frame of these kinetic 
experiments. 
 From these results it is apparent that maleimide polymerization initiated by DBU 
or TBP is unavoidable, even in low polarity solvents. While DBU is optional during 
“one-pot” aminolysis/thiol-maleimide modification of RAFT polymers, mild reducing 
agents such as phosphines are generally required to prevent disulfide formation from 
occurring between polymeric thiols during the RAFT agent aminolysis step.258,301 
Initially, we explored triphenylphoshine as a more sterically hindered, and therefore less 
nucleophilic phosphine, but maleimide polymerization was again observed in each of the 
four solvents tested in this work (data not shown). Recently, Ho et al. reported on 
trialkylphosphites as cheaper and less toxic alternatives to trialkylphosphines as reducing 
agents during “one-pot” RAFT polymer aminolysis/thiol-ene reactions.317 
Trialkylphosphites can undergo conjugate addition to electron deficient olefins but are 
less nucleophilic than phosphines and typically require elevated temperatures (100 °C) 
for reaction to take place.318,319 As seen in Figure 4.21d, the reaction of 
trimethylphosphite (TMP) with 65 results in no measureable change in [Mal]/[Mal]0 in 
MeCN, EtOH, and CH2Cl2. Only after prolonged reaction times (12 h) in DMSO is a 65 
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% decrease in [Mal]/[Mal]0 observed. Consequently, TMP is a suitable alternative to 
phosphines as a reducing agent during thiol-maleimide reactions when used in less polar 
solvents. It should also be noted that trace amounts of water must be present for 
trialkylphosphite (and phosphine) reduction of disulfides to occur.320 Therefore, rigorous 
anhydrous conditions should be avoided during RAFT polymer aminolysis when using 
trialkylphosphites as reducing agents. 
 
Scheme 4.11. Proposed mechanisms of initiation, propagation, and termination for the 
nucleophile-initiated anionic polymerization of N-substituted maleimides. 
 
 The proposed mechanisms of initiation, propagation, and termination for the 
anionic polymerization of N-substituted maleimides initiated by protic or aprotic 
nucleophiles are illustrated in Scheme 4.11. Conjugate addition of the nucleophile to the 
maleimide double bond to form the zwitterionic enolate 61 in identical fashion to first 
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step of nucleophile-initiated thiol-maleimide reactions. However, if the thiol 
concentration is suitably low relative to maleimde concentration ([Mal] > [thiol]), 
propagation can occur faster than proton transfer to the enolate 61, resulting in the 
formation of the propagating macrozwitterionic species 66. For maleimide 
polymerization initiated by protic nucleophiles (e.g. 1° or 2° amines), termination can 
occur by proton transfer from the nucleophile to afford a terminated chain 67a. 
Conversely, aprotic nucleophiles do not posess a transferable proton and consequently 
can not under go “long range” Michael addition. However, termination by nucleophilic 
displacement of the positively charged nucleophilic residue (66d) by the enolate terminus 
of an adjacent chain (66c) could result in regeneration of the nucleophile while also 
producing a new macrozwitterionic polymer chain (67cd) equal in mass to the sum of 66c 
and 66d. These differences in termination mechanisms adequately describe the continued 
decrease in [Mal]/[Mal]0 observed during reaction of aprotic nucleophiles with 65 
whereas reaction of a protic nucleophile (HexAM) rapidly reach a constant value of 
[Mal]/[Mal]0 owing to termination by proton transfer. Additional evidence of termination 
by nucleophilic displacement was also obtained by noting that the solution viscosity of 
the reaction of 65 with DBU continues to increase for several days after complete 
maleimide consumption, eventually leading to complete vitrification. This continued 
increase in solution viscosity would be expected if the macrozwitterions formed from the 
reaction of DBU and 65 were functioning as macro A-B monomers capable of continued 
step-growth polymerization resulting in a continued increase in molecular weight. 
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Reaction of Thiols with N-Methylmaleimide (65) 
 It is evident from the kinetic plots shown in Figure 4.21 that strong N- and P-
based nucleophiles can react with maleimides to form either the Michael addition product 
or polymaleimide depending upon the nucleophile type (protic or aprotic) and solvent 
polarity. Therefore, it is plausible that other strong nucleophiles such as thiolates can 
initiate the anionic polymerization of maleimides in polar solvents. To this end, we chose 
to investigate the reaction of ethyl 2-mercaptopropionate (E2MP) with 65 under 
conditions identical to those outlined in Figure 4.21, except with the addition of TEA to 
generate the nucleophilic thiolate species. E2MP was chosen as a model thiol due to its 
structural similarity to the polymeric thiol that would be produced upon aminolysis of a 
polyacrylate RAFT polymer. 
 
Figure 4.22. Effect of solvent on the time-dependent fractional change in [Mal]/[Mal]0 
during the TEA-catalyzed reaction of E2MP with 65 as measured by in situ 1H NMR 
analysis. 
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 As shown in Figure 4.22, only the reaction of E2MP and 65 in CH2Cl2 gives the 
change in [Mal]/[Mal]0 expected for exclusive thiol-maleimide Michael addition 
([Mal]/[Mal]0 = 0.9, dashed line). Meanwhile, the reactions conducted in more polar 
solvents (DMSO, EtOH, and MeCN) show a continued decrease in [Mal]/[Mal]0 up to 12 
h, with 100% maleimide conversion reached in 90 min in DMSO. Initially, we 
anticipated the kinetic profiles for the reactions of E2MP and 65 (Figure 4.22) to rapidly 
reach a constant [Mal]/[Mal]0 value due to rapid enolate termination by means of proton 
transfer, as previously observed for the reactions of HexAM and 65 (Figure 4.21a). 
However, a continued decrease in [Mal]/[Mal]0 up to 12 h is evidence of either slow 
reaction of thiol or an additional reaction pathway. 
 Closer inspection of the kinetic profiles for reactions conducted in EtOH and 
MeCN reveals an inflection point at the first time point (2.5 min) when [Mal]/[Mal]0 ≈ 
0.9, indicating that thiol-maleimide Michael addition likely occurs faster than subsequent 
maleimide propagation in these solvents. Furthermore, in situ 1H NMR indicated 100% 
thiol conversion prior to the first time point (2.5 min) for reactions conducted in DMSO, 
MeCN, and CH2Cl2 (Figures A9-A11, Appendix A) whereas thiol conversion could not 
be measured for the reaction performed in EtOH-d6 due to deuterium exchange between 
the solvent and thiol proton. Quantitative thiol consumption early in each reaction 
requires that proton transfer from thiol to enolate also occurs rapidly. Therefore, the 
continued decrease in [Mal]/[Mal]0 observed at longer reaction times in more polar 
solvents is not likely attributable to slow reaction of thiol and is suggestive of an alternate 
maleimide reaction pathway. 
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 One plausible explanation for the continued decrease in [Mal]/[Mal]0 at longer 
reaction times is TEA-initiated maleimide polymerization. The time-dependent change in 
[Mal]/[Mal]0 plots (Figure A12, Appendix A) for the reactions of TEA with 65 in DMSO 
and EtOH show a decrease in [Mal]/[Mal]0 of 0.07 and 0.04 respectively after 12 h. 
Meanwhile, no change in [Mal]/[Mal]0 was observed in MeCN and CH2Cl2 after 12 h. 
Accordingly, TEA-initiated maleimide polymerization is insufficient to account for the 
significant decrease in [Mal]/[Mal]0 that occurs within the same time period during the 
reactions of E2MP with 65 in these solvents. 
 Another potential explanation for the continued decrease in [Mal]/[Mal]0 
observed in the kinetic plots of Figure 4.22 involves deprotonation of the thiol-maleimide 
Michael adduct by TEA to regenerate the nucleophilic enolate species. Initially, this 
seems unlikely since the pKa of TEA (10.75) is much lower than that of most 
succinimide-derived enolates (~25). However, enolate formation of 2-aminosuccinimide 
residues in peptides has been shown to occur under mildly basic conditions in aqueous 
media (pH = 7.4), indicating that heteroatom-substitution of the succinimide -carbon 
can reduce enolate pKa compared to unsubstituted succinimides.
321 
 To test whether thiol-maleimide Michael addition products are capable of 
reinitiating maleimide polymerization in the presence of TEA, the Michael adduct of 
benzyl mercaptan and N-methylmaleimide (43) was synthesized and purified by column 
chromatography. The Michael adduct of E2MP and 65 was not synthesized due to 
potential complications arising from the presence of chemically distinct diastereomers 
and the complexity in identifying the 1H NMR chemical shifts of the resulting four 
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stereoisomers. Meanwhile, the synthesis of 43 from benzyl mercaptan and 65 affords a 
racemic mixture of chemically indistinct enantiomers. 
 
Figure 4.23. Effect of solvent on the time-dependent fractional change in [Mal]/[Mal]0 
during the TEA-catalyzed reaction of 43 with 65 as measured by in situ 1H NMR 
analysis. 
 
 Figure 4.23 shows that [Mal]/[Mal]0 decreases with time during the TEA-
catalyzed reactions of 43 and 65 in DMSO, EtOH, and MeCN whereas no change in 
[Mal]/[Mal]0 is observed in CH2Cl2 up to 12 h. The kinetic profiles obtained in each 
solvent for the reactions of 43 and 65 in Figure 4.23 accurately reflect the kinetic profiles 
observed below [Mal]/[Mal]0 = 0.9 (dashed line) for the analogous reactions of E2MP 
and 65 shown in Figure 4.22. This is not a surprising result since the dashed line in 
Figure 4.22 represents the change in [Mal]/[Mal]0 predicted for formation of the thiol-
maleimide Michael adduct. Any decrease in [Mal]/[Ma]0 below a value of 0.9 in Figure 
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4.22 would presumably occur as a result of TEA-promoted regeneration of the 
nucleophilic enolate species and therefore resemble the kinetic profiles in Figure 4.23.  
 Also worth noting is that TEA has little influence on the time-dependent 
[Mal]/[Mal]0 plots for the reaction of HexAM and 65 in DMSO as shown in Figure A13 
in Appendix A. This indicates that the amine-maleimide adduct is not capable of 
reinitiation of maleimide polymerization under these reaction conditions and that 
reinitiation is likely unique to thiol-maleimide adducts. 
 
Figure 4.24. a) Time-dependent fractional change in peak area (At/A0) for protons Ha, Hb, 
and Hc during TEA-catalyzed H-D exchange of 43 in DMSO. b) 
1H NMR spectral 
overlay of select time points during H-D exchange experiments with 43. 
 
125 
 
 
 We next sought to provide direct evidence that TEA is a strong enough base to 
generate the enolate of 43 in polar solvents. To this end, we used in situ 1H NMR analysis 
to measure the relative rates of hydrogen-deuterium exchange (H-D) of 43 in a 
DMSO/D2O mixture in the presence of TEA. Figure 4.24a shows the time-dependent 
fractional change in peak area (At/A0) for the three chemically distinct protons of 43 
which could be abstracted by TEA to form an enolate on either the -carbon (Ha) or the 
-carbon (Hb and Hc) relative to the benzylsulfanyl group. For simplicity, only the 
structure of the S enantiomer is shown in Figure 4.24a, whereas 43 is actually comprised 
of a racemic mixture of enantiomers. The kinetic plot of Figure 4.24a reveals that H-D 
exchange was only observed for proton Ha with a 97% decrease in At/A0 occurring by 35 
min. Sigma withdrawing effects by the adjacent thioether are most likely responsible for 
the increased acidity of Ha, leading to exclusive enolate formation at the -carbon. Figure 
4.24b shows the 1H NMR spectral overlay of select time points during the H-D exchange 
experiments with 43. The peak corresponding to Ha decreases in area with time while 
maintaining the doublet of doublets (dd) splitting pattern that arises from spin-spin 
coupling with Hb and Hc. Meanwhile, the peaks corresponding to the geminal protons Hb 
and Hc do not change in area, but rather show changes in splitting pattern from dd to d as 
spin-spin coupling of Hb and Hc with Ha are diminished through deuterium exchange. 
Also apparent in Figure 4.24b is the significant downfield chemical shift of Ha (3.78 
ppm) relative to Hb (3.07 ppm) and Hc (2.46 ppm) that arises from the deshielding (sigma 
withdrawing) effects of the benzylsulfanyl group. 
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Scheme 4.12. Proposed reaction pathways for the TEA-catalyzed thiol-maleimide 
reaction in which reversible enolate formation is operational. 
 
 Scheme 4.12 shows the proposed reaction pathways for the TEA-catalyzed thiol-
maleimide reaction when a stoichiometric excess of maleimide relative to thiol is 
employed in polar solvents. Thiolate addition to maleimide forms the -enolate 63 which 
can either abstract a proton from thiol or +NH(Et)3 to give the thiol-maleimide adduct 64, 
or react directly with maleimide to form the propagating species 68 when conditions 
favor propagation over termination (i.e. [Mal]>>[thiol]). Deprotonation of 64 by TEA 
forms the -enolate 69 which can reversibly terminate by proton transfer or react with 
maleimide to form the propagating species 70. The propagating species 68 and 70 derived 
from - and -enolates respectively can continue to react with maleimide until 
termination occurs by proton transfer. Also, the termination products of 68 can in theory 
reinitiate maleimide polymerization by -enolate formation. These additional reaction 
pathways can account for the continued decrease in [Mal]/[Mal]0 following initial 
formation of the thiol-maleimide Michael adduct for the TEA-catalyzed reactions of 
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E2MP with 65 shown in Figures 4.23. It should also be noted that exclusive enolate 
formation at the -carbon rules out the possibility of TEA-catalyzed -elimination (retro 
Michael addition) as a means of regenerating the nucleophilic thiolate species after 
formation of the thiol-maleimide Michael adduct. 
 “One-pot” Aminolysis/Thiol-Maleimide End Group Functionalization of RAFT 
Polymers 
 It is apparent that many of the reagents (e.g. amines and phosphines) commonly 
used during “one-pot” RAFT polymer aminolysis/thiol-maleimide reactions can react 
with maleimides to form polymaleimide or Michael addition byproducts and potentially 
outcompete the desired polymeric thiol-maleimide Michael reaction. Also, we have 
shown that intermediate strength bases such as TEA can deprotonate thiol-maleimide 
Michael adducts in polar solvents to form a nucleophilic -enolate capable of subsequent 
reaction with maleimide. However, the effects of these side reactions on RAFT polymer 
end group functionalization efficiency are not yet well understood. Also not well 
understood is the influence of aminolysis method on end group functionalization 
efficiency. The simplest method involves simultaneous aminolysis of the RAFT polymer 
in the presence of maleimide and does not require the use of a reducing agent to prevent 
disulfide formation. However, the competing amine-maleimide aza-Michael addition 
could prevent quantitative RAFT agent aminolysis and subsequently reduce the degree of 
end group functionalization. Alternatively, the sequential method allows for complete 
aminolysis of the RAFT agent to occur prior to the addition of maleimide in a second 
step. This route limits side reactions between the amine and maleimide but necessitates 
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the use of a reducing agent to prevent polymeric disulfide formation from occurring 
during the aminolysis stage. 
 
Scheme 4.13. “One-pot” aminolysis/thiol-maleimide modification of 45 with 46. 
 
 To investigate the effects of solvent, catalyst, reducing agent, and aminolysis 
method on RAFT polymer end group functionalization efficiency, we first synthesized 
the water soluble polymer poly(N,N-dimethylacrylamide) (45) using the RAFT agent 2-
cyano-2-propyl benzodithioate (44). Low dispersities (Ð = 1.06) and excellent agreement 
between the number average molecular weights determined by size exclusion 
chromatography (Mn(SEC) = 3360 g/mol) and by 
1H NMR (Mn(NMR) = 3220 g/mol) are 
evident of a controlled polymerization and high dithiobenzoate chain-end fidelity. “One-
pot” reactions of 45 with N-benzylmaleimide (46) were conducted at room temperature 
for 12 h using the initial molar ratios of [45]0:[HexAM]0:[46]0 = 1.0:2.5:5.0 as outlined in 
Scheme 4.13. End group analysis by 1H NMR was performed in D2O by comparing the 
integrated peak area of the benzyl aromatic protons (7.50 – 7.15 ppm) to the known 
integrated peak area of the N,N-dimethyl side chain and methyne backbone protons (3.30 
– 2.20 ppm) of 45 (Figures A14-A15, Appendix A). The poor solubility of 46 and its 
nucleophile-initiated byproducts (i.e. poly(46)) in D2O allows for accurate quantification 
of only 46 that is covalently attached to 45. 
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Table 4.5 
“One-pot” aminolysis/thiol-maleimide reactions of 45 with 46.a 
entry methodb solvent catalyst/ 
red agent 
funct.e 
(%) 
CTAf 
(%)  
colorg 
(12 h) 
1a 1 CH2Cl2 DBU
c 93 0 R 
1b 1 MeCN DBU 37 0 R 
1c 1 EtOH DBU 25 15 R 
1d 1 DMSO DBU 0 0 R 
2a 1 CH2Cl2 - 89 0 Y 
2b 1 MeCN - 81 3 O 
2c 1 EtOH - 8 90 O 
2d 1 DMSO - 31 46 R 
3a 2 CH2Cl2 - 95 0 Y 
3b 2 MeCN - 95 0 R 
3c 2 EtOH - 84 0 Y 
3d 2 DMSO - 72 0 R 
4a 2 CH2Cl2 TBP
d 89 0 R 
4b 2 MeCN TBP 86 0 R 
4c 2 EtOH TBP 84 0 R 
4d 2 DMSO TBP 72 0 R 
5a 2 CH2Cl2 TMP
d 98 0 Y 
5b 2 MeCN TMP 99 0 Y 
5c 2 EtOH TMP 86 0 Y 
5d 2 DMSO TMP 89 0 Y 
 
a[45]0:[HexAM]0:[46]0 = 1.0:2.5:5.0. 
bMethod 1: simultaneous aminolysis/thiol-maleimide; Method 2: sequential aminolysis/thiol-
maleimide. c[45]0:[DBU]0 = 1.0:1.0. 
d[45]0:[TBP or TMP]0 = 1.0:5.0. 
ePercent end group functionalization of 45 with 46 as measured 
by 1H NMR. fPercent CTA remaining after reaction of 45 with 46 as measured by 1H NMR. gReaction color after 12 h: red (R), orange 
(O), or yellow (Y). 
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 Table 4.5 summarizes the results of the “one-pot” aminolysis/thiol-maleimide 
reactions of 45 with 46 with the last column indicating the color exhibited by each 
reaction after 12 h. Entries 1a-d reflect our initial attempts to catalyze thiol-maleimide 
end group functionalization reactions with DBU as a catalyst and were performed using 
the simultaneous aminolysis method (method 1). A distinct trend of decreasing end group 
functionalization efficiency with increasing solvent polarity was observed with 0% 
functionalization achieved in DMSO. These results are relatable to the trend observed for 
the reactions of DBU and 65 shown in Figure 4.21b, where the rate of DBU-initiated 
maleimide polymerization increases with solvent polarity. From these results, we 
conclude that in polar solvents, DBU-initiated maleimide polymerization is outcompeting 
the desired polymeric thiol-maleimide reaction.  
 Table 4.5 entries 2a-d show the effect of simultaneous aminolysis/thiol-maleimide 
Michael addition in the absence of DBU on end group functionalization efficiency. 
Incomplete aminolysis was observed in all solvents except CH2Cl2 (2a) with reactions 
performed in DMSO (2d) and EtOH (2c) retaining 46% and 90% respectively of the 
original dithiobenzoate functionality. Accordingly, only 31% and 8% end group 
functionalization was observed in DMSO EtOH respectively. These results show that the 
amine-maleimide aza-Michael addition can occur faster than CTA aminolysis in more 
polar solvents and are consistent with the effect of solvent polarity on the reaction rates 
of HexAM with 65 shown in Figure 1a. 
 The reactions performed in Table 4.5 entries 3a-d were identical to those 
performed in entries 2a-d except the HexAM was allowed to react with 45 for 30 min 
prior to the addition of 46 (Method 2). CTA aminolysis was qualitatively confirmed to 
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occur within 30 min by noting the change in color that takes place as the dithiobenzoate 
end groups (orange) are aminolyzed to the corresponding N-hexylthiobenzamide 
(yellow). Entries 3a-d show that 100% CTA aminolysis was acheived in all solvents 
while end group functionalization efficiencies were significantly improved compared to 
reactions conducted using the simultaneous aminolysis method (entries 2a-2d). High end 
group functionalization (95%) was achieved in the less polar aprotic solvents CH2Cl2 (3a) 
and MeCN (3b) while moderate degrees of functionalization were obtained in EtOH 
(84%, 3c) and DMSO (72%, 3d). While these results are promising, it is well known that 
disulfide coupling of polymeric thiols can occur during CTA aminolysis, resulting in both 
reduced end group functionalization efficiencies and high molecular weight impurities, 
thus necessitating the use of a reducing agent.258 
 Table 4.5 entries 4a-d show the use of TBP as a reducing agent results in 
decreased end group functionalization efficiencies for reactions performed in CH2Cl2 (4a) 
and MeCN (4b) compared to analogous reactions conducted without TBP (entries 3a and 
3b respectively). Meanwhile, no effect of TBP was observed on the functionalization 
efficiencies of reactions performed in EtOH and DMSO (entries 4c and 4d respectively). 
From these results and the kinetic plots in Figure 4.21c, we conclude that 
trialkylphosphines are not suitable reducing agents during thiol-maleimide end group 
modification of RAFT polymers due to competing phosphine-initiated maleimide 
polymerization. Alternatively, using the less nucleophilic TMP as a reducing agent 
affords substantially increased degrees of end group functionalization in all solvents as 
seen in Table 4.5 entries 5a-d with 98% and 99% end group functionalization acheived in 
CH2Cl2 (5a) and MeCN (5b) respectively. 
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Stoichiometric Considerations 
 Efficient and quantitative end group functionalization of RAFT polymers using 
aminolysis/thiol-maleimide chemistry also requires consideration of the reactant feed 
ratios. Ideally, minimal excess of maleimide should be used relative to polymeric thiol to 
limit the waste of potentially costly maleimide compounds. However, inevitable side 
reactions such as amine-maleimide aza-Michael addition must be taken into account 
when choosing reactant stoichiometry such that [Mal]0 > [PnSH] + [amine]; [PnSH] and 
[amine] are the polymeric thiol and unreacted amine concentrations respectively after 
complete RAFT agent aminolysis has occurred. In this work, we found that aminolysis of 
45 with HexAM using a molar ratio of [45]0:[HexAM]0 = 1.0:2.5 results in complete loss 
of dithiobenzoate end groups within 30 min. However, other work conducted by our 
group (not reported herein) has shown that dithiobenzoate-functional polystyrene 
synthesized by RAFT requires several hours for complete aminolysis to occur using the 
same dithiobenzoate to amine ratio. Therefore, the reactant feed ratios reported herein 
should be considered as a starting point for stoichiometric optimization of different 
RAFT polymer systems. 
 The type of RAFT agent being aminolyzed must also be considered when 
choosing reactant stoichiometry. Dithiobenzoate-terminated polymers react with one 
equivalent of amine to yield polymeric thiol and thiobenzamide byproducts in equimolar 
amounts. Conversely, trithiocarbonate-terminated polymers can react with two 
equivalents of amine to give the polymeric thiol, Z-group derived thiol, and thiourea 
byproduct in equimolar amounts. In this case, the reactant stoichiometry must allow for 
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[Mal]0 > [PnSH] + [amine] + [ZSH] where [ZSH] is the concentration of small molecule 
Z-group derived thiol. 
Section 4. Growth-Then-Coupling Method of Molecular Brush Synthesis from RAFT 
Polymers and Thiol-Reactive Oxanorbornenes 
Overview 
 In recent years, extensive efforts have been made towards developing synthetic 
methodologies to prepare functionally diverse and structurally complex molecular brush 
copolymers. Molecular brush or “bottle-brush” copolymers are comprised of polymeric 
side-chains attached to a polymer backbone and exhibit highly branched spherical or 
cylindrical morphologies with minimal intermolecular chain entanglement owing to the 
volume-exclusion interactions between sterically crowded polymeric side-chains.322 
Consequently, molecular brush (co)polymers have been used as polymer 
nanotherapeutics,212 rheological modifiers,323 surfactants,324 and as discrete 
nanostructures.325 The increased interest in molecular brushes has driven current efforts 
towards developing facile and versatile synthetic routes. 
 Molecular brush copolymers can be synthesized using grafting-to, grafting-from, 
grafting-through, or more recently by transfer-to routes.322,326 Of these approaches, 
grafting-through ensures the highest grafting density with 100% of polymer backbone 
repeat units bearing a polymeric side-chain. Lately, the strong thermodynamic driving 
force of ring opening metathesis polymerization (ROMP) of norbornene-functional 
macromonomers (MMs) has been demonstrated as an effective method of overcoming 
the issues of steric hindrance and low concentration of polymerizable end groups 
typically associated with grafting-through synthetic approaches.202,211 
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 Norbornene-functional macromonomers can be synthesized using either “direct-
growth” (DG-MM) or “growth-then-coupling” (GC-MM) methods as reviewed recently 
by Xia and coworkers.218 DG-MM synthesis has been accomplished using norbornene-
functional initiators during ring opening polymerization (ROP)189 and atom transfer 
radical polymerization (ATRP).211 In addition, norbornene-functional chain transfer 
agents have been used to prepare macromonomers using RAFT polymerization.201,212,213 
Synthesizing MMs by RAFT is particularly advantageous due to the wide variety of vinyl 
monomers available and ease of controlling end-group functionality. However, DG-MM 
synthesis by RDRP techniques such as RAFT requires polymerization optimization for a 
given monomer-type to minimize radical addition to the norbornene olefin during 
polymerization.214 Furthermore Xia and coworkers have demonstrated that trace amounts 
of difunctional macromonomer impurities resulting from radical-radical coupling of α-
norbornene-functional polymers can result in undesired molecular brush branching and 
broadened molecular weight distributions.218 Consequently, facile and efficient GC-MM 
synthetic routes are desired. 
New Synthetic Route Toward Norbornene-Functional RAFT Polymer Macromonomers 
 We envisioned a GC-MM synthetic route that exploits the latent reactivity of 
thiocarbonylthio-terminated RAFT polymers. In Chapter IV Section III we demonstrated 
the efficient and quantitative end group functionalization of RAFT polymers using “one-
pot” aminolysis/thiol-maleimide chemistry. Accordingly, norbornene end-functional 
RAFT polymers should be accessible using thiocarbonylthio end-functional RAFT 
polymers and a maleimide-functional oxanorbornene (52) as illustrated in Scheme 4.14. 
Furthermore, it should be possible to end-functionalize RAFT polymers using a 
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methanethiosulfonate (MTS)-functional oxanorbornene (56) to give the corresponding 
disulfide-containing macromonomer. Molecular brushes comprised of side chains 
attached by disulfide linkages are of particular interest for drug delivery applications 
where selective intracellular reduction of disulfides would trigger molecular brush 
disassembly and favor polymer clearance in vivo. 
 
Scheme 4.14. “One-pot” end group functionalization of RAFT polymers with thiol-
reactive oxanorbornenes 52 and 56. 
 
Synthesis of Thiol-Reactive oxaNorbornenes. 
 Maleimide-functional (52) and MTS-functional (56) oxanorborne derivatives 
were synthesized according to Schemes 4.15 and 4.16 respectively. Substituted 
oxanorbornedicarboximides are readily synthesized from the Diels-Alder reaction of 
furan and N-substituted maleimides. However, subsequent chemical reactions of 
oxanorbornene intermediates must be conducted at temperatures below 100 °C in order to 
avoid the furan-maleimide retro Diels-Alder reaction.327 Consequently, low temperature 
imide forming reactions were utilized for the synthesis of 52 and 56. Using the method 
developed by Keller and Rudinger,328 reaction of N-methoxycarbonylmaleimide (48) 
with primary amines in saturated NaHCO3 at 0-23 °C affords the corresponding N-
substituted maleimides which precipitated out of the aqueous reaction mixture in 
moderate to high yields and required no additional purification. 
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 Reaction of sodium methanethiosulfonate (55) with primary bromide-functional 
oxanorbornenedicarboximide (54) affords in good yield the MTS-functional product 56. 
In contrast to symmetric disulfides which undergo thiol-disulfide exchange to form a 
mixture of mixed and homo disulfide products, reaction of MTS activated disulfides with 
thiols gives exclusively the mixed disulfide owing to the excellent leaving group ability 
and poor nucleophilicity of the methanesulfinic acid group. Consequently, this selectivity 
has been extensively used to prepared disulfide end-functional RAFT polymers.296 
 
Scheme 4.15. Synthetic route for 52. 
 
 
 
Scheme 4.16. Synthetic route for 56. 
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“One-pot” Synthesis of RAFT Polymer Macromonomers from Thiol-Reactive 
oxaNorbornenes 
 We first synthesized dithiobenzoate-terminated poly(styrene) (57) and poly(N,N-
dimethylacrylamide) (58) as representative RAFT polymers for end group 
functionalization with thiol-reactive oxanorbornenes. Low dispersities and excellent 
agreement between the molecular weights determined by NMR and SEC-MALLS for 57 
(Mn(NMR) = 3090 g/mol, Mn(SEC) = 2980 g/mol, Ð = 1.03) and 58 (Mn(NMR) = 3710 
g/mol, Mn(SEC) = 3630 g/mol, Ð = 1.05) are indicative of controlled RAFT 
polymerization and high dithiobenzoate chain end fidelity. 
 The work in Chapter IV Section III of this dissertation shows that quantitative end 
group functionalization of RAFT polymers using “one-pot” aminolysis/thiol-maleimide 
chemistry is attainable using sequential aminolysis/maleimide addition, less polar 
solvents (e.g. CH2Cl2), and mild reducing agents (e.g. trimethylphosphite) while avoiding 
the use of aprotic nucleophilic catalysts such as amidines and phosphines. Similar 
reaction conditions were used for the reactions of 57 or 58 with 52 as outlined in the 
experimental section. Figure 4.25 shows the 1H NMR spectra of 57 before end group 
modification (Figure 4.25c) and after reaction with 52 (Figure 4.25b). Complete 
aminoylsis of the dithiobenzoate end groups of 57 is observed by noting the 
disappearance of the aromatic protons at 8.0 – 7.3 ppm (Figure 4.25b).  Ultimately, 98% 
end functionalization of 57 is achieved with the characteristic oxanorbornene peaks a, b, 
and c visible in Figure 4.25b. Similarly, reaction of the RAFT polymer 58 with 52 results 
in complete dithiobenzoate aminolysis and near-quantitative (>99%) end group 
functionalization efficiency as determined by 1H NMR (Figure 4.26). Minimal change in 
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Mn(SEC) and Ð of end-modified polymers (59 and 61) compared to the starting RAFT 
polymers (57 and 58) indicates little or no polymeric disulfide coupling (Table 4.6). 
 
Figure 4.25. 1H NMR (300 MHz, acetone-d6) end group analysis of 57, 59, and 60. 

 
Figure 4.26. 1H NMR (300 MHz, D2O) end group analysis of 58, 61, and 62. 
 
 End group functionalization of RAFT polymers 57 or 58 with 56 were also 
performed as “one-pot” reactions. RAFT polymer aminolysis was conducted in the 
presence of 56 using relative ratios of [57/58]0:[56]0:[amine]0 = 1.0:6.0:10. 
1H NMR end 
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group analysis of 56-modified RAFT polymers (60 and 62 respectively) confirms 
quantitative aminolysis of dithiobenzoate end groups along with the appearance of the 
characteristic oxanorbornene peaks. Reactions of 57 or 58 with 62 afforded moderately 
high end group functionalization efficiencies (95% and 94% respectively) with no 
significant change in Mn or Ð compared to the parent RAFT polymers indicating little or 
no polymeric disulfide coupling (Table 4.6). 
Table 4.6 
Summary of end group functionalization of RAFT polymers 57 and 58 with thiol-reactive 
oxanorbornenes 52a and 56.b 
 
entry 
RAFT 
polymer 
Mn(NMR)c 
(g/mol) 
Mn(SEC)d 
(g/mol) 
Ðd 
norb. 
deriv. 
funct.e 
(%) 
Mn(SEC)f 
(g/mol) 
Ðf 
1 (59) 57 3090 2980 1.03 52 98 3290 1.06 
2 (60) 57 3090 2980 1.03 56 96 3360 1.05 
3 (61) 58 3710 3630 1.05 52 >99 3950 1.07 
4 (62) 58 3710 3630 1.05 56 94 3930 1.05 
 
a[57/58]0:[52]0:[amine]0 = 1.0:5.0:2.5. 
b[57/58]0:[56]0:[amine]0 = 1.0:6.0:10. 
c Mn(NMR) was determined by comparing the integral 
area of the dithibenzoate aromatic protons (5H) to either the aromatic protons of 57 or the N,N-dimethyl and methyne protons of 58. 
cTheoretical Mn values were calculated according to the equation Mn,th=(ρMWmon[M]0/[CTA]0) + MWCTA where ρ is the fractional 
monomer conversion, MWmon is the molecular weight of the monomer, and MWCTA is the molecular weight of the CTA.  
dMn(SEC) 
and Ð values of 57 and 58 were determined by SEC-MALLS (DMF 20 mM LiBr). eDetermined by 1H NMR. fMn(SEC) and Ð values 
measured after end group modification. 
Ring Opening Metathesis Polymerization of oxaNorbornene End-Functional RAFT 
Polymers 
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Scheme 4.17. ROMP of -oxanorbornenyl-functionalized macromonomers (59–62) into 
the corresponding molecular brushes (P59–P62). 
 
 The -oxanorbornenyl-functionalized macromonomers (59-62) were next 
polymerized by ROMP using the 3rd Generation Grubbs catalyst (19) (Scheme 4.17). 
Polymerizations were conducted in CH2Cl2 using stoichiometric ratios of [MM]0:[19]0 = 
50:1.0 and allowed to proceed for 6 h prior to termination via the addition of ethyl vinyl 
ether. SEC-MALLS analysis of aliquots taken during preliminary experiments confirmed 
that all reactions reached maximal MM conversion within 6 h. Figure 4.27a shows the RI 
traces for dithiobenzoate-terminated poly(styrene) RAFT polymer before (57) and after 
(59) end-functionalization with 52. 91% MM conversion was reached during the ROMP 
of 59, affording the corresponding molecular brush (P59) of low dispersity and with 
reasonable agreement between Mnth and Mnexp (Mnexp = 159,600 g/mol, Ð = 1.06) (Table 
4.7). Similarly, ROMP of the disulfide-containing MM (60) resulted in 87% MM 
conversion and produced the molecular brush P60 of low dispersity (Mn = 198,200 
g/mol, Ð = 1.04) (Table 4.7). Worth noting is the bimodal shape of the residual MM peak 
following ROMP of 59 and 60 as shown in Figures 4.27a and 4.27b respectively. The 
residual MM peak appearing at longer elution volumes corresponds well with the peak 
elution volume of the respective MM. Meanwhile, the peak exhibiting a lower elution 
volume corresponds well with the high molecular weight shoulder exhibited by the RAFT 
polymer 57 and the resulting MMs (59 and 60). Consequently, the higher elution volume 
peak is likely due to coupled polymer resulting from termination by radical-radical 
coupling during RAFT polymerization. Such coupled polymer would not retain the 
RAFT agent end group and would not be functionalizable by 52 or 56. Nonetheless, these 
results show that macromonomers derived from 57 and thiol-reactive oxanorbornene 
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derivatives 52 and 56 can be polymerized by ROMP to give the corresponding molecular 
brush of low dispersity and of relatively high MM conversion. 
 
 
Figure 4.27. a) SEC RI traces of the parent RAFT polymer (▬ 57), 52-functional 
macromonomer (▬ 59), and corresponding molecular brush (▬ P59). b) SEC RI traces 
of the parent RAFT polymer (▬ 57), 56-functional macromonomer (▬ 60), and 
corresponding molecular brush (▬ P61). 

 SEC RI traces of macromonomers (61 and 62) synthesized from the water soluble 
RAFT polymer poly(N,N-dimethylacrylamide) (58) are shown in Figures 4.28a and 
4.28b respectively. In contrast to the ROMP of poly(styrene)-based MMs (59 and 60), 
ROMP of 61 and 62 exhibited limited MM conversion and yielded molecular brushes of 
broad dispersities as shown in Table 4.7. Despite >99% oxanorbornenyl end group 
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functionalization of 61 and 94% functionalization of 62, ROMP of 61 and 62 only 
reached 57% and 76% conversion respectively in 6 h. Furthermore, extending the 
reaction time beyond 6 h (data not shown) was determined to have no influence on MM 
conversion for the ROMP of 61 or 62. From these observations we hypothesize that 
catalyst 19 is likely degrading due to residual oxygen or as a result of some unforeseen 
degradation reaction. It is well known that polar solvents and functional groups can 
coordinate with Ru-based metathesis catalysts, consequently competing with monomer 
for the catalyst binding site and slowing the rate of ROMP.329 Indeed, the rate of 
polymerization measured during the ROMP of 61 and 62 is slower than that measured for 
the ROMP of the poly(styrene)-based MMs 59 and 60 (data not shown). Therefore it is 
plausible that the dimethylacrylamide side chains coordinate with 19 and slow the rate of 
polymerization enough for degradation of 19 (e.g. oxidation) to occur before complete 
consumption 61 or 62. 
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Figure 4.28. a) SEC RI traces of the parent RAFT polymer (▬ 58), 52-functional 
macromonomer (▬ 61), and corresponding molecular brush (▬ P61). b) SEC RI traces 
of the parent RAFT polymer (▬ 58), 56-functional macromonomer (▬ 62), and 
corresponding molecular brush (▬ P62). 
 
Table 4.7 
ROMP of RAFT-derived macromonomers summary. 
 
entry MM 
MM conv.a 
(%) 
Mnthb 
(g/mol) 
Mnexpc 
(g/mol) 
Ðc 
1 59 91 135,600 159,600 1.06 
2 60 87 129,600 198,200 1.04 
3 61 57 103,500 161,000 1.24 
4 62 76 137,900 141,700 1.23 
 
aMacromonomer conversion was determined from the relative integral areas of the SEC RI traces at t = 0 min and t = 6 h. bTheoretical 
Mn values were calculated according to the equation Mnth=(ρMWMM[MM]0/[19]0) where ρ is the fractional macromonomer conversion 
and MWMM is the molecular weight of the macromonomer. 
cExperimental Mn and Mw/Mn values were determined by SEC-MALLS 
(DMF 20 mM LiBr). 
Reduction-Induced Molecular Brush Disassembly 
 Polymer therapetuics have made extensive use of disulfide reduction as an 
intracellular specific bond-breaking reaction in order to trigger therapeutic agent release 
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and polymer disassembly/degradation following cellular internalization.171 Similarly, we 
envision the use of disulfide-containing molecular brushes as highly branched “delivery 
vehicles” which would exhibit extended circulation times in vivo and undergo reduction-
induced disassembly upon cellular internalization to promote subsequent polymer 
clearance from the body. Accordingly, we investigated the reduction-induced 
disassembly of P62, which is comprised of water soluble poly(N,N-dimethylacrylamide) 
side chains attached to a poly(oxanorbornenedicarboximide) backbone via disulfide 
linkages, under physiological conditions (pH = 7.4 PBS buffer) (Scheme 4.18). DL-
dithiothreitol (DTT) was used as a representative reducing agent at [DTT] = 5 mM in 
accordance with the natural concentration range of glutathione found in mammalian cells 
(1-10 mM). Residual macromonomer present after ROMP of 62 (Figure 4.28) was 
removed by dialysis against water (MWCO = 15 kDa) followed by lyophilization. Figure 
4.29 shows the monomodal SEC RI trace of P62 after dialysis (black trace). 
 
Scheme 4.18. DTT reduction of P62 in pH = 7.4 PBS buffer (10 mM) at 23 °C. 
 
  DTT reduction of P62 was monitored by SEC-MALLS (DMF 20 mM LiBr) by 
injecting aliquots at timed intervals using an autosampler. A solution of P62 in pH = 7.4 
PBS was initially prepared in a GPC vial equipped with piercable cap to give a final 
disulfide concentration of 1 mM. Subsequently, a stock solution of DTT in PBS was 
added to the GPC vial to give a final [DTT] = 5 mM. The first aliquot, which was 
injected 5 min after addition of DTT, is shown in Figure 4.29 (red trace). Remarkably, 
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disappearance of the peak corresponding to P62 is observed by the first aliquot. The 
appearance of a new peak at ~17.5 mL is nearly equivalent to the elution volume of 62 
(elution volume = 17.4 mL). The second new peak with elution volume = 20.2 mL is that 
of the PBS buffer salts. Also worth noting is that precipitation was observed in the GPC 
vial following the addition of DTT and is likely due to the insolubility of the 
poly(oxanorbornenedicarboximide) backbone (Scheme 4.18) in PBS.  
 
Figure 4.29. SEC RI trace of the disulfide-containing molecular brush after purification 
by dialysis (▬ P62) and SEC RI trace (▬) of P62 5 min after the addition of DTT (5 
eq.). P62 molecular brush reduction reactions were performed in pH = 7.4 phosphate 
buffered saline (10 mM) at 23 °C. 
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CHAPTER V 
CONCLUSIONS 
Section 1. Tunable pH- and CO2-Responsive Sulfonamide-Containing 
 Polymers by RAFT Polymerization  
 A series of pMSA polymers with tunable, pH-dependent solubility in aqueous 
media has been synthesized by RAFT polymerization. Initially, polymerizations 
conducted in DMF at 70 °C gave polymers with broad molecular weight distributions, 
but upon reducing the polymerization temperature to 30 °C and employing the low 
decomposition temperature initiator V-70, polymers of narrow molecular weight 
distribution and increased thiocarbonylthio chain end functionality were obtained.  
Selection of the sulfonamide R-group of MSA monomers is a facile means of adjusting 
pKa and ultimately the critical onset of precipitation pH (pH*) of the corresponding 
pMSA. Thus it is possible to “fine tune” pH-dependent polymer solubility in the 
biologically relevant regime (pH = 4.5-7.4). Additionally, we demonstrated, the 
reversible CO2-responsiveness of pMSAs in aqueous media, further indicating the 
potential of pMSAs in biological and nanotherapeutic applications. 
Section 2. Mechanistic Insights into Temperature-Dependent Trithiocarbonate 
Chain-End Degradation during the RAFT Polymerization of N-Arylmethacrylamides 
 Methacrylamide-induced trithiocarbonate degradation during RAFT 
polymerization has been investigated. N-phenyl-promoted nucleophilic attack of the 
terminal trithiocarbonate by the ultimate methacrylamide unit was shown to occur by N-5 
cyclization/elimination, resulting in rapid loss of active chain ends in DMF at 70 °C. The 
3-phenyl-2-thioxothiazolidin-4-one RAFT polymer chain ends resulting from N-5 
cyclization/elimination were shown to have little direct influence on the RAFT process 
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and thus function as “dead” chain ends. Suppression of methacrylamide-induced 
trithiocarbonate degradation during the RAFT polymerization of N-arylmethacrylamides 
can be achieved by reducing the reaction temperature to 30 °C. Work is currently 
underway in our labs to study the influence of N-aryl amide substitution on both the 
reaction mechanism and rate of N-5 cyclization/elimination. 
Section 3. “One-Pot” Aminolysis/Thiol-Maleimide End Group Functionalization 
 of RAFT Polymers: Identifying and Preventing Michael Addition Side Reactions 
 In this work we have elucidated a number of deleterious nucleophile-promoted 
side reactions that occur during the “one-pot” aminolysis/thiol-maleimide end group 
modification of RAFT polymers. Nucleophilic thiol-ene Michael addition catalysts 
including amines, amidines, and phosphines were shown to initiate the anionic 
polymerization of N-methylmaleimide in a range of solvents with the rate of reaction 
increasing with solvent polarity. We also demonstrated that in more polar solvents, thiols 
can initiate the anionic polymerization of maleimides when [Mal] > [thiol]. Mechanistic 
evidence of TEA-catalyzed enolate formation of the thiol-maleimide adduct was acquired 
using proton-deuterium exchange experiments of thiol-maleimide adducts and used to 
prove that thiol-maleimide adducts were capable of direct initiation of maleimide 
polymerization in the presence of a weak base. Ultimately, optimal reaction conditions 
for the selective and near quantitative “one-pot” end group modification of RAFT 
polymers using thiol-maleimide chemistry was identified  
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Section 4. Growth-Then-Coupling Method of Molecular Brush Synthesis from RAFT 
Polymers and Thiol-Reactive Oxanorbornenes 
This section details a new “grafting through” synthetic route towards molecular brushes 
capable of intracellular-induced disassembly. RAFT polymer-derived macromonomers 
were synthesized using “one-pot” aminolysis/thiol reactions with maleimide- or 
methanethiosulfonate-functional oxanorbornenes. Subsequent ring opening metathesis 
polymerization (ROMP) of the resulting macromonomers afforded molecular brushes 
with RAFT polymer side chains attached to a polyoxanorbornene backbone via either 
permanent thioether linkages or reversible disulfide linkages. Molecular brushes 
comprised of disulfide linkages were shown to undergo reduction-induced disassembly 
and show promise a new class of stimuli-responsive polymer therapeutics.
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APPENDIX A 
SUPPORTING INFORMATION 
 
Figure A1. Mn versus % conversion for 37-mediated polymerization of 33 at 70 °C. 

 
Figure A2. Mn versus % conversion for 37-mediated polymerization of 34 at 70 °C. 

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Figure A3. Mn versus % conversion for 37-mediated polymerization of 33 at 30 °C. 

 
Figure A4. Mn versus % conversion for 37-mediated polymerization of 34 at 30 °C. 

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Figure A5. Beer-Lambert plot and molar extinction coefficients (ε) for 37, 41, and 42 in 
acetonitrile measured using a Lambda 35 UV-vis spectrometer (λ = 320 nm). 

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Figure A6. (a) 1H NMR (600 MHz, DMF-d7) spectrum of 1-dodecanethiol, (b) 
1H NMR 
(600 MHz, DMF-d7) spectrum acquired at t = 491 min during the in situ degradation 
analysis of 41 at 70 °C, (c) 1H NMR (600 MHz, DMF-d7) spectrum of 40. Peaks of 
interest corresponding to degradation byproducts formed during in situ degradation 
analysis (Figure A6b) are colored red and blue and correspond well with key peaks of 
analogous compounds 1-dodecanethiol (red) and 40 (blue) (Figures A6a and A6c 
respectively). 

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Figure A7. Expanded region (3.00 - 0.5 ppm) of the 1H NMR (600 MHz, DMF-d7) 
spectrum acquired at t = 5 min during in situ degradation analysis of 41 at 70 °C. 

 
Figure A8. Expanded region (3.00 - 0.5 ppm) of the 1H NMR (600 MHz, DMF-d7) 
spectrum acquired at t = 491 min during in situ degradation analysis of 41 at 70 °C. 
Overlapping peaks are colored red or blue for improved visualization. 
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Figure A9. a) 1H NMR spectrum of E2MP in DMSO-d6 at T = 0 min. b) 
1H NMR 
spectrum during the reaction of E2MP and 65 in DMSO-d6 at T = 3 min. Disappearance 
of the thiyl (peak c) and methyne (peak d) protons of E2MP confirm quantitative thiol 
conversion by 3.0 min. 
 
 
 
Figure A10. a) 1H NMR spectrum of E2MP in MeCN-d3 at T = 0 min. b) 
1H NMR 
spectrum during the reaction of E2MP and 65 in MeCN-d3 at T = 2.3 min. Disappearance 
of the thiyl (peak c) and methyne (peak d) protons of E2MP confirm quantitative thiol 
conversion by 2.3 min 

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Figure A11. a) 1H NMR spectrum of E2MP in CD2Cl2 at T = 0 min. b) 
1H NMR 
spectrum during the reaction of E2MP and 65 in CD2Cl2 at T = 2.5 min. Disappearance 
of the thiyl (peak c) and methyne (peak d) protons of E2MP confirm quantitative thiol 
conversion by 2.5 min. 

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Figure A12. Effect of solvent on the time-dependent fractional change in [Mal]/[Mal]0 
during the reaction of TEA with 65 as measured by in situ 1H NMR analysis. 
 
 
Figure A13. Effect of solvent on the time-dependent fractional change in [Mal]/[Mal]0 
during the TEA-catalyzed reaction of HexAM with 65 as measured by in situ 1H NMR 
analysis. 

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Figure A14. 1H NMR (300 MHz, D2O) spectrum of 45. 
 
 
Figure A15. Representative 1H NMR (300 MHz, D2O) spectrum of 46-functionalized 45 
(Table 4.5 entry 1a). 

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Figure A16. 1H NMR spectrum (300 MHz, CDCl3) of 52. 
 
Figure A17. 1H NMR spectrum (300 MHz, CDCl3) of 56. 

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APPENDIX B 
N-ARYLAMIDE NUCLEOPHILICITY 
Overview 
 Previously, we described the unique influence of N-phenyl methacrylamide 
substitution on the limited RAFT polymerization control of methacryloylsulfonamides 
(27-32)97 and N-phenylmethacrylamide (33)330 at 70 °C in DMF. We showed that chain 
end degradation during the trithiocarbonate-mediated polymerization of 33 at elevated 
temperatures occurs by N-5 nucleophilic attack of the terminal thiocarbonyl moiety by 
the ultimate methacrylamide unit. Although mechanistic insights were gained into the 
specific degradation pathway (N-5 cyclization/elimination) as discussed in Chapter IV 
Section II, the nature of the true nucleophilic species involved in N-5 cyclization and the 
influence of N-phenyl amide substitution is still not understood. The purpose of this work 
is to better understand the influences of N-phenyl substitution on amide nucleophilicty 
and develop a fundamental understanding of how substituents influence the mechanism 
of amide-based nucleophilic reactions. 
 
Scheme A1. Influence of ionized (A2) or conjugate base (A4) resonance forms on amide 
nucleophilicity. 
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 The structures and reactivity of neutral amides (A1) are greatly influenced by the 
ionized resonance form (A2) whereby the lone pair on nitrogen is delocalized onto the 
carbonyl oxygen, increasing the double bond character of the C-N bond and increasing 
the electron density of the carbonyl oxygen atom (Scheme A1). Consequently, N-
substituted amides exhibit planar structures due to restricted C-N bond rotation and react 
with electrophiles via the oxygen atom to afford the O-substituted product (A3). 
Alternatively, amide anions derived from protic amides and strong bases (e.g. NaH) (A4), 
react with electrophiles almost exclusively via the nitrogen atom to give the N-substituted 
product (A5). Selective reaction of amide anions at the nitrogen atom has been 
rationalized using the “hard and soft Lewis acids and bases” (HSAB) theory which 
attempts to predict/explain the outcomes of substitution reactions involving ambident 
nucleophiles (i.e. nucleophiles with two potential nucleophilic sites). HSAB theory can 
be applied to ambident nucleophiles such as amide anions by way of Kornblum’s rule 
which states: 
“… hard acids prefer hard bases and soft acids prefer soft bases. In an SN1 
mechanism, the nucleophile attacks a carbocation, which is a hard acid. In 
an SN2 mechanism, the nucleophile attacks the carbon atom of a molecule, 
which is a softer acid. The more electronegative atom of an ambident 
nucleophile is a harder base than the less electronegative atom. Therefore, 
as the character of a given reaction changes from SN1 to SN2 like, an 
ambident nucleophile becomes more likely to attack with its less 
electronegative atom.”331 
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In other words, SN2 reactions involving amide anions will proceed via the less 
electronegative nitrogen atom ( = 3.0) rather than more electronegative oxygen atom ( 
= 3.5), where  is the Pauling electronegativity value. This adequately describes the 
selectivity in forming the N-substituted product A5 upon reaction of amide anion A4 with 
an electrophilic species by an SN2 mechanism as shown in Scheme A1. However, 
according to these theories, the neutral amide of 41 should react via the oxygen atom to 
give O-5 cyclization/elimination products (41B) rather than the observed N-5 
cyclization/elimination products (41A) as shown in Scheme A2. The key to 
understanding this mechanism and its products must therefore lie in the role of N-aryl 
substitution on amide nucleophilicity. 
 
 
Scheme A2. Proposed degradation of 41 by N-5 cyclization/elimination (pathway A). 
 
 In Chapter IV Section II we show that i) N-phenyl methacrylamide substitution 
increases the observed rate of trithiocarbonate degradation of 41 compared to N-benzyl 
substitution (42) and ii) degradation of 41 proceeds by N-5 cyclization/elimination. We 
can rationalize these observations if N-phenyl substitution promotes amide N-H 
dissociation to give the amide anion (and solvated proton) where the amide anion is the 
true nucleophilic species. As shown in Scheme A3, dissociation of an N-arylamide (A6) 
affords the corresponding amide anion with O- and N-based resonance structures A7 and 
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A8 respectively. However, direct N-aryl substitution provides additional resonance forms 
A9-A11 that can further stabilize the amide anion. These additional resonance forms 
should reduce the pKa of A6 by stabilizing the conjugate base and consequently shift the 
equilibrium towards the dissociated amide anion species ([CON¯Ph]) compared to an 
analogous amide with N-alkyl substituents. Indeed, comparison of the literature pKa 
values of N-methylacetamide (pKa = 25.9, DMSO)
332 and N-phenylacetamide (pKa = 
21.5, DMSO)333 confirms the influence of N-aryl substitution on increased amide acidity 
in polar organic solvents. From these observations, we hypothesize that N-aryl 
substitution decreases the pKa of 41 and consequently increases [CON
¯Ph], accounting 
for the increased rate of degradation by N-5 cyclization/elimination as compared to 42. 
 
 
Scheme A3. Possible N-arylamide conjugate base resonance forms. 
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 To test this hypothesis, we have synthesized single monomer unit insertion 
adducts A12 and A13 which possess either electron withdrawing p-chloro or electron 
donating p-methoxy groups respectively (Figure A18). According to our theory, the 
electron withdrawing p-chloro substituent of A12 should decrease the amide pKa and 
consequently increase the amide anion concentration ([CON¯PhCl]) resulting in an 
increased rate of degradation by N-5 cyclization/elimination as compared to 41. 
Conversely, electron donating p-methoxy substitution should increase the amide pKa of 
A13 relative to 41 and decrease the rate of degradation by N-5 cyclization/elimination as 
compared to 41. Meanwhile we have already shown in Chapter IV Section II that 41 
degrades significantly faster than 42 by N-5 cyclization/elimination. It should therefore 
hold true that pKa41 < pKa42. Indirect evidence of the relative pKa values of 41 and 42 can 
be inferred by noting the relative chemical shifts of the amide N-H protons in Figures 
4.16 and 4.17 respectively (Chapter IV Section II). The N-H chemical shift (600 MHz, 
DMF-d7) of 41 (9.64 ppm) is significantly downfield shifted compared to the N-H 
chemical shift of 42 (8.34 ppm). Greater deshielding of the N-H proton of 41 relative to 
42 is indicative of increased acidity (lower pKa). 
 
Figure A18. Proposed inverse relationship between amide pKa and apparent amide 
nucleophilicity. 
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 In this work, we will study the influence of amide substituent, solvent polarity, 
temperature, and acid/base catalysis on the kinetics of N-5 cyclization/elimination of the 
SMUI adducts 41, 42, A12, and A13 in order to test our theory of N-arylamide 
nucleophilicity. This work is currently on-going and therefore the following results and 
conclusions are incomplete. However, the results reported herein thus far support our 
current theory of N-arylamide nucleophilicity. 
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Experimental 
4-Chlorophenylmethacrylamide A14 
 
 Methacryloyl chloride (5.83 mL, 59.7 mmol) was added dropwise over 15 min to 
a stirred solution of 4-chloroaniline (7.25 g, 56.8 mmol) and triethylamine (8.32 mL, 59.7 
mmol) in CH2Cl2 (150 mL) that was previously cooled using an ice bath. Upon complete 
addition of methacryloyl chloride, the reaction was stirred at 0 °C for 30 min followed by 
stirring at room temperature for an additional 60 min. The reaction mixture was then 
transferred to a separatory funnel and washed with 0.1 N HCl (1 × 150 mL), saturated 
NaHCO3 (1 × 150 mL), and saturated NaCl (brine) (1 × 150 mL) before drying over 
MgSO4. The solvent was removed via rotary evaporation and the isolated solids 
recrystallized from hot hexanes:THF (90:10) to yield A14 (10.05 g, 90%) as colorless 
needle-like crystals. 1H NMR (300 MHz, CDCl3): δ 7.52 (s, 1H), 7.43 (d, 2H), 7.23 (d, 
2H), 5.72 (s, 1H), 5.40 (s, 1H), 1.98 (s, 3H). 
4-Methoxyphenylmethacrylamide A15 
 
 Methacryloyl chloride (5.83 mL, 59.7 mmol) was added dropwise over 15 min to 
a stirred solution of p-anisidine (7.00 g, 56.8 mmol) and triethylamine (8.32 mL, 59.7 
mmol) in CH2Cl2 (150 mL) that was previously cooled using an ice bath. Upon complete 
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addition of methacryloyl chloride, the reaction was stirred at 0 °C for 30 min followed by 
stirring at room temperature for an additional 60 min. The reaction mixture was then 
transferred to a separatory funnel and washed with 0.1 N HCl (1 × 150 mL), saturated 
NaHCO3 (1 × 150 mL), and saturated NaCl (brine) (1 × 150 mL) before drying over 
MgSO4. The solvent was removed via rotary evaporation and the isolated solids 
recrystallized from hot hexanes:THF (90:10) to yield A15 (7.60 g, 70%) as colorless 
needle-like crystals. 1H NMR (300 MHz, CDCl3): δ 7.38 (d, 3H), 6.79 (d, 2H), 5.71 (s, 
1H), 5.37 (s, 1H), 3.73 (s, 2H), 1.99 (s, 3H). 
Synthesis of A12 
 
 A solution of 27 (3.41 g, 9.9 mmol), A14 (1.93 g, 9.9 mmol), and V-70 (0.609 g, 
2.0 mmol) in DMF (35 mL) was prepared in a round bottomed flask equipped with 
magnetic stir bar and the reaction degassed via three freeze-pump-thaw cycles and 
backfilled with argon. The reaction mixture was heated at 30 °C in an oil bath for 48 h, 
followed by exposure to air and freezing in liquid N2. The reaction mixture was then 
diluted with EtOAc (150 mL) and transferred to a separatory funnel and washed with 
75% brine (1 × 150 mL), H2O (1 × 150 mL), brine (1 × 150 mL), and dried over MgSO4. 
The crude product was then purified by column chromatography (85:15 Hexanes:EtOAc, 
Rf = 0.20) yielding A12 (0.427 g, 8%) as a yellow solid. 
1H NMR (300 MHz, CDCl3): δ 
8.41 (s, 1H), 7.32 (d, 2H), 7.23 (d, 2H), 3.20 (t, 2H), 2.47 (s, 2H), 1.95 (s, 3H), 1.56 (b, 
2H), 1.41 (d, 6H), 1.18 (b, 18H), 0.81 (t, 3H). 
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Synthesis of A13 
 
 A solution of 27 (3.41 g, 9.9 mmol), A15 (1.89 g, 9.9 mmol), and V-70 (0.609 g, 
2.0 mmol) in DMF (35 mL) was prepared in a round bottomed flask equipped with 
magnetic stir bar and the reaction degassed via three freeze-pump-thaw cycles and 
backfilled with argon. The reaction mixture was heated at 30 °C in an oil bath for 48 h, 
followed by exposure to air and freezing in liquid N2. The reaction mixture was then 
diluted with EtOAc (150 mL) and transferred to a separatory funnel and washed with 
75% brine (1 × 150 mL), H2O (1 × 150 mL), brine (1 × 150 mL), and dried over MgSO4. 
The crude product was then purified by column chromatography (75:25 Hexanes:EtOAc, 
Rf = 0.28) yielding A13 (0.452 g, 9%) as a yellow solid. 
1H NMR (300 MHz, CDCl3): δ 
8.26 (s, 1H), 7.26 (d, 2H), 6.78 (d, 2H), 3.72 (s, 3H), 3.21 (t, 2H), 2.48 (s, 2H), 1.96 (s, 
3H), 1.58 (b, 2H), 1.40 (d, 6H), 1.18 (b, 18H), 0.81 (t, 3H). 
In situ 1H NMR Analysis 
 A representative procedure is as follows: A solution of 41 (2 × 10-2 M) in DMSO-
d6 (0.6 mL) was prepared in an NMR tube equipped with pierceable rubber septum and 
the solvent degassed by two freeze-pump-thaw cycles followed by backfilling the NMR 
tube with argon. 1H NMR spectra were acquired at predetermined temperatures using a 
Bruker Ascend™ 600 MHz spectrometer. 
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Results and Discussion 
 If the rate determining step of N-5 cyclization/elimination of 41 is dependent 
upon [CON¯Ph], a non-nucleophilic base should catalyze the reaction by promoting the 
formation of the nucleophilic CON¯Ph species. To this end, we examined the effect of 
triethylamine (TEA) (pKa = 9.00, DMSO)
334 as a base catalyst for N-5 
cyclization/elimination of 41 in DMSO-d6 at room temperature (23 °C). As shown in 
Figure A19, 100% degradation of 41 was observed within the time required to obtain the 
first spectrum (5 min) with peaks corresponding to the degradation byproducts given 
prime designation. In contrast, the half life of 41 in DMF-d7 at 70 °C in the absence of 
TEA was measured to be t1/2 = 7.18 h (Chapter IV Section II). 
 
 
Figure A19. 1H NMR (300 MHz, DMSO-d6) overlay following the TEA-catalyzed 
degradation of 41 at room temperature. 
 
 Base-catalyzed degradation of 41 is evidence of the rate determining step of N-5 
cyclization/elimination being dependent upon [CON¯Ph]. Consequently, we can develop 
a kinetic theory based upon Scheme A2 where the rate of irreversible trithiocarbonate 
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(TTC) degradation due to intramolecular nucleophilic attack by an adjacent amide can be 
expressed as follows: 
 𝑅𝑎𝑡𝑒 =  −
𝑑[𝑇𝑇𝐶]
𝑑𝑡
=  𝑘𝑎𝑝𝑝[𝐶𝑂𝑁𝐻𝑅]𝑡𝑜𝑡 (A1) 
 
where [TTC] is the concentration of 41, [CONHR]tot is the total concentration of 
associated and dissociated amide, and kapp is the apparent rate constant for intramolecular 
nucleophilic attack. Assuming that nucleophilic attack (pathway A and/or B, Scheme A2) 
is the rate determining step, the total rate of trithiocarbonate degradation can be expressed 
as the sum of the rates of degradation by both N-5 and O-5 intramolecular nucleophilic 
attack: 
 −
𝑑[𝑇𝑇𝐶]
𝑑𝑡
=  𝑘1[𝐶𝑂𝑁¯𝑅] + 𝑘2[𝐶𝑂𝑁𝐻𝑅] (A2) 
 
where [CON¯R] is the concentration of amide anion, [CONHR] is the concentration of 
neutral amide, and k1 and k2 are the first order rate constants for N-5 and O-5 nuclephilic 
attack respectively. We have shown that degradation of 41 occurs exclusively by N-5 
cyclization such that k2 = 0. This allows for simplification of Eq A2 to the following: 
 −
𝑑[𝑇𝑇𝐶]
𝑑𝑡
=  𝑘1[𝐶𝑂𝑁¯𝑅] (A3) 
 
The quantity [CON¯R], which cannot be measured directly, can be determined from the 
measurable quantity [CONHR] and the dissociation constant (Ka) according to the 
equilibrium shown in Eq A4. 
 [𝐶𝑂𝑁𝐻𝑅] ⇆  [𝐶𝑂𝑁¯𝑅][𝐻+] (A4) 
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 𝐾𝑎 =
[𝐶𝑂𝑁¯𝑅][𝐻+]
[𝐶𝑂𝑁𝐻𝑅]
  (A5) 
 
In the absence of external acid or base, [CON¯R] = [H+] such that: 
 [𝐶𝑂𝑁¯𝑅] = 𝐾𝑎
1
2[𝐶𝑂𝑁𝐻𝑅]
1
2 (A6) 
 
Substitution of Eq A6 into Eq A3 gives: 
 −
𝑑[𝑇𝑇𝐶]
𝑑𝑡
= 𝑘1𝐾𝑎
1
2[𝐶𝑂𝑁𝐻𝑅]
1
2 (A7) 
 
The total trithiocarbonate concentration [TTC], which is equal to the total amide 
concentration ([CONHR]tot) can be expressed as: 
 [𝑇𝑇𝐶] = [𝐶𝑂𝑁𝐻𝑅]𝑡𝑜𝑡 = [𝐶𝑂𝑁𝐻𝑅] + [𝐶𝑂𝑁¯𝑅] (A8) 
 
When Ka is small and [CONHR] >> [CON
¯R], Eq A8 simplifies to [TTC] = [CONHR] 
and can be substituted into Eq A7 to give: 
 −
𝑑[𝑇𝑇𝐶]
𝑑𝑡
= 𝑘1𝐾𝑎
1
2[𝑇𝑇𝐶]
1
2 (A9) 
 
Integration of Eq. A9 using the integral form of an nth order rate equation (Eq A10) gives 
the final integrated rate equation of trithiocarbonate degradation by N-5 cyclization (Eq. 
A11). 
 
1
[𝐴]𝑛−1
=
1
[𝐴]0
𝑛−1 + (𝑛 − 1)𝑘𝑡 (A10) 
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 [𝑻𝑻𝑪]
𝟏
𝟐 = [𝑻𝑻𝑪]𝟎
𝟏
𝟐 −
𝟏
𝟐
𝒌𝟏𝑲𝒂
𝟏
𝟐 𝒕 (A11) 
 
According to Eq A11, plotting [TTC]1/2 versus time will give the y-intercept = [TTC]0
1/2 
and slope = -(1/2)k1Ka
1/2. 
 
 
Figure A20. [TTC]1/2 vs time plots for the degradation of 41 and 42 in DMF-d7 at 70 °C 
([TTC]0 = 0.0329 M). 
 
 We next used Eq A11 to replot the kinetic data obtained previously for the 
degradation reactions of 41 and 42 from Figures 4.18a and 4.18b respectively (Chapter 
IV Section II). As shown in Figure A20, the graph of [TTC]1/2 vs time yields linear plots 
for the degradation of 41 and 42 in DMF-d7 at 70 °C. The k1Ka
1/2 values for 41 and 42 in 
DMF at 70 °C were calculated from the slopes of the linear plots in Figure A20 to be 2.22 
× 10-4 M1/2 s-1 and 1.86 × 10-5 M1/2 s-1 respectively. However, in order for k1 to be 
determined, Ka for the amide must be known. 
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 While Ka for the amides of interest in this study (41, 42, A12, A13) could be 
measured by potentiometric or photometric titrations in DMSO using a strong base such 
as sodium dimsyl,335 rapid trithiocarbonate degradation would likely occur due to 
nucleophilic attack of the thiocarbonyl by the dimsyl anion and also as a result of base-
catalyzed N-5 cyclization. Therefore an alternative method of determining Ka in situ is 
desired. This can be accomplished by disturbing the amide dissociation equilibrium (Eq 
4) via the addition of a known amount of strongly dissociating “super acid,” such as bis 
trifluoromethanesulfonimide, and measuring the effect of [H+] on kapp (Eq 1) which is a 
function of both k1 and Ka. If the dissociation constant of the acid (Ka,acid) is suitably large 
compared to Ka of the amide, [H
+]≈[HX] where [HX] is the concentration of externally 
added acid. The relationship between [HX] and [CON¯R] can then be expressed as 
follows: 
 [𝐶𝑂𝑁¯𝑅] =
𝐾𝑎[𝐶𝑂𝑁𝐻𝑅]
[𝐻𝑋]
 (A12) 
 
Combination of Eq A1, Eq A3, and Eq A12 gives: 
 𝑘𝑎𝑝𝑝[𝑇𝑇𝐶] =
𝑘1𝐾𝑎[𝐶𝑂𝑁𝐻𝑅]
[𝐻𝑋]
 (A13) 
 
Recalling that [TTC]≈[CONHR], Eq A13 can be simplified to: 
 𝒌𝒂𝒑𝒑 =
𝒌𝟏𝑲𝒂
[𝑯𝑿]
 (A14) 
 
Plotting kapp vs. [HX]
-1 would yield a slope = k1Ka. Ka can then be determined by 
combining the slopes from Eq A11 and Eq A14: 
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 𝑘1 =
−2𝑠𝑙𝑜𝑝𝑒1
𝐾𝑎
1
2
 (from Eq 11) (A15) 
 
 𝑘1 =
𝑠𝑙𝑜𝑝𝑒2
𝐾𝑎
  (from Eq 14) (A16) 
 
 𝑲𝒂 =
𝟏
𝟒
(
𝒔𝒍𝒐𝒑𝒆𝟐
𝒔𝒍𝒐𝒑𝒆𝟏
)
𝟐
 (A17) 
 
where slope1 is the slope of [TTC]
1/2 vs. time plot (Eq A11) and slope2 is the slope of kapp 
vs. [HX]-1 plot (Eq A14). 
 Despite not yet knowing the Ka values for the amides of interest in this study, we 
can make the following predictions regarding the influence of amide substituents on the 
values of k1 and Ka for uncatalyzed N-5 cyclization/elimination reactions. 
 
1) Electron withdrawing substituents will increase the value of Ka. 
 
Electron withdrawing substituents will stabilize the conjugate base of the amide and thus 
shift the equilibrium towards the dissociated amide anion thus increasing the value of Ka. 
 
2) Electron withdrawing substituents will reduce the value of k1. 
 
At first this seems counterintuitive since we predict that electron withdrawing 
substituents will increase the rate of degradation by N-5 cyclization/elimination. 
However, k1 is a function of the relative nucleophilicity of the amide anion. Electron 
withdrawing substituents will increase the stability of the amide anion relative to electron 
donating substituents and consequently reduce the nucleophilicity (and reduce k1) of the 
amide anion. Accordingly, we predict that electron withdrawing stubstituents will cause 
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Ka
1/2 to increase more than k1 will decrease, such that the product of k1Ka
1/2, which is 
directly proportional to the rate of degradation by N-5 cyclization, will increase. In other 
words, the increase in concentration of the nucleophilic species [CON¯Ph] more than 
compensates for the reduced nucleophilicity of that species. 
 We can initially evaluate these predictions if we assume the pKa values of 41 and 
42 in DMF-d7 are similar to the pKa values of N-phenylacetamide (pKa = 21.5, DMSO) 
and N-methylacetamide (pKa = 25.9, DMSO) respectively. Using these estimated pKa 
values for 41 and 42 along with the k1Ka
1/2 values determined previously from the slopes 
of the kinetic plots in Figure A20, we calculated the k1 values for degradation by N-5 
cyclization/elimination of 41 and 42 to be 1.25 × 107 M1/2 s-1 and 1.66 × 108 M1/2 s-1 
respectively. As predicted, the k1 value of the more acidic amide (41) is lower (by ~1 
order of magnitude) than the k1 value for the less acidic amide (42) despite the rate of N-
5 cyclization/elimination of 41 being greater than that of 42. 
Conclusions 
 We have estabilised a mechanistic theory in order to explain the influence of N-
aryl substitution on the observed relative rates of N-5 cyclization/elimination of 41 and 
42 at elevated temperatures. In addition, we have developed a kinetic model based upon 
the “amide dissociation mechanism” which thus far fits the previously obtained kinetic 
data. We also show that degradation by N-5 cyclization/elimination is base catalyzed and 
we are currently investigating the influence of electron withdrawing/donating substituents 
and solvent polarity on the N-5 cyclization/elimination rate constants (k1) and 
dissociation constants (Ka) of select amides. Ultimately, this work has the potential to 
provide greater insights into the nucleophilic character of amides. 
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